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 Abstract  
Despite significant advances in recent years, our fundamental understanding and the ability to 
predict and control the polymorphic outcome of the crystallisation process remains limited. 
The aim of this work is to investigate how manipulation of the process conditions and 
application of new experimental strategies may provide new modes of polymorph selection 
during crystallisation from solution.  
In the first part of this thesis, batch crystallisation of pure and glycine-doped L-glutamic acid 
was investigated using single-photon laser light scattering and synchrotron wide angle X-ray 
scattering (WAXS) techniques. Surprisingly, in the presence of the additive, a marked 
increase in the amount of homogeneously nucleated β was observed, ultimately leading to  
a significant enhancement in the polymorphic transformation rate. Thus, for the first time, it 
was demonstrated that the crystallisation rates of one amino acid can be promoted using 
another amino acid as a doping material.  
The second part of this work focuses on the containerless crystallisation of L-glutamic acid 
from a droplet in an acoustic levitator. Using in-situ WAXS and Raman spectroscopy 
measurements, it was found that, contrary to the Ostwald’s rule of stages, the more stable β is 
the first and only polymorph that forms. The metastable α did not nucleate even in the 
presence of the additives that have previously been reported to stabilise the metastable 
polymorph. It was postulated that the previously unreported selective crystallisation is due to 
a lower nucleation barrier for β at the surface of a droplet when compared to the 
centrosymmetric bulk.  
The entirely new effects presented in this work demonstrate how changing the crystallisation 
conditions may perturb the initial series of nucleation events and ultimately have a significant 
effect on the subsequent polymorphic transformation and thus on the crystallisation process 
as a whole. Furthermore, these original findings open new avenues of research and raise 
many fundamental questions on how nature finds intriguing ways to help crystallisation of 
the more stable polymorphic form. From the industrial standpoint, the insights derived from 
this study may contribute to the design of new nucleation and transformation modulators.  
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Introduction  
Crystallisation is a complex process where a particular substance undergoes a phase transition 
from solution, melt or more rarely vapour to the crystalline solid state. The solid resulting 
from the process, a crystal, has an ordered internal arrangement of molecules. Some 
molecules, however, have the ability to adopt different arrangements in the solid state. This 
phenomenon is commonly referred to as polymorphism and can greatly complicate efforts to 
control the crystalline form of the compound of interest. Despite many years of scientific 
endeavour, our fundamental understanding of the molecular mechanisms occurring in the 
crystallisation of polymorphic materials from solution remains one of the greatest challenges 
in science. Fortunately, the recent advances in both experimental and computational methods 
are beginning to provide new insights into the crystallisation process.  
Over the past years, there has been an increased interest in controlling the crystallisation 
pathways using molecular additives. It has been shown that such additives can influence 
nucleation and growth rates and even lead to selective formation of a particular polymorphic 
form. The latter appears to be of critical importance since different polymorphs may have 
very different physical properties, such as solubility, crystal morphology or melting point. 
Since molecular crystals make up a large number of substances produced by the chemical 
industry, from pharmaceuticals and cosmetics through food and agricultural products to 
specialty chemicals, the ability to manipulate the crystal structure and therefore material 
properties is of great academic and industrial interest.  
The initial motivation for this work was to investigate the previously unreported polymorphic 
transformation promoting effect of glycine serendipitously discovered by the author during 
studies on the influence of various amino acid additives on the crystallisation process of  
L-glutamic acid. The goal was to provide insights into the underlying molecular mechanisms 
responsible for the observed effect and, in particular, explore the effect of the additive on the 
nucleation process, the most critical stage which defines the overall time dependent 
crystallisation evolution of the system. Additionally, during the course of the project, the 
opportunity arose to, for the first time, study the crystallisation behaviour of L-glutamic acid 
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from a droplet of solution suspended in an acoustic levitator. The containerless crystallisation 
technique is considered to be of particular interest since it allows exploring the nucleation and 
crystal growth phenomena without any surface contributions of a conventional reaction 
vessel.  
We believe that the findings from this research would be interesting and stimulating for both 
industrial and scientific communities. The generic nature of the work presented in this thesis 
should open new research avenues for a comprehensive appreciation of the overall 
complexity of the crystallisation of polymorphic materials, from clean metastable solution via 
polymorphic transformation to stable crystalline phase. The insights derived from these studies 
could facilitate the design of potent new synthetic nucleation and transformation modulators for 
diverse polymorphic systems. Ultimately, this would allow better control of the polymorph 
selection process in a wide range of crystalline materials.  
 16 
Project objectives  
In light of the presented research challenges, the following aims and objectives have been set for 
this project:  
(i) At constant initial supersaturation and crystallisation temperature, investigate the 
effect of various levels of glycine on the nucleation and polymorphic 
transformation times of L-glutamic acid.  
(ii) Determine mole fractions and the corresponding mole fraction rates evolutions of 
metastable α and stable β form of L-glutamic acid for the conditions defined in (i).  
(iii) Compare these evolutions with the simultaneously measured concentration 
evolutions and find a correlation between them.  
(iv) Find the physical reasons and mechanism by which the additive enhances the 
kinetics of growth/dissolution of the two forms, and hence the polymorphic 
transformation time.  
(v) Establish the concentration range at which the promoting effect of glycine is 
present.  
(vi) At constant crystallisation temperature and starting from saturated solution, 
investigate nucleation and growth of L-glutamic acid during crystallisation from  
a pure droplet and in the presence of additives.  
(vii) Propose a qualitative model explaining why under conditions defined in (vi) the 
nucleation process results in formation of a different polymorph than expected.  
(viii) Examine the effect of additives on the growth process for the conditions defined  
in (vi) and determine a mechanism by which the additives operate.  
 17 
Key contributions  
The key contributions of this work are:  
(i) For the first time, it was demonstrated that glycine used as an additive promotes 
primary nucleation of the stable β form of L-glutamic acid, ultimately leading to  
a significant increase in the subsequent polymorphic transformation.  
(ii) It was shown that, contrary to the Ostwald’s rule of stages, the more stable  
β is the first and only polymorph that forms during crystallisation of L-glutamic 
acid from a levitated droplet.  
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Thesis structure  
Following the introduction, this thesis is organised into the following chapters.  
Chapter 1 introduces the basic concepts in the field of crystallisation and presents the main 
nucleation and crystal growth theories on which this research is based. Chapter 2 contains  
a literature review covering the crystal structures and physical data of L-glutamic acid 
polymorphs and surveys previous work related to the topic of this study. The experimental 
methods, procedures and materials used in this work are outlined in Chapter 3.  
Chapters 4 and 5 cover batch crystallisation studies of L-glutamic acid. In Chapter 4, the 
effect of various levels of glycine on the nucleation and polymorphic transformation rates is 
investigated using laser light scattering and concentration monitoring techniques. The 
evolution of polymorphic mole fractions studied under the same experimental conditions 
using WAXS is presented and thoroughly discussed in Chapter 5.  
Chapter 6 considers nucleation and crystal growth of L-glutamic acid during crystallisation 
from a levitated droplet. Studies of pure solution and solution doped with various levels of 
other amino acid additives were carried out using in-situ WAXS, Raman spectroscopy and 
droplet size monitoring techniques.  
The final conclusions and recommendations for further work are presented in Chapters 7  
and 8, respectively.  
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Chapter 1  
Theoretical background  
Crystallisation is a complex process where a particular substance undergoes a phase 
transition from liquid, melt or rarely gas to the solid state with an ordered three-dimensional 
molecular array that we call a crystal. The crystallisation process can be divided into three 
stages: generation of the supersaturation condition, nucleation and crystal growth.  
The following chapter provides essential background and introduces concepts related to 
nucleation and crystal growth.  
1.1 Crystals and crystal structures  
1.1.1 Crystalline and amorphous state  
In the solid state, one of the three general states of matter, molecules are packed closely 
together, the intermolecular interactions are strong and, consequently, atomic motion is 
confined to vibration about a mean position. At a given temperature, a solid material has 
fixed shape and volume. The structure of a solid is rigid and generally resists compression 
very strongly.  
Depending on the structural order of a solid, it can be classified as amorphous or crystalline. 
In an amorphous solid, structural units are arranged in a random manner and there is no long-
range atomic order, although some local ordering can still be present (Figure 1.1a). Atoms of 
a crystalline solid are arranged in regular repeating three-dimensional pattern (Figure 1.1b) 
(McKie and McKie, 1974). The regular repetition of the individual entities over distances 
equivalent to many thousands of atomic dimensions gives rise to characteristic properties of 
crystalline materials:  
 Strictly defined melting point  
 Variation of physical properties with the direction in which they are measured 
(anisotropy)  
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 Constant angles between crystal faces for a given crystalline material  
 Crystal symmetry  
1.1.2 Unit cell  
A perfect crystal is composed of atoms, molecules or ions arranged in a pattern that repeats 
regularly in space. Points in a periodic pattern that represent these structural units and all 
have identical surroundings are called lattice points. An atom or a group of atoms may be 
associated with a lattice point but does not necessarily need to lie on it. An infinite array of 
lattice points in three-dimensional space defines the basic crystal structure.  
The smallest repeat unit within the lattice that can be used to build the entire crystal is 
denoted as a unit cell. The unit cell in a lattice can be selected in a variety of ways but the one 
with sides that have the shortest lengths and are most nearly perpendicular is most commonly 
chosen. For instance, in a lattice shown in Figure 1.2, the rectangular unit cell would 
normally be chosen.  
In a three-dimensional unit cell, the lengths of the sides of are denoted a, b and c and the 
angles between bc, ac and ab sides are denoted α, β and γ, respectively (Figure 1.3).  
1.1.3 Miller indices  
The spatial orientation of lattice planes can be mathematically described in terms of their 
axial intercepts using Miller indices. Such mathematical notation uses three integer numbers 
h, k, and l, defined by:  
  
 
 
         
 
 
         
 
 
 (1.1) 
where X, Y and Z are the axial intercepts, and a, b and c are the corresponding unit cell 
lengths.  
The values of h, k and l are usually written as (hkl), noting that negative values are designated 
with a bar over the number, as in  ̅ for –2 (Cullity and Stock, 2001). A set of example lattice 
planes with corresponding description using Miller indices is given in Figure 1.4.  
It is generally accepted that indices of a particular face are written either unenclosed – as 312 
– or in round brackets – (312). Indices in braces – {312} – denote a family of parallel planes 
and square brackets – [312] – are used to define zone axis direction (Phillips, 1963).  
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Figure 1.1 Schematic structures of amorphous and crystalline SiO2  
 
 
 
 
 
 
Figure 1.2 Schematic representations of structural motifs in a crystal lattice  
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Figure 1.3 A parallel-sided unit cell in a space lattice and the notation for the sides and angles  
 
The Miller indices can also readily be used to calculate the separation of planes. For a general 
orthorhombic lattice, the separation dhkl of the {hkl} planes is given by:  
 
    
  
  
  
 
  
  
 
  
  
 (1.2) 
1.2 Structural imperfections in crystals  
The most important feature of a crystalline solid is a very regular arrangement of atoms and 
molecules in space. However, in real crystals this regularity is often disturbed by 
imperfections. Although only a very small fraction of atoms is usually affected, defects can 
give rise to important chemical and mechanical properties of crystalline materials and also 
influence the crystal growth process (Mullin, 2001).  
There are four main classes of crystal lattice defects: zero-dimensional (point defects),  
one-dimensional (line defects), two-dimensional (surface defects) and three-dimensional 
(volume defects).  
1.2.1 Point defects  
Point defects are not extended in space in any dimension and typically involve a few extra or 
missing atoms. They can be classified into three types (Figure 1.5):  
 Vacancies are lattice sites from which units are simply missing, leaving ‘holes’ in the 
structure. These units may be atoms, molecules or ions.  
α 
β 
γ 
a 
b 
c 
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 Interstitials are foreign atoms that occupy sites in the spaces between the crystal 
lattice atoms. The interstices are usually small and the occurrence of interstitial 
defects often leads to a distortion of the lattice.  
 Substitutional impurities are foreign units that substitute for matrix atoms.  
A vacancy, with no corresponding interstitial atom, is sometimes called a Schottky defect, 
whereas a single interstitial atom is referred to as an anti-Schottky imperfection.  
A combination of defects consisting of one vacancy and one interstitial is called a Frenkel 
imperfection (Cracknell, 1969).  
1.2.2 Line defects  
The two main types of line defects are edge and screw dislocations. Most crystals have large 
number of dislocations. They can form during crystal growth (grown-in dislocations) or 
during mechanical deformation (mechanical dislocations). Both edge and screw dislocations 
are responsible for slip or shearing in crystals.  
An edge dislocation is a defect where one plane of atoms terminates in the middle of the 
crystal. This causes the stacking of the atom sheets to be distorted for a few layers on either 
side of the extra half layer. An edge dislocation can very easily move thorough a crystal; this 
process is illustrated in Figure 1.6a below. If a sideways force is applied to the bottom layers 
of the crystalline structure, atom A may move further away from atom B and closer to atom 
C. As a result, the bond between A and B breaks, a new bond is formed between A and C, 
and the dislocation moves one atomic distance to the right (Figure 1.6b). The process 
continues until the dislocation has reached the edge of the crystal (Figure 1.6c). The direction 
and magnitude of slip is characterised by the Burgers vector.  
When the atoms are displaced along the dislocation line, rather than at right angles to it, we 
speak of a screw dislocation. This type of lattice distortion plays an important role in the 
crystal growth mechanism. If a single atom becomes attached to the crystal surface it will not 
be held on very firmly and might become detached again. However, if this extra atom arrives 
to the end of a screw dislocation, it is much more firmly attached to the crystal since it is 
anchored by more than one of its faces (Figure 1.7). The attachment of growth units to the 
face of the dislocation results in the development of a spiral growth pattern.  
  
 24 
 
 
Figure 1.4 Various lattice planes described using Miller indices  
 
 
 
 
Figure 1.5 Schematic representation of common point defects: (a) interstitial impurity,  
(b) substitutional impurity, (c) vacancy  
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Figure 1.6 Movement of an edge dislocation through a crystal  
 
 
 
 
 
Figure 1.7 A screw dislocation (Cracknell, 1969)  
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1.2.3 Surface defects  
Grain boundaries are defined as the mismatch regions on the interface between crystals 
having different crystallographic orientations. They usually occur when two individual 
crystals meet during the growth process. Aside from irregular growth, surface defects can 
also be produced as a result of mechanical or thermal stresses.  
Two types of boundaries, tilt and twist, can be distinguished depending on the degree of 
mismatching between the grains (Figure 1.8). A low-angle tilt boundary can be considered to 
be a line of dislocations. A twist boundary with a small degree of misalignment is equivalent 
to a succession of parallel screw dislocations (Mullin, 2001).  
1.2.4 Volume defects  
Volume defects, often referred to as inclusions, are pockets of foreign solid, liquid or gas 
impurities entrapped inside a crystal. They can be divided into two classes: primary, 
associated with growth and constituting samples of fluid in which crystal grew, and 
secondary, formed later often as a result of crystal cracking and incorporation of mother 
liquor. Volume defects can take different forms and shapes, such as bubbles, fjords (parallel 
channels), veils (thins sheets of small bubbles) and negative crystals (faceted inclusions), and 
most frequently they are randomly distributed throughout the crystal. Large and fast growing 
crystals are more likely to develop inclusions (Mullin, 2001).  
Cavities are usually formed at a face centre. This phenomenon was described by Bunn 
(1949), Humphreys-Owen (1949) and Denbigh and White (1966) who discovered that the 
diffusion field around a small crystal tends to develop spherical symmetry and as a result 
more solute is transported to the centre. However, when the crystal grows beyond a certain 
size, the corners and edges grow more rapidly than the face centres; growth layers are 
generated on the macroface, grow inwards and meet to seal the inclusion (Figure 1.9).  
1.3 Driving force for crystallisation  
1.3.1 Solubility curves 
Solubility is a measure of the maximum amount of solid that can be dissolved in a volume of 
liquid at a specific temperature and pressure. Solubility of a substance is commonly 
expressed as a mass concentration, in grams of solute per kilogram of solvent or in grams of 
solute per 100 millilitres of solvent. A plot of the solubility data versus temperature produces   
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Figure 1.8 Two types of grain boundaries: (a) tilt, (b) twist  
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Figure 1.9 Development of an inclusion  
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the solubility curve that corresponds to the saturation concentration of a solute in a particular 
solvent.  
For the majority of substances, the solubility of a solute in a solvent increases with 
temperature, but a few exceptions to this rule are known. Since accurate solubility 
measurements demand laboratory facilities and can be very time consuming, many equations 
have been proposed to predict the solubility data but none has been found to be of general 
applicability. While for some systems simple techniques of interpolation and extrapolation 
can yield data comparable to experimental results, for others the estimated data can only be 
used for rough assessment (Mullin, 2001). For that reason, an experimental determination of 
solubility is usually preferred. 
1.3.2 Supersaturation  
A saturated solution is at thermodynamic equilibrium with the solid phase at a given 
conditions of temperature and pressure. It is, however, possible to prepare a solution where 
the amount of dissolved solid is greater than the saturation equilibrium value. The state of 
supersaturation is essential for both nucleation and crystal growth to occur.  
The relationship between supersaturation and probability of spontaneous crystallisation can 
be represented on a solubility-supersolubility diagram (Figure 1.10) which can be divided 
into three zones:  
(i) The stable zone, where the solution is unsaturated and crystallisation in impossible.  
(ii) The metastable zone, where the solution is supersaturated but where spontaneous 
crystallisation is improbable; however, growth of a seed crystal placed in the 
metastable solution would occur.  
(iii) The labile zone, where spontaneous crystallisation is probable but not inevitable.  
A supersaturated solution can be prepared by slow cooling of a hot concentrated solution 
without agitation or by evaporation of a solvent. In the former method, supersaturation is 
created by a drop of temperature solution that reduces the solubility of the solute. In the latter, 
the state of solution supersaturation is achieved by removing a certain amount of solvent and 
consequently increasing the solute concentration. In practice, however, a combination of both 
methods is often employed.  
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Figure 1.10 The solubility-supersolubility diagram and change in supersaturation on  
(a) cooling, (b) solvent evaporation, (c) combined cooling and solvent evaporation  
 
There are several ways to express the supersaturation of a system but the two most common 
are the supersaturation ratio, S, and the relative supersaturation, σ. These quantities are 
defined by:  
  
 
  
 (1.3) 
      
    
  
 (1.4) 
where c is the solution concentration and c* is the equilibrium saturation at the given 
temperature.  
1.4 Nucleation  
The condition of supersaturation alone is not sufficient cause for a system to begin to 
crystallise. The formation of the new phase requires the existence of minute solid bodies, 
embryos, nuclei or seeds, that act as crystallisation centres (Jancic and Grootscholten, 1984). 
The nucleation process may be induced artificially by agitation, ultrasonic irradiation, electric 
and magnetic fields or extreme pressures.  
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Nucleation in systems that do not contain crystalline matter is referred to as ‘primary’ 
nucleation. Primary nucleation can occur spontaneously (homogeneous) or it may be induced 
by foreign particles (heterogeneous). On the other hand, the process of formation of nuclei in 
the vicinity of crystals present in the supersaturated system is described as ‘secondary’ 
nucleation.  
1.4.1 Primary homogeneous nucleation  
In homogeneous nucleation, in order to form a stable nucleus, the constituent molecules not 
only have to aggregate into a fixed orientated lattice but also resist the tendency to redissolve. 
The actual process of formation of nuclei is hard to envisage. It is, however, believed that  
a nucleus arises from a sequence of molecular additions rather than from simultaneous 
collision of the required number of molecules. A newly formed cluster becomes stable when 
the nucleus achieves a certain critical size after which nucleation and subsequent nucleus 
growth occur. Nuclei that fail to grow above the critical size become unstable and redissolve 
into the bulk of the fluid (Mullin, 2001).  
The classical theory of nucleation developed from the work of Gibbs (1948), Volmer (1939) 
and Becker and Döring (1935) is based on the condensation of a vapour to a liquid but can 
also be extended to crystallisation from solutions and melts. According to the classical 
theory, the overall excess free energy, ΔG, between a small spherical solid particle of solute 
of radius r and the solute in solution is equal to the sum of the surface excess free energy,  
ΔGS (a positive quantity), and the volume excess free energy, ΔGV (a negative quantity). 
Thus,  
            (1.5) 
         
 
 
       (1.6) 
where ΔGv is the free energy change of the transformation per unit volume and γ is the 
interfacial tension.  
A plot of ΔG versus nucleus radius size, r, is shown in Figure 1.12. The maximum value, 
ΔGcrit, which corresponds to the critical nucleus, rc, can be obtained by maximising the 
Equation 1.6 above, i.e. when dΔG / dr = 0. Thus,  
   
  
              0 (1.7) 
and therefore,  
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 (1.8) 
where ΔGv is a negative quantity. Hence, combining equations 1.6 and 1.8 we get  
       
     
 (   ) 
 
     
 
 
 (1.9) 
The rate of nucleation, J, i.e. the number of nuclei formed per unit time per unit volume, can 
be expressed in the form of the Arrhenius reaction velocity equation commonly used for the 
rate of thermally activated process (Mullin, 2001):  
      (      ) (1.10) 
where K is the kinetic factor, k is the Boltzmann constant and T is the temperature.  
The Gibbs-Thomson relationship for a non-electrolyte can be expressed as  
    
   
   
 (1.11) 
Consequently,  
  
 
 
     
 
 (1.12) 
where S is the supersaturation and v is the molecular volume.  
Subsequent substitution of Equation 1.12 into Equation 1.8 gives  
     
  
  
 
     
 
 (1.13) 
and from Equation 1.9,  
       
       
 (     ) 
 (1.14) 
Substituting ΔGcrit into the Arrhenius equation gives  
      [ 
       
     (   ) 
] (1.15) 
The above relationship indicates that the rate of nucleation is a function of three system 
variables, namely, interfacial tension γ, degree of supersaturation S, and temperature T. It 
should also be noted that the geometrical factor 16π/3 in the equation above is only valid for  
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Figure 1.11 Classification of nucleation mechanisms  
 
 
 
 
Figure 1.12 Free energy diagram for nucleation explaining the existence of a critical nucleus  
(ΔG is the overall excess free energy, ΔGS is the surface excess free energy, ΔGV is the volume  
excess free energy and r is the radius of a spherical solid particle of solute)   
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the case of a spherical nuclei and must be replace by an appropriate value if a different shape 
of a nuclei is assumed, e.g. 32 for a cube.  
From Equation 1.13, the radius, rcrit, of a spherical critical size nucleus can be calculated:  
      
   
     
 (1.16) 
Since for a given volume the nucleation rate is inversely proportional to the induction time  
(J ∝ 1/) (Van Hook and Bruno, 1949, Nielsen, 1964), Equation 1.15 can be rearranged:  
      
       
   
 
  (   ) 
 (1.17) 
where A is constant. Consequently, the value of γ can be calculated from the slope of the 
obtained linear dependence of ln τ on T −3(ln S)−2.  
1.4.2 Primary heterogeneous nucleation  
Since it is virtually impossible to achieve a solution completely free of foreign bodies, such 
as dust particles, a true homogenous nucleation is generally an uncommon event. The 
presence of foreign bodies can induce nucleation at lower degrees of supercooling or 
supersaturation than those required for spontaneous nucleation. As a result, the overall free 
energy change associated with heterogeneous formation of a critical nucleus, ΔG'crit, must be 
less than the corresponding free energy change under the homogeneous condition, ΔGcrit, i.e.  
                (1.18) 
where the factor φ is less than unity.  
When considering homogeneous nucleation, a spherical shape of the droplet was assumed. 
During heterogeneous nucleation, one should consider a liquid droplet on a smooth surface of 
a substrate. A segment of a sphere with the curvature radius r and the projected radius r sin θ, 
where θ is the wetting angle, is presented in Figure 1.13. With the specific surface energies 
of the droplet, σ, the substrate, σS, and the substrate-droplet interface, σi, the equilibrium 
condition can be expressed as (Mullin, 2001):  
            (1.19) 
and thus  
     
     
 
 (1.20) 
 34 
The relationship between the factor φ and the angle θ was established by Volmer (1939) as:  
  
(      )(      ) 
 
 (1.21) 
From the plot of the above function (Figure 1.14), it can be deduced that for the case of 
complete non-affinity between the crystalline solid and the foreign solid surface, i.e.  
θ = 180°, the overall free energies of homogeneous and heterogeneous nucleation are the 
same. For the case of partial affinity, when 0° < θ < 180°, ΔG'crit is lower than ΔGcrit. Finally, 
for the case of complete affinity, θ = 0°, that corresponds to the seeding of a supersaturated 
solution with crystals of the required crystalline product, no nuclei have to be formed in the 
solution as the nucleation free energy is zero.  
1.4.3 Secondary nucleation  
At a lower supersaturation level, the nucleation process can readily be promoted by addition 
of seed crystals of the solute. Formation of a new crystal solely because of the prior presence 
of seed crystals is called secondary nucleation.  
Secondary nucleation can occur by a number of different mechanisms (Constable, 1968):  
 initial breeding – when a new crystal is introduced into a supersaturated solution,  
a crystalline dust from its surfaces may be sweep off and these can then become new 
growth centres  
 needle breeding – the out-growths of crystals that grow in the form of needles are 
weak and after detachment or breaking can act as nucleation sites  
 polycrystalline breeding – where secondary nuclei result from fragmentation of  
a weak polycrystalline mass  
 collision breeding – a process resulting from the interaction between a growing 
crystals and the crystalliser walls, a stirrer or impeller, or other crystals  
For materials of high and moderate solubility, collision breeding is considered to be the most 
significant nucleation mechanism in crystallisers (Davey and Garside, 2000).  
1.5 Crystal growth  
As a result of exposure to supersaturated solution, the surface of stable nuclei, i.e. those that 
grew larger than the critical size, begins to grow since the number of growth units joining the 
surface is greater than then the number leaving. The ability to capture approaching molecules  
  
 35 
 
 
 
Figure 1.13 Equilibrium shape of a liquid droplet on a substrate surface (θ is the wetting angle,  
r is the radius of a droplet, and σ, σS, and σi are specific surface energies of the droplet,  
the substrate and the substrate-droplet interface, respectively)  
 
 
 
 
 
Figure 1.14 Ratio of free energies of heterogeneous and  
homogeneous nucleation as a function of the contact angle  
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and their subsequent incorporation into the crystal surface depends on the number and 
strength of interactions between the surface and the growth unit and can be quantified using 
the α factor originally defined by Jackson (1958) and later refined by Jetten et al. (1984):  
   (
   
  
      ) (1.22) 
where ξ is the surface anisotropy factor, ΔHf is the heat of fusion and xeq is the solubility.  
If the value of α is less than 3, the surface of a crystal contains many kink and step sites and 
every growth unit arriving at the surface becomes incorporated into the crystal. Hence, the 
growth is continuous. Values of α between 3 and 5 indicate a decrease in the inherent 
roughness of the interface and thus some of the growth units that arrive at the surface do not 
find a growth site and either return to the solution phase or join other growth units to form 
surface islands or nuclei. The latter mechanism is referred to as a birth and spread model. If 
the value of α is greater than 5, the molecular surface of a crystal is flat and the growth can 
only take place if a step can be formed in a low-energy process. Structural defects, in 
particular screw dislocation, provide such a route and the growth usually proceeds by the 
screw dislocation mechanism (Davey, 1982).  
1.5.1 Adsorption layer theories and spiral growth  
The adsorption layer theory, originally postulated by Volmer (1939), holds that the units of 
the crystallising substance that arrive at the surface of a growing crystal do not get 
incorporated into the crystal structure immediately but are able to migrate over the crystal 
face and will link into the lattice in positions where attractive forces are greatest. Three 
distinct stages can be identified in the process:  
(i) Bulk transport of the growth units to the adsorption layer.  
(ii) Diffusion of the solute molecules to the surface of the growing crystal.  
(iii) Desolvation and adsorption of the crystallising entities onto the growing surface.  
A model suggested by Kossel (1934) represents a flat crystal surface as made up of moving 
layers of monoatomic height, termed steps, which may contain kinks (Figure 1.15). The 
loosely adsorbed growth units are most easily incorporated at kinks as they have more 
potential binding sites than steps and faces and consequently the system can gain more 
energy when joining occurs at kinks. As the crystallising units get incorporated to the surface, 
the kinks move along the step and the face is eventually completed. A fresh step is created by 
surface nucleation and usually starts at the corners.  
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Accordingly, the growth of a crystal should be fastest when its faces are entirely covered with 
kinks and its rate should decrease as the face continues to grow and the number of kinks 
decreases. It can indeed be observed that broken crystal surfaces rapidly heal and then 
proceed to grow at much slower rates. On the other hand, however, it was also noticed that at 
low supersaturations, far below those needed to induce surface nucleation, crystals of certain 
species, such as iodine, grow at much greater rates than those predicted by Kossel’s model, 
indicating that the latter is unreasonable for growth at moderate to low supersaturation 
(Mullin, 2001).  
To account for the above observations, Frank (1949) postulated that the majority of crystals 
grow with imperfections and the ideal layer-by-layer growth is uncommon. Dislocations 
cause steps to be formed and therefore promote growth. Frank (1949) considers the screw 
dislocations to be particularly important for crystal growth as they eliminate the necessity for 
surface nucleation. The emergent step of a dislocation spiral extends over only a part of the 
crystal surface but it winds up during growth to create a growth hillock and the surface grows 
as if it was covered with kinks (Figure 1.16). Hence, the latter mechanism is referred to as  
a spiral growth model.  
The mechanism of growth based on dislocation theory was further studied by Burton, Cabrera 
and Frank (1951) who mathematically described the relationship between crystal growth rate 
and supersaturation:  
          (   ) (1.23) 
Where R is the crystal growth rate, σ is supersaturation, and A and B are complex 
temperature-dependent constants which include parameters depending on step spacings. From 
the supersaturation-growth rate relationship it can be seen that at low supersaturation the BCF 
equation approximates to R ∝ σ2 but at high supersaturation to R ∝ σ, i.e. the growth law 
changes from parabolic to linear as the supersaturation increases (Figure 1.17).  
1.5.2 Birth and spread model  
The ‘birth and spread’ (B+S) mechanism is based on two-dimensional nucleation, followed 
by the lateral spread of the monolayers (Ohara and Reid, 1973). In the B+S model, growth 
develops from surface nucleation that can occur at the edges, in the corners and on the faces 
of a crystal. Further surface nuclei can develop on the top of the growing monolayer, even 
before the spread is finished (Figure 1.18).   
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Figure 1.15 Kossel’s model of a growing crystal showing (A) flat surfaces, (B) steps, (C) kinks,  
and three stages of the crystal growth: (i) bulk transport, (ii) boundary layer diffusion,  
(iii) incorporation of the crystallising entity  
 
 
 
 
 
Figure 1.16 Development of a growth spiral starting from a screw dislocation (Mullin, 2001)  
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Figure 1.17 The Burton-Cabrera-Frank supersaturation-growth  
relationship: (i) parabolic growth law, (ii) linear growth law  
 
 
 
 
 
 
 
Figure 1.18 Development of the polynuclear growth by the birth and spread mechanism (Mullin, 2001)  
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The relationship between a face growth velocity and supersaturation in the B+S model can be 
expressed as  
     
      (    ) (1.24) 
where R is the face growth rate normal to the plane of the face, and A1 and A2 are system-
related constants.  
Mullin (2001) indicates that the terms ‘nuclei on nuclei’ (NON) and ‘polynuclear growth’ are 
sometimes used in the literature to describe growth behaviour analogous to the birth and 
spread model.  
1.5.3 Continuous growth  
When the surface of a growing crystal is rough at the molecular level, i.e. when the surface 
contains many kink and step sites, every growth unit arriving at the surface will become 
incorporated into the growing crystal face because of no energy barrier for binding (Davey 
and Garside, 2000). In such case, the linear growth rate R normal to the surface is 
proportional to the supersaturation and can be expressed as  
     (1.25) 
where β is a system-related constant.  
1.6 Polymorphism  
A substance is said to exhibit polymorphism when it is capable of crystallising into different, 
but chemically identical, crystalline forms. Although different polymorphs of a given 
substance have identical composition, they may exhibit different physical properties, such as 
solubility, melting point, density, colour or bioavailability. Different crystalline forms 
exhibited by one substance may be the consequence of variation in the crystallisation 
temperature or a change of solvent.  
1.6.1 Types of polymorphism  
During the crystallisation process molecules attempt to minimise their free energies. 
Structural differences between the crystalline lattices originate from alternative ways in 
which the molecules pack within the crystal. The crystal packing may be driven by 
intermolecular interaction (enthalpy) or by consideration of entropy, leading to a different 
structure in each case (Davey and Garside, 2000).   
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Depending on the mechanisms of origin, polymorphism can be classified as packing and 
conformational. Packing polymorphism results from various arrangements of 
conformationally rigid molecules. Distinct conformational states of the same molecule can 
also lead to different crystal forms and then we speak of conformational polymorphism. Most 
organic crystals, however, have a mixed origin and exhibit differences in both conformational 
and packing arrangement of the constituent molecules (Hilfiker, 2006).  
1.6.2 The phase rule  
On the basis of thermodynamic principles, Gibbs (1876, 1878) formulated the phase rule that 
relates the number of components, C, phases, P, and degrees of freedom of a system, F, by 
means of the equation:  
        (1.26) 
The number of degrees of freedom in the above equation is the number of system variables, 
such as temperature, pressure and concentration, which must be fixed in order to specify the 
equilibrium state.  
The Gibbs phase rule may also be used to characterise polymorphic behaviour of a substance. 
Since two polymorphic forms constitute two homogeneous phases, i.e. C = 1 and P = 2, the 
system has only one degree of freedom. Thus, at constant pressure, equilibrium between the 
two polymorphs occurs at a fixed temperature, whereas at constant temperature it occurs at  
a fixed pressure. Moreover, since the number of degrees of freedom cannot be negative,  
a maximum of three polymorphs can be in equilibrium with each other.  
1.6.3 Ostwald’s rule  
In the early 19
th
 century it was first observed that rapid cooling may lead to formation of 
unstable crystals whose form is different to the one which would normally be expected. This 
type of behaviour was generalised by Ostwald (1893, 1897) who proposed a ‘rule of stages’ 
which states that upon crystallisation a system will initially adopt the crystal structure which 
leads to the smallest loss in free energy and that these crystals will subsequently transform 
stepwise to the most stable crystal form. In other words, the resulting reaction is, in fact, not 
the one that is thermodynamically most likely, but the one that has the fastest rate. However, 
as noted by Ostwald, the theory is not universal and exceptions to the ‘rule’ exist, e.g. slow 
cooling of supersaturated 1,3-dioleoyl-2-palmitoyl glycerol solution (Bayes-Garcia et al., 
2011).  
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Although a number of studies attempted to provide a theoretical explanation for Ostwald’s 
theory, the ‘rule’ still lacks a definite theoretical proof. It does, however, operate often 
enough to be regarded as important for large-scale precipitation processes.  
1.6.4 Enantiotropism and monotropism  
Depending on the ability to transform reversibly or irreversibly from one form to another, 
polymorphic systems can be classified as enantiotropic and monotropic, respectively.  
The term monotropic is used to describe a system where crystal forms are not 
interconvertible, i.e. one polymorph, because of lower solubility, is more stable than the other 
(Figure 1.19a). If, however, one polymorphic form can be reversibly changed into another by 
varying the temperature or pressure, the system is said to be enantiotropic (Figure 1.19b).  
Bernstein (2002) points out that the determination of whether a particular substance exhibits 
mono- or enantiotropic behaviour is particularly important when choosing crystallisation 
strategy as additional precautions may need to be taken to preserve the stable form or to 
prevent undesirable transformation.  
1.6.5 Commercial importance of polymorphism  
Polymorphism plays an important role in a number of industries, including pharmaceuticals, 
foods, dyes, pigments and explosives. In the chemical industries the demand for high yields 
and high production rates requires operation of the processes far from equilibrium, thus 
intensifying the tendency to form metastable structures. Because each polymorphic form has 
its own unique combination of mechanical, thermal and physical properties, insufficient 
understanding of solid-state properties can lead to serious setbacks. It is thus important to  
 
 
Figure 1.19 Solubility curves in (a) monotropic and (b) enantiotropic systems (Davey and Garside, 2000)   
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recognise and be able to control the phenomenon of polymorphism, and in consequence 
manufacture materials with well-defined properties (Davey and Garside, 2000, Bernstein, 
2002).  
The awareness of importance of polymorphism is most evident in the field of 
pharmaceuticals. An in-depth study of the polymorphic forms is caused by the strict quality 
control requirements. Using a thermodynamically unstable polymorph in the production of 
tablets or creams may sometimes be the reason why undesirable changes into the 
thermodynamically stable form take place in such formulations after a time of storage, 
potentially leading to a complete loss of activity of a particular substance. On the other hand, 
some thermodynamically unstable modifications which show a very low transition tendency 
can intentionally be applied to take advantage of specific properties they may possess (Henck 
and Kuhnert-Brandstatter, 1999).  
Since the development of a new drug from a promising lead compound to a marketed product 
is a long and expensive process, the intellectual property implications are another important 
reason for an intensive investigation of polymorphism in the pharmaceutical industry 
(Hilfiker, 2006). Since a particular crystalline form of a drug can possess considerable 
chemical, physical or biological advantages over the market competitors, granting and 
maintenance of exclusive patent rights to a particular polymorph may have considerable 
economic consequences.  
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Chapter 2  
L-Glutamic acid as a model compound  
L-Glutamic acid was chosen as a model system for investigation of the effect of change in the 
process conditions and experimental strategy on the nucleation, growth and solution-
mediated transformation of its polymorphs. The following chapter outlines the physical data 
and chemical characteristics of the model compound and presents a thorough review of the 
literature published to date concerning crystallisation of L-glutamic acid.  
2.1 Amino acids  
Amino acids are difunctional molecules containing, as their name implies, both amino and 
carboxyl groups. Two amino acid molecules can join together by a condensation reaction to 
form a peptide bond, C(O)NH. Amino acids are the basic building blocks of proteins.  
A protein may consist of a hundred or more amino acid units. All twenty amino acids are 
involved in the synthesis of proteins but humans can produce only ten of them. The 
remaining ten have to be supplied by the diet (McMurry, 1996).  
The twenty common naturally-occurring amino acids are α-amino acids and all, except for 
proline which does not contain a primary amino group, have a general formula 
H2NCHRCOOH. In α-amino acids, both the amino group and the carboxyl group are attached 
to the same carbon atom, which is called the α-carbon. The other two substituents of the  
α-carbon are hydrogen atom and an organic side chain group R (Figure 2.1). Therefore, all 
amino acids except for glycine, where R = H, are chiral. While both D- and L- amino acids 
exist in nature, only the L- form is found in proteins synthesised by the human body 
(Clayden, 2001).  
Depending on the nature of the side chain group, amino acids can be divided into 7 classes 
(Table 2.1):  
• Aliphatic amino acids: have open, sometimes branched side chains  
• Aliphatic hydroxyl amino acids: contain hydroxyl group in their side chains  
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Figure 2.1 General structure of an α-amino acid  
 
• Basic amino acids: side chains contain basic amino groups  
• Acidic amino acids and amide derivatives: contain an additional carboxyl group or 
an amide group in their side chains  
• Aromatic amino acids: side chains contain aromatic rings  
• Sulphur containing amino acids: contain sulphur atoms in the side chains  
• Cyclic amino acid: proline is the only amino acid whose side group is cyclic and 
links to the α-amino group  
2.2 Selection criteria  
L-Glutamic acid, often abbreviated as L-Glu or LGA, is one of the proteinogenic amino acids 
and plays an important role in the human body. It is the most important neurotransmitter in 
the vertebrate nervous system and a key molecule in cellular metabolism. Commercially,  
L-glutamic acid is used as a substrate of many pharmaceuticals, cosmetics and agricultural 
products. In the form of its sodium salt, monosodium glutamate, L-glutamic acid is used as  
a major flavour enhancing component of foods with a meaty, savoury taste.  
L-Glutamic acid is a typical polymorphic compound that can exist in two crystalline forms. 
Since the system has been widely studied in the past, extensive structural, thermodynamic 
and kinetic data is available. The two polymorphs of L-glutamic acid are known to undergo 
solution-mediated transformation but have been reported to be stable in the solid state. The 
X-ray diffraction patterns and Raman spectra of the two forms are easily distinguishable from 
one another. While the solubility of L-glutamic acid is low and thus only relatively small 
amounts of material need to be used to prepare the experimental solutions, it is soluble 
enough to not cause difficulties when weighing out samples using a typical laboratory 
balance. Furthermore, when standard laboratory procedures are followed, L-glutamic acid 
does not pose toxicity concerns.   
CH2N
R
H
O
OH
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Table 2.1 Twenty common naturally-occurring amino acids and their classification  
Aliphatic amino acids 
Glycine Alanine 
Valine 
Leucine Isoleucine 
Aliphatic hydroxyl amino acids Basic amino acids 
Serine Threonine 
Histidine 
Lysine 
Arginine 
Acidic amino acids and amide derivatives Cyclic amino acid 
Aspartic acid 
Glutamic acid 
Asparagine 
Glutamine 
Proline 
Aromatic amino acids Sulphur containing amino acids 
Phenylalanine 
Tryptophan 
Tyrosine 
Methionine 
Cysteine 
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The above-mentioned characteristics of L-glutamic acid make it a good candidate for a model 
system, both from scientific and industrial perspective. Additionally, since many amino acids 
have, to some extent, similar structure and all contain both amino and carboxyl groups, the 
findings of this research can potentially be applied to other compounds belonging to this 
class, such as L-aspartic acid that contains one fewer CH2 group than the model compound 
considered in this work, consequently making the study an even more valuable contribution 
to science.  
2.3 Molecular and crystal structure  
The molecular formula of L-glutamic acid is C5H9NO4 and its molar mass is 147.13 g mol
-1
. 
L-Glutamic acid, like all other amino acids, comprises of both amine and carboxylic acid 
functional groups (C(NH2)(COOH)) and a characteristic side chain (CH2CH2COOH). In the 
crystal lattice as well as in the aqueous solution, as a result of a proton transfer from the 
carboxylic acid end to the amino group, the functional groups are present in their charged 
forms, COO
–
 and NH3
+
, respectively (Figure 2.2). Although the atom groups carry formal 
positive and negative charges, the molecule remains neutral as a whole. The latter state is 
referred to as a zwitterionic form.  
L-Glutamic acid is a polymorphic compound and its molecules can adopt two different 
conformations in the solid state, denoted α and β. The crystal structure of the α form was first 
reported by Bernal (1931) and the β polymorph was later discovered by Hirokawa (1955). 
The unit cell parameters, originally determined using X-ray diffraction, were later refined by 
Lehmann et al. (1972) and Lehmann and Nunes (1980) using neutron diffraction data and are 
summarised in Table 2.2. Both polymorphs have primitive orthorhombic unit cells and 
belong to P212121 space group. Furthermore, Hirayama et al. (1980) also proposed three 
hypothetical intermediate molecular conformations that might explain the mechanism of the  
α to β transition.  
L-Glutamic acid molecules crystallise in their zwitterionic state with molecular packing of 
both forms dominated by intermolecular hydrogen bonding. The most significant difference 
between the two structures is the adopted molecular conformation (Bernstein, 1991). The 
torsional angles τ1 and τ2, defined by carbons 1, 2, 3, 4 and 2, 3, 4, 5, respectively, have 
values of 59.3° and 68.3° in the α structure and –171.5° and −73.1° in the  
β polymorph and are shown in Figure 2.3. The packing structures of the α and β crystal 
forms, generated using CCDC Mercury software, are shown in Figure 2.4. As a result of  
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Figure 2.2 Skeletal structure of L-glutamic acid in its (left) neutral and (right) zwitterionic form  
 
 
 
 
 
Table 2.2 Crystallographic data of L-glutamic acid polymorphs  
Polymorph α (metastable) β (stable) 
Crystal system Orthorhombic Orthorhombic 
Space group P212121 P212121 
Unit cell lengths (Å) a  10.282(10)  
b  8.779(8)  
c  7.068(7) 
a  5.159(5)  
b  17.30(2)  
c  6.948(7) 
Unit cell angles α  90°  
β  90°  
γ  90° 
α  90°  
β  90°  
γ  90° 
Number of molecules per unit cell 4 4 
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α-L-glutamic acid 
 
 
 
 
  
β-L-glutamic acid 
 
Figure 2.3 Conformation of L-glutamic acid in (top) the α and (bottom) the β crystal structure.  
Colouring convention: grey – carbon, red – oxygen, blue – nitrogen, white – hydrogen.   
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α-L-glutamic acid 
 
 
 
 
β-L-glutamic acid 
 
Figure 2.4 Packing structures of (top) α and (bottom) β L-glutamic acid. Colouring convention:  
grey – carbon, red – oxygen, blue – nitrogen, white – hydrogen. 
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these characteristic molecular arrangements and large conformational differences in the 
crystal lattice, the two polymorphs of L-glutamic acid have unique X-ray diffraction patterns 
(Figure 2.5) (Lehmann et al., 1972, Lehmann and Nunes, 1980) and Raman spectra  
(Figure 2.6) (Dhamelincourt and Ramírez, 1991, Ono et al., 2004) that can be used to 
perform phase identification.  
The two crystal forms have very distinct morphologies. The α form crystals are prismatic 
(Figure 2.7a) and are thus preferable for industrial handling since they filter and wash easily. 
On the other hand, the β polymorph crystals are acicular (Figure 2.7b) and because of their 
needle-like shape tend to break and pack as an impervious layer causing difficulties in 
downstream processing.  
The relative stability of the two polymorphs of L-glutamic acid was determined from 
solubility (Sakata, 1961b) and enthalpy measurements (Sakata and Takenouchi, 1963). Later 
studies by Hirayama et al. (1980) showed that the molecular conformation adopted in the  
β polymorph is more stable and favourable than the one in the α form. The two polymorphs 
of L-glutamic acid are related monotropically (Kitamura, 1989). Kinetics favours the 
formation of the metastable form, while thermodynamics favours formation of the stable 
form (Bernstein, 2002). During typical batch crystallisation, in agreement with the Ostwald’s 
rule of stages, it was observed that it is the less stable α polymorph that nucleates and grows 
first and then undergoes a solution-mediated transformation where the stable β crystals grow 
at the expense of the metastable α dissolving (Cardew and Davey, 1985, Kitamura, 1989). 
The solubility data for the two polymorphs of L-glutamic acid reported by Kitamura (1989) is 
shown in Figure 2.8.  
2.4 The existing approaches to study crystallisation  
Previous work aimed at understanding and controlling the polymorphic outcome from 
crystallisation processes can be classified into two fundamentally different approaches:  
(i) studies of kinetic features of solution-mediated transformation (Cardew and 
Davey, 1985, Davey et al., 1985, Davey et al., 1986, Davey et al., 2002),  
(ii) studies based on control of crystal polymorphism with the assistance of 
stereospecific nucleation inhibitors (Weissbuch et al., 1991, Lahav and 
Leiserowitz, 1993), which may be used to prevent the nucleation of undesired 
polymorphic structures (Staab et al., 1990, Weissbuch et al., 1994, Davey et al., 
1997). 
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Figure 2.5 Experimentally observed X-ray diffraction patterns of  
(top) the α and (bottom) the β form of L-glutamic acid   
α-L-glutamic acid 
 
β-L-glutamic acid 
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Figure 2.6 Experimentally observed Raman spectra of  
(top) the α and (bottom) the β form of L-glutamic acid   
β-L-glutamic acid 
 
α-L-glutamic acid 
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(a) (b) 
Figure 2.7 Microscope images showing (a) the α and (b) the β L-glutamic acid crystal morphology  
 
 
 
 
 
Figure 2.8 Solubility curves of L-glutamic acid polymorphs (Kitamura, 1989)  
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The former approach has revealed that kinetic studies of the solution-mediated phase 
transformation between metastable and stable polymorphs is controlled by the crystallisation 
rate of a stable form. A model has been developed for this type of phase transformation based 
on the assumption that the starting point for the transformation is a slurry of monosized 
crystals of a metastable phase in contact with a saturated solution containing nuclei of  
a stable phase (Cardew and Davey, 1985). In this simplistic view, as the ‘nuclei’ grow, the 
solution concentration falls below the solubility of the metastable phase and becomes 
undersaturated with respect to this phase. The crystals of the metastable phase thus dissolve 
producing supersaturation for the continued growth of the stable phase, and the process 
continues until all metastable phase has disappeared and the solution composition has fallen 
to the solubility of the stable phase. The concurrence of dissolution/growth processes would 
suggest that at least during some period of the transformation the growth and dissolution rates 
of the two phases must be balanced. Thus, using the mass balance rate of the two phases 
leads to qualitatively expected supersaturation-time plateau which characterises solution 
mediated polymorphic transformation (Davey et al., 1986). Further progress of the 
knowledge in this area has shown that the stable phase nuclei, known as the secondary nuclei 
(Garside and Davey, 1980), are created at the surfaces of the metastable crystalline phases 
(Cashell et al., 2003a). However, a mechanism of their formation is still poorly understood 
(Ferrari and Davey, 2004).  
The latter approach, based on stereospecific nucleation inhibitors, assumes a priori that 
clusters are present whose packing mirrors the known crystal structures of the polymorphs. 
Under this assumption, doping materials have been successfully designed to control the 
polymorphic outcome by selective inhibition of unwanted structures using the concept of 
tailor-made additives. However, such results suffer from a notable ambiguity in their 
interpretation, since the additives may be active during the nucleation or growth process, or 
during both. Hence, even with its relative simplicity and elegance, the above model does not 
provide information on the structure of self-assembled clusters in solution and the kinetics of 
their formation (Davey et al., 2001).  
In spite of the fact that the two approaches, (i) and (ii), have considerably advanced the 
knowledge in the area, the issues such as time evolution and the mechanism of the process at 
each stage, which includes initial nucleation of both phases from a metastable state of clear 
solution, their growth prior to solution-mediated transformation and the transformation 
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process itself, still need a substantial amount of attention. In particular, the coupling between 
different stages and how a selected additive may be used to tune the overall process.  
2.5 Primary factors affecting the crystallisation of L-glutamic acid  
It has been shown that the outcome of the crystallisation process of L-glutamic acid can be 
controlled by manipulation of the crystallisation parameters, such as temperature, 
supersaturation, cooling rate and agitation. Ono et al. (2004) demonstrated that when 
saturated solution of L-glutamic acid at 80°C is cooled rapidly to 25°C, predominantly the 
metastable α crystals are obtained. On the other hand, when the solution saturated at 90°C is 
cooled slowly, the nucleation of the stable β crystals takes place between 40°C and 50°C 
(Sakata, 1961a). Moreover, Kitamura (1989) showed that the temperature effect on the  
relative nucleation rates of the polymorphs in the crystallisation of L-glutamic acid is much 
more remarkable than the effect of supersaturation ratio. At temperatures lower than 25°C the 
α form is predominant. However, at constant supersaturation ratio, the nucleation rate of  
α decreases as the temperature is increased. Above 60°C the crystallisation process yields 
mainly the more stable β polymorph. Cashell et al. (2004) investigated the effect of agitation 
rate on the crystallisation of L-glutamic acid under the same conditions, cooling of 
supersaturated solution from 80°C to 45°C. It was shown that while without agitation β is the 
only polymorph that is formed, slow agitation speed results in approximately  
57% stabilisation of the metastable form and high agitation rate leads to exclusive formation 
of the α polymorph.  
The polymorphic composition of solution changes during the crystallisation process as the 
initially nucleated α crystals undergo transformation to the β form. The α polymorph remains 
in solution for a long period of time if kept at low temperature but the transformation rate 
increases as the temperature of solution is increased (Kitamura, 1989, Ono et al., 2004). The 
transformation mechanism is believed to be ‘solution-mediated’ (Cardew and Davey, 1985) 
since the dry α crystals are indefinitely stable if separated from their mother liquor 
immediately after crystallisation (Kitamura, 1989, Davey et al., 1997).  
Kitamura (1989) divided the crystallisation process of L-glutamic acid into four stages 
(Figure 2.9). In Region I the decrease in solution concentration is due to the nucleation and 
growth of both polymorphs. Region II begins when the saturation level of the α polymorph is 
attained and is characterised by nearly constant solution concentration since the β form 
nucleates and grows at the expense of dissolution of α, i.e. the polymorphic transformation 
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occurs. The driving force for the formation of β is the difference in solubility between the two 
polymorphs. Moreover, Garti and Zour (1997) argue that the rate-determining step is the 
growth of the more stable form and not the dissolution of α. If this was not the case and  
β nucleated faster than α dissolved, a decrease in solution concentration would be observed. 
Region II ends when α crystals are completely dissolved. In Region III the stable form 
continues to grow until solution concentration achieves the solubility level of β. In Region IV 
the growth stops as the driving force for further crystallisation of β no longer exists.  
2.6 Crystallisation kinetics  
The growth kinetics and morphological change of α to β polymorph of a single crystal of  
L-glutamic acid were investigated using optical (Kitamura and Ishizu, 2000) and atomic force 
microscopy (AFM) (Kitamura and Onuma, 2000). The growth rates of α crystal in the [110], 
[010] and [001] directions, and that of β crystals in the [100] direction were established to be 
controlled by surface reaction. The dependence of the growth rate on the relative 
supersaturation indicated that the growth mechanism of both α and β polymorphs belongs to 
the birth and spread mechanism rather than the spiral growth mechanism.  
Furthermore, Kitamura and Ishizu (2000) also observed morphological changes in the growth 
of α seed crystal (Figure 2.10) and postulated that they are caused by a differences in the 
dependence of the growth rate on the supersaturation between (111) and (110) faces, 
indicating the important contribution of the kinetic process to the morphological change.  
Crystal morphologies of the two polymorphic forms of L-glutamic acid are shown in  
Figure 2.11. The fastest growing faces for α and β are (111) and (101), respectively (Davey et 
al., 1997). At the same supersaturation and at 25°C, the growth rate of the (111) face of the  
α crystal is several times greater than that of the (101) face of β. It was suggested that the 
higher growth rate of α may be due to the large kinetic factor and low edge free energy of the 
metastable form. It was also observed that the ratio of the growth rate of β to α increases with 
increasing solution supersaturation (Kitamura and Ishizu, 2000).  
2.7 Polymorphic transformation mechanism  
Kitamura and Funahara (1994) observed that the β form crystals tend to appear at the surface 
of the crystallising solution and suggested that nucleation of the β form may occur at the 
surface. In later work by Garti and Zour (1997), it was postulated that the nucleation process  
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Figure 2.9 Concentration change during crystallisation of L-glutamic acid at 45°C (Kitamura, 1989)  
 
 
 
Figure 2.10 Morphological change of the α crystal during growth (Kitamura and Ishizu, 2000)  
 
 
 
Figure 2.11 Crystal morphologies of (left) α- and (right) β-L-glutamic acid (Kitamura, 2002)   
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is heterogeneous, whereby secondary nucleation of the β polymorph takes place at the surface 
of the existing α crystals. The experimental evidence for the latter was provided by Cashell et 
al. (2003a) using a combination of scanning electron microscopy (SEM) and Raman 
spectroscopy. In further studies, Cashell et al. (2003b) also showed that both α and β forms of 
L-glutamic acid nucleate in the initial stage of cooling crystallisation and, due to the faster 
growth of α favoured by kinetics, the small amount of β initially nucleated on the surface of 
the metastable polymorph may become encapsulated in the α crystal. The secondary 
nucleation of β was later investigated by Ferrari and Davey (2004) who postulated that the 
observed phenomenon is caused by poor conformational discrimination at the {111}-type 
faces of α ultimately leading to the surface nucleation of β.  
Cashell et al. (2004) demonstrated that prolonged agitation during slow cooling may be 
sufficient to disrupt nucleation of the β form crystals on the surface of the α polymorph. It 
was noted that when solutions are continuously agitated the α crystals that are formed are of 
poor quality and lack the necessary well-formed crystallographic facets on which the β form 
could nucleate. The latter observation further supports the mechanism of secondary 
nucleation of β on the surface of α crystals originally postulated by Garti and Zour (1997) and 
elaborated by Cashell et al. (2003a) and Ferrari and Davey (2004).  
2.8 Reactive crystallisation of L-glutamic acid 
In the cooling crystallisation process considered above the maximum driving force that can 
be achieved is limited by the solubility of L-glutamic acid in water. Moreover, as pointed out 
by Roelands et al. (2005), the starting point of nucleation during cooling the solution to the 
desired temperature cannot be exactly determined. Roelands et al. (2005) argue that pH-shift 
precipitation from a solution of sodium L-glutamate and sulphuric acid using a Y-shaped 
mixing tee with a static mixer inserted in the outflow tube has the advantage of a well-defined 
high initial supersaturation and can be used as an alternative method for crystallisation of  
L-glutamic acid. Further studies by Roelands et al. (2007), using the latter technique, showed 
that at supersaturation less than 13 without post-mixing aggregated crystals of β are formed 
while post-stirring generates the metastable α polymorph. At supersaturations greater than 17, 
with and without post-stirring, formation of smooth spheres was first observed which later 
transformed into rough spherulitic crystals of the β phase. Roelands et al. (2007) proposed 
that at the higher investigated supersaturation range the spheres are droplets formed by highly 
metastable liquid-liquid phase separation from which the stable β subsequently nucleates. It 
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was also postulated that at the lower supersaturation range without post-stirring the 
aggregates of β form according to the same mechanism, whereas with post-stirring the liquid-
liquid phase separation is disrupted because concentration fluctuations are equalised by 
mixing and the metastable α nucleates directly from the homogenised solution.  
2.9 Additives as secondary determinants in the crystallisation process  
While solution supersaturation, temperature and stirring rate are considered to be the primary 
factors affecting the outcome of the crystallisation process, Kitamura (2002) identified 
additives as the secondary determinants. The effect of doping materials is comprised of the 
effect on the nucleation and that on the growth. Therefore, in order to understand the 
underlying mechanism of additives action, both processes should be examined separately. 
However, the only report where the effect of amino acid additives on the nucleation of  
L-glutamic acid was investigated is the work by Kitamura and Funahara (1994) who noted 
that L-phenylalanine increases the nucleation time of both polymorphic forms but no 
mechanistic explanation was provided. On the other hand, the effect of amino acid additives 
on the growth process of L-glutamic acid has long been a subject of study. Moreover, it has 
been demonstrated that the difference in relative kinetics can be used to manipulate the 
outcome of the crystallisation process.  
Using an optical and atomic force (AFM) microscopy, Kitamura and Ishizu (1998) showed 
that when L-phenylalanine is added to the crystallising solution the growth rate of α in the 
[111] direction is suppressed. While it was observed that the new (110) face appears, the 
growth rate of the (001) face seemed not to be influenced by the presence of the additive. It 
was speculated that the (001) face may not be affected because L-phenylalanine cannot be 
adsorbed because of the repulsion between the phenyl group and the carboxyl acid groups in 
the (001) face. Moreover, growth hindering of the (101) face of β was also observed. For both 
polymorphs the growth hampering effect increases with increasing concentration. The critical 
concentration of L-phenylalanine at which the growth of α stops is about twice that for β, 
indicating the preferential inhibition of the growth of β (Kitamura and Ishizu, 1998).  
Kitamura and Funahara (1994) observed that the precipitation ratio of α in the initial stage of 
crystallisation increases with the concentration of L-phenylalanine and the additive can be 
used to hinder the polymorphic transformation and almost entirely suppress the formation of 
the stable polymorph. However, no effect was observed when D-phenylalanine was used as 
an additive. The latter implies that the effect is highly stereoselective. It was postulated that 
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the L- isomer can adsorb on the crystal surface through the common part of amino acid and 
can hinder further attachment of L-glutamic acid growth units with the phenyl ring which 
cannot be incorporated into the crystal structure. On the other hand, the adsorption of the  
D- isomer is not possible because the configuration of the common group is not compatible 
with that in the bulk crystal and hence no effect on the growth is observed.  
In further studies, the effect of other amino acids was investigated. Kitamura and Nakamura 
(2001) demonstrated that three hydrophobic amino acids, L-valine, L-isoleucine and  
L-leucine, can also be used to hamper the crystallisation rate of α-L-glutamic acid. The effect 
of the former additive was most pronounced whereas that of the latter was smallest. It was 
suggested that the effect of L-valine is due to the high adsorption density and the readiness of 
forming inclusions, rather than the steric hindrance of the substituted groups. On the other 
hand, it was the methyl group at the β carbon that seemed to effectively inhibit the growth of 
L-glutamic acid when L-isoleucine and L-leucine were used as the doping material. Cashell et 
al. (2005) identified that at high concentration levels a range of amino acids, namely  
L-aspartic acid, L-lysine, L-arginine, L-cysteine, L-serine and L-methionine,  
a significant amount of the additive uptake is observed causing significant changes in the  
α form morphology. It was demonstrated that the {011} and {001} facets disappear and the 
{110} and {111} facets emerge. Accordingly, it was postulated that the molecules of the 
doping material are preferentially attached to the slowest growing {110} and {111} facets 
and thus stabilise the metastable form by disrupting β developing on the surface of α. 
Moreover, Cashell et al. (2005) indicated that the presence of a bulky phenyl side chain in  
L-phenylalanine and L-tyrosine is an essential feature in achieving stabilisation of the 
metastable polymorph at low additive levels. The hindering effect of additives on the growth 
of the three dominant faces of β-L-glutamic acid was investigated by Sano et al. (1997) and 
was found to be stronger in the {010} and {001} faces than in the {101} face. The observed 
growth inhibition was in the decreasing order of L-phenylalanine, L-lysine, L-aspartic acid 
and L-alanine, and for L-phenylalanine and L-aspartic acid was found to significantly increase 
when the level of the additive was increased. However, the overall discriminating capacity of 
the β form for the recognition of the additive molecules was found to be lower than in the  
α polymorph. Therefore, it was concluded the selective crystallisation of L-glutamic acid in 
the presence of the additives can be attributed to the difference in the inhibitory effects on the 
two dominant faces of the metastable form.  
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In addition to the kinetic consideration of the effect of additives discussed above, another 
approach that received considerable attention is the concept of ‘tailor-made’ additives. The 
latter was introduced by Addadi et al. (1982) who showed that additives can be ‘tailored’, i.e. 
carefully selected on a purely structural basis, to carry out a specific task in the crystallisation 
process. In this approach, a habit modifying additive should have structural characteristics of 
the host molecule, i.e. similar groups participating in hydrogen boding, but should also have  
a modified part that differs in some way. Thus, once incorporated into the structure, ‘tailor-
made’ additives will disrupt the bonding sequences present in the crystal and disturb the 
growth of specific faces (Black et al., 1986).  
In later studies, Davey et al. (1997) demonstrated that additives can be successfully chosen on 
the basis of conformational recognition to inhibit the appearance of the stable β polymorph of 
L-glutamic acid by selectively binding to and hindering the fastest growing faces of β crystals 
without affecting the fast growing faces of the metastable form. Davey et al. (1997) showed 
that 1,5-dicarboxylic acids that mimic the β form conformation, namely transglutaconic acid 
and trimesic acid, could enter the surface with its carboxyl functionalities substituting for 
those of L-glutamic acid. The missing amino group would not be noticed until the next 
growth layer was laid down when its absence or substitution for a bulkier moiety would 
disrupt the growth of β, yielding the metastable α crystals as the main outcome of the 
crystallisation process. The attempts to use α-like additives, such as glutaric acid and  
2-methylglutaric acid and hence directly crystallise the stable β polymorph were, however, 
unsuccessful.  
Generally, additives may not only inhibit the crystallisation of an unwanted polymorph, but 
can also lead to new and unexpected phenomena irrespective of whether the crystallising 
material is polymorphic or non-polymorphic. There has been a widely accepted view that 
molecular modifiers in solution are capable of directing growth morphology, but have only 
neutral or inhibitory effects on primary nucleation and growth kinetics (Elhadj et al., 2006). 
While the former view remains largely unchallenged (Galkin and Vekilov, 2000), the latter 
was recently questioned by in-situ atomic force microscopy (AFM) studies on 
biomineralisation of calcite which have shown that two acidic proteins (isolated and purified 
from abalone shell nacre) dramatically accelerate calcite growth while still altering the 
surface morphology through interactions with specific atomic steps on the (104) face (Elhadj 
et al., 2006, Fu et al., 2005). Following this discovery, additional evidence of a growth 
accelerating effect has been demonstrated for the same material grown in the presence of 
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synthetically designed small model peptides (peptoids) (Chen et al., 2011). In spite of the 
scarcity of the data that exists on nucleation and crystal growth enhancement, one may ask  
a more general question, ‘Should accelerating effects occur for the primary nucleation of 
polymorphic materials in the presence of selectively chosen molecular modifiers, and how 
this initial condition may influence, at the later stage, the kinetics of solution-mediated 
transformation of metastable to stable polymorphic form?’ Giving an answer to this question 
is central to the ability to control the transformation process between polymorphs of 
crystalline materials in a wide range of consumer products from foods, through cosmetics to 
pharmaceuticals.  
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Chapter 3  
Experimental methods  
The nucleation, growth and polymorphic transformation processes during batch and 
containerless crystallisation of L-glutamic acid were investigated using a range of 
experimental techniques, including, but not limited to, single-photon laser light scattering, 
synchrotron wide angle X-ray scattering and Raman spectroscopy. The following chapter 
provides the essential background on the principles behind the methods and apparatus that 
were employed, and describes the materials and experimental procedures used in this study.  
3.1 Materials used  
All chemicals used were of analytical grade and used as received from the supplier, and are 
listed in Table 3.1. All solutions were prepared using purified and deionised water.  
3.2 Apparatus and experimental techniques  
3.2.1 Batch crystallisation  
Crystallisation plays an important role in a range of industries, especially those 
manufacturing pharmaceuticals, cosmetics, specialty chemicals and foods. Just like any other 
production process, crystallisation can be operated in two modes, batch and continuous. The 
advantage of batch crystallisation is that it yields materials of high purity, narrow crystal size 
distribution and relatively large crystal size. Unlike the continuous mode, batch processes are 
relatively flexible and allow for changing product specification. Moreover, as batch 
operations are repetitive in nature, information from previous runs can be used to improve 
future operations, allowing trouble-free production for the manufacturers. For those reasons, 
they are preferred in industries where materials of low volume and high value, such as 
pharmaceuticals, are manufactured.  
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Table 3.1 Chemicals used in the experiments  
Chemical name Purity Supplier Batch number 
L-Glutamic acid ≥ 99.0% VWR International Ltd. K35376147609 
Glycine ≥ 99.7% VWR International Ltd. K34798166542 
L-Alanine ≥ 99.0% Sigma-Aldrich Company Ltd. K39066207835 
L-Phenylalanine ≥ 99.0% Sigma-Aldrich Company Ltd. K37363256808 
    
3.2.1.1 Nucleation time measurements  
The most common technique employed to study the nucleation process is measurement of the 
change in solution turbidity as light is transmitted through the sample. When solution 
nucleates, fewer photons of the original beam propagate towards the detector located opposite 
the light source. Accordingly, the moment when a drop in the measured light intensity occurs 
can be assumed to correspond to the onset of the nucleation process. In practice, however, 
since the extinction of light must be sufficient to cause a detectable change in the transmitted 
light intensity, the recorded increase in turbidity in not only due to nucleation but also due to 
growth of the newly formed crystals (Hartel, 2001).  
An alternative and a more robust approach to study the nucleation process are light scattering 
techniques. In this work a variation of a static light scattering method with a novel light 
detection system is employed. While the light scattering methods typically use analogue 
photon counting, a single-photon counting technique used in this study provides better 
resolution of solution fluctuations and a higher signal to noise ratio (Becker, 2010). The latter 
characteristics make single-photon detection a promising system for the nucleation 
measurements since it is the low intensity scattering that is produced in the early stage of 
formation of a solid phase during crystallisation from solution.  
The experimental apparatus used to measure the nucleation time of pure and glycine-doped  
L-glutamic acid from solution consists of a laser source, a set of apertures and lenses to focus 
and direct the light beam, a crystallisation cell where the nucleation takes place and a system 
that detects and quantifies the intensity of the scattered light (Figures 3.1 and 3.2).  
The light source is a 150 mW Omnichrome Argon-Ion laser (wavelength: 514 nm). The light 
is collimated which limits the spread of the beam as it propagates. The laser beam is focused  
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Figure 3.1 Front view of the experimental set-up for the nucleation time studies  
 
 
 
 
Figure 3.2 Side view of the experimental set-up for the nucleation time studies  
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using an 80 mm diameter focus lens with a 250 mm focal length and an aperture to shape the 
beam.  
The nucleation cell is an 80 mL jacketed glass crystalliser with three windows made of  
1.5 mm thick borosilicate glass. Two of the windows are parallel and on opposite sides of the 
cell and the third window is perpendicular to them. The temperature of water in the jacket is 
controlled using a Huber Ministat 240 water bath. The nucleation cell is covered in black tape 
to reduce reflections and potential detection of light scattered at other angles. The solution 
was agitated using a magnetic stirring bar and the temperature in the cell was measured using 
a thermocouple connected to an IKA-Werke RET Control-Visc hotplate.  
The laser light passes through the two parallel windows and interacts with solution in the cell 
leading to light scattering. Any light that scatters through the window perpendicular to the 
direction of the beam passes through a collimator and a focal lens (both 80 mm, focal lengths 
of 300 mm and 500 mm) to the detection apparatus. The collimated light is focused on the 
exposed end of a 120 μm diameter multi-mode optical fibre that transmits the signal to the 
Thorn EMI Electron Tubes (FACT 50) Photomultiplier.  
Within the photomultiplier individual photons collide with a photocathode, which is held at  
a 1.1 kV negative voltage, resulting in the release of a photoelectron. The released electrons 
collide with alkali metal cathode plates, known as dynodes, which are also held at a high 
negative potential resulting in multiple electrons being released for each collision. This 
process results in an amplified voltage peak being produced by each collected photon.  
The electrical signal is then sent through a Stanford Research Systems SR440 DC-300MHz 
amplifier, with a total gain of 25, into a Stanford Research Systems S400 photon counter 
which processes the signal and sums up the number of photon pulses detected over  
a predefined period of time. A discrimination level of 10 mV was set for the system to 
disregard any signal below the threshold voltage.  
The signal from the photon counter is sent using a National Instruments SCC-68 Interface 
Card to a computer running a custom-written LabView software that continuously records the 
experimental data. Every 1 V pulse that is recorded corresponds to 999 photons detected.  
3.2.1.2 In-house studies of polymorphic transformation  
Crystallisation was performed in a 500 mL jacketed round bottom glass reactor equipped 
with a Hanna Instruments HI-76310 probe for conductivity and temperature monitoring. The 
probe was calibrated using Jenway Calibration Standard (12880 μS/cm at 25°C), and was 
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attached to a Hanna Instruments HI-2300 Microprocessor Conductivity Meter and a computer 
with data recording software. During the experiments, the top of the crystalliser was sealed in 
order to prevent evaporation of the solvent and contamination of solution. The temperature of 
the water jacket was controlled by a programmable Huber CC230 thermostatic water bath.  
An external circulation loop was used to ensure homogeneity of the vessel contents. The 
solution was being withdrawn from the bottom of the crystalliser and then pumped back to 
the top of the vessel by an Iwaki MD10 magnetic drive pump, at a constant flow rate of  
1.6 L per minute. Chemically inert silicon rubber tubing was used to connect the crystalliser 
and the pump.  
3.2.1.3 Synchrotron-based studies of growth and polymorphic transformation  
Moreover, when experiments were performed at the synchrotron facility, an additional 
jacketed glass flow cell was incorporated into the circulation loop to position the crystallising 
solution in the synchrotron beam and enable continuous sampling. The incident X-rays 
passed through the windows in the centre of the cell where the solution was flowing. The 
windows were made of a thin Kapton film (25 μm), aligned parallel and separated by  
a distance of 1 mm.  
The experimental set-up is schematically shown in Figure 3.3 and a detailed view of the flow 
cell is presented in Figure 3.4.  
3.2.2 Acoustic levitation  
Over the past years, acoustic levitation has increasingly been used to study crystallisation 
phenomena in a variety of materials. In contrast to the traditionally used batch reactors where 
the solution is rapidly mixed and the crystal nuclei form as a result of homo- and 
heterogeneous nucleation, the former approach has the advantage of holding the sample 
without contact with container walls thus allowing for an essentially homogeneous process as 
adsorption of solute molecules on the foreign bodies, such as container walls or blades of the 
agitator, is avoided. Acoustic levitation has been successfully employed to study 
crystallisation phenomena in-situ using energy dispersive X-ray spectroscopy (EDX) 
(Leiterer et al., 2006), small- and wide-angle X-ray diffraction (SAXS/WAXS) (Delissen et 
al., 2008, Wolf et al., 2008) or Raman spectroscopy (Klimakow et al., 2010, Radnik et al., 
2011). Moreover, since the technique circumvents the need for a sample container, some of 
the problems intrinsic to the conventional experimental methods, such as scattering and 
contributions from the sample container, are not present.  
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Figure 3.3 Experimental set-up used in the growth and polymorphic transformation studies  
 
 
Figure 3.4 Detailed view of the flow cell used in the growth and polymorphic transformation studies  
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An acoustic levitator (tec5, Oberursel, Germany), consisting of a sonotrode and a reflector, 
was used as a sample holder (Figure 3.5). The sonotrode emits an ultrasonic wave with  
a frequency of 58 kHz and a sound pressure level of 156 dB. When the sonotrode and the 
reflector (a concave acoustic mirror) are adjusted concentrically and at a distance of multiple 
of half the wavelength (d = nλ / 2), a standing wave with equidistant nodal points is formed in 
the gap between the transducer and the reflector (Figure 3.6). In several pressure nodes of 
this wave, as a result of axial radiation pressure and radial Bernoulli stress, a dissolved 
sample droplet with an effective diameter of less than half wavelength can be placed and held 
in a levitated position (Vandaele et al., 2005). When a liquid sample is levitated, gradual 
evaporation of the solvent occurs and the concentration of the solute increases with time. As  
a result of an increase in solution supersaturation, crystal nucleation and subsequent growth 
are induced. Acoustic levitation can therefore be employed to investigate the crystallisation 
phenomena in liquid samples of small volume without the influence of the sample container.  
The containerless crystallisation was investigated in-situ using wide-angle X-ray diffraction 
(WAXS) and Raman spectroscopy techniques. The change in droplet volume was monitored 
using a telecentric infrared flash light and recorded by a CCD camera on the other side of the 
droplet (Figure 3.7). The ambient temperature at the sample position was 296 K ± 1 K. The 
relative humidity was 55% ± 5%. A series of tests by Klimakow et al. (2010), using the same 
experimental set-up, indicated that the temperature and pressure conditions in the direct 
environment of the droplet show only minimal deviations from the conditions prevailing in 
the experimental hutch and the measured positional displacement was smaller than 20 μm. 
The sample remains in a fixed position during the measurement even after evaporation of the 
solvent.  
3.2.3 Synchrotron Wide-Angle X-ray Scattering  
Synchrotron radiation is the electromagnetic radiation emitted when a current of charged 
particles, typically electrons, travel in curved path at relativistic speeds, i.e. near the speed of 
light. Some of the radiation from the bending magnets, and most or all of the radiation from 
specially designed wiggler and undulator insertion devices, leaves the ring through tangential 
ports called beam lines that allow radiation to pass experimental stations located outside the 
ring (Winick, 1995).  
The synchrotron radiation is extremely intense over a broad range of wavelengths, extending 
from the microwave region into the hard X-ray band of the electromagnetic spectrum, and its  
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Figure 3.5 A droplet of L-glutamic acid solution suspended in air using an acoustic levitator  
 
 
Figure 3.6 Schematic representation of the principle of acoustic levitation  
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Figure 3.7 Schematic representation of the set-up used in the levitated droplet experiment  
 
intensity is several orders of magnitude higher than the radiation produced by conventional 
laboratory sources. Moreover, high collimation (small angular divergence of the beam), 
polarisation, high brilliance and pulsed-time structure make synchrotron radiation a powerful 
tool for studies of dynamic systems in a wide range of disciplines, ranging from condensed 
matter physics and materials science through to biology and medicine.  
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of other amino acid additives. WAXS data would provide information to examine the mole 
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When X-rays pass through a crystal they interact with the investigated sample and are 
scattered on electrons of atoms that make up a crystal (Glatter and Kratky, 1982). The 
scattered X-ray waves can interfere constructively and destructively along certain directions 
of space. Diffraction is observed when X-rays scattered by the families of planes have  
a difference in phase equal to an integer number of wavelengths, i.e. when the Bragg 
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a pattern of peaks which is unique to a specific material. The scattering at angles 2θ larger 
than 5° provides information on molecular and atomic ordering and is referred to as wide 
angle X-ray scattering (WAXS).  
The Wide-Angle X-ray Scattering (WAXS) spectra were recorded in-situ at the synchrotron 
microfocus beamline (μ-Spot, BESSY II, the Helmholtz Centre Berlin for Materials and 
Energy, Germany) in order to determine the crystallised mass fractions of the metastable and 
stable forms of L-glutamic acid. A circular beam adjusted to the centre of the droplet with  
a cross section of 100 µm at photon flux of 1 × 10
9
 s
-1
 at a ring current of 100 mA was used. 
All experiments were carried out using a double crystal monochromator (Si 111). The beam 
energy was 12.0 keV which corresponds to a wavelength of 1.0332 Å. The WAXS patterns 
were recorded 200 mm behind the sample with a two-dimensional X-ray detector 
(MarMosaic, CCD 3072×3072 pixels and a point spread function width of about 100 μm).  
The scattered radiation collected on a flat plate detector leads to formation of diffraction rings 
around the beam axis, the so called Debye-Scherrer rings (Debye and Scherrer, 1916). The 
obtained scattering data was corrected for background scattering and converted into diagrams 
of scattered intensities, I, as a function of the scattering vector, q, (q is defined as  
q = 4π sin(θ) / λ, where θ is the scattering angle between the beam axis and the ring and λ is 
the radiation wavelength) using the FIT2D software package. For phase analysis, the 
scattering vector was converted into the 2θ values (Cu Kα radiation λ = 1.5418 Å). The 
scanning range was 6 to 60 degrees 2θ. The X-ray data acquisition time was 15 seconds.  
3.2.4 Raman Spectroscopy  
Raman spectroscopy is a spectroscopy technique for measuring characteristic vibrational 
modes of molecular groups. Raman scattering is a two-photon inelastic light scattering 
process. The incident photon is of much greater energy than the vibrational quantum energy, 
and loses part of its energy to the molecular vibration with the remaining energy scattered as 
a photon with reduced frequency. The interaction between light and matter is an off-
resonance condition involving the Raman polarisability of the molecule (Larkin, 2011).  
Spectrometric analysis of the scattered radiation shows strong Rayleigh line at the 
unmodified frequency of radiation used to excite the sample but also contains frequencies 
arrayed above and below the frequency of the Rayleigh line. The Raman lines are generally 
weak in intensity, approximately 0.001% of the source (Bugay and Williams, 1995). Raman 
bands at wavenumbers less than the Rayleigh line are called Stokes lines, while anti-Stokes 
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lines occur at greater wavenumbers than the source of radiation. Since the anti-Stokes lines 
are less intense, the Stokes portion of the spectrum is generally used. The differences between 
the Rayleigh line and the Raman line frequencies correspond to the vibrational frequencies 
present in the molecules of the sample. The Raman vibrational bands are characterised by 
their frequency, intensity and band shape and are unique to a particular molecule (Larkin, 
2011). The abscissa of the spectrum is usually labelled as wavenumber or Raman shift (cm
-1
).  
The Raman spectra of the levitated droplet were recorded in-situ using a RXN Raman 
Spectrometer (Kaiser Optical Systems, Ecully, France) equipped with a thermoelectrically 
cooled CCD detector and a fibre optic probe. The samples were excited using a 785 nm diode 
laser and with a maximum power of 70 mW. The laser beam was focused on a droplet with  
a spot diameter of 1 mm and a focal distance of 178 mm. The Raman scattered light was 
collected in a 180° backscattering geometry. Spectra were recorded between 350 cm
-1
 and 
3300 cm
-1
 with a time resolution of 30 seconds.  
3.2.5 Droplet volume monitoring  
The change in position, shape and volume of a droplet were monitored using a telecentric 
infrared flashlight and recorded by a microscope equipped with a CCD camera on the 
opposite side of the droplet (Figure 3.7). Because of the strong absorption of water in the 
infrared region (λ = 880 nm), a shadow of the droplet is observed and the area of the shadow 
could be measured. The rotational symmetry around the axis of levitation allowed estimation 
of the volume of the droplet from the area of the shadow using the formula for the volume of 
an ellipsoid of rotation, V = 4π / 3a2b, where a and b are the width and height of the droplet 
shadow, respectively. The measured volumes were converted to mL using the calibration data 
obtained with standardised spheres (Delissen et al., 2008). The images of the droplet were 
taken every 1 minute.  
3.2.6 Solution concentration evolution  
The conductivity measurements can be related to the concentration of L-glutamic acid in 
solution. The initial conductivity (point A in Figure 3.8) corresponds to the original 
concentration of the supersaturated L-glutamic acid solution that was prepared. The value at 
the beginning of the first plateau on the conductivity curve (point B in Figure 3.8) coincides 
with the solubility of the metastable form. The final conductivity (point C in Figure 3.8) 
corresponds to the solubility concentration of the stable polymorph. The relationship between 
solution conductivity and concentration, plotted in Figure 3.9, is approximately linear and the  
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Figure 3.8 Equivalent points on the conductivity plot obtained during batch crystallisation of  
L-glutamic acid at 45°C and on the solubility curves by Kitamura (1989)  
 
 
 
 
Figure 3.9 Relationship between solution conductivity and concentration of L-glutamic acid  
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resulting equation can be used to convert the probe readings into L-glutamic acid 
concentration in solution.  
3.3 Experimental procedures  
3.3.1 Batch crystallisation  
3.3.1.1 Nucleation time measurements  
The nucleation time of pure and glycine-doped L-glutamic acid solutions was investigated at 
supersaturation σ of 0.5, 0.6, 0.7, 0.8 and 0.9 at 35°C. The experimental solutions were 
prepared by dissolution of 11.625 g, 12.400 g, 13.175 g, 13.950 g and 14.725 g of L-glutamic 
acid in 500 mL of purified and deionised water, respectively. The mass of L-glutamic acid to 
be used was determined using the solubility data by Kitamura (1989). The effect of the 
presence of the additive was investigated at four doping levels, namely 1250 ppm, 2500 ppm, 
5000 ppm and 7500 ppm (mol/mol). The dissolution was enhanced by agitation with  
a magnetic stirrer bar at 250 rpm and heating the solution at 60°C for two hours using an 
IKA-Werke RET Control-Visc hotplate. The vessel was sealed to prevent solvent 
evaporation. When the dissolution process was complete, the experimental solution was 
filtered using a pre-heated vacuum filter, transferred into the pre-heated nucleation cell and 
slowly cooled down to 35°C.  
In order to remove any solid residues from previous runs and therefore to minimise the 
probability of heterogeneous formation of new crystals, the nucleation cell was washed with 
purified and deionised water at 60°C and stirred for one hour before each experiment. The 
latter also allows the stirring bar to heat up. After the experimental solution was transferred 
into the pre-heated cell and after the solution cooled down to 35°C, the laser, stirring and 
recording of the number of scattered photons were all turned on at the same time. The water 
bath temperature was set to 35.5°C to compensate for heat losses. The data collection was 
continuous with the accumulation time of 10 μs. The recorded signal consists of low intensity 
background noise, resulting from the density and compositional fluctuations of solution, and 
a number of large amplitude pulses due to scattering of individual photons. The occasional 
spikes in the spectrum result from statistical fluctuations due to short sampling time. For the 
clarity of presentation, throughout this report the recorded data will be plotted as a running 
average of 20 measurements (Figure 3.10).   
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Figure 3.10 Single-photon laser light scattering data on the induction time of L-glutamic acid (σ = 0.5) 
obtained in one of the nucleation experiments for pure solution. Blue crosses correspond to individual 
measurements whereas the black line represents a running average of 20 data points.  
The scattering data was recorded until the solution became opaque and the laser light could 
no longer pass through the cell. The laser beam generator, water bath and stirring were then 
turned off. After each experimental run, the nucleation cell was rinsed several times with 
deionised water to ensure complete removal of all chemical residues.  
3.3.1.2 In-house studies of polymorphic transformation  
The procedure used to prepare pure and glycine-doped solution of L-glutamic acid at 
supersaturation σ of 0.5 at 35°C for the in-house batch transformation experiments was the 
same as the one used in the nucleation time studies (Section 3.3.1.1).  
Prior to each experiment, the crystalliser and the circulation loop were thoroughly rinsed with 
purified and deionised water to remove any possible contaminants, such as dust or solid 
residues remaining from earlier runs. After filtration, the solution was transferred into the 
pre-heated batch crystalliser. Once the solution temperature reached 35°C, the crystalliser 
vessel was then carefully examined in order to ensure that the solution is free of crystals as 
these could act as seeds for nucleation. Subsequently, the circulation pump was turned on 
and, simultaneously, the conductivity and temperature data recording was started. The 
measurements were taken every 10 seconds. The crystallisation was investigated isothermally 
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at 35°C and, in order to compensate for heat losses through the glass vessel walls, the water 
bath temperature was set to 35.5°C.  
The probe readings were monitored throughout duration of the experiment to assess the 
progress of the L-glutamic acid polymorphic transformation. When the polymorphic 
interconversion was finished, the water bath and the pump were turned off, and the data 
recording was stopped. The resulting crystals were then filtered off, washed, dried and stored 
for further investigation. After each of the experiments the equipment was rinsed several 
times with deionised water to ensure complete removal of all chemical residues.  
3.3.1.3 Synchrotron-based studies of growth and polymorphic transformation  
The procedure followed to prepare solutions for synchrotron growth and transformation 
studies and operate the batch crystalliser was similar to that described in Section 3.3.1.2. 
However, in order to increase the polymorphic transformation rate and therefore allow more 
experimental runs within the allocated synchrotron beam time, the isothermal crystallisation 
was performed at 45°C.  
Pure solution of L-glutamic acid at supersaturation σ of 0.5 at 45°C, corresponding to  
16.719 g of solute in 500 mL of water, and solutions in the presence of 2500 ppm, 5000 ppm 
and 7500 ppm (mol/mol) of glycine were investigated. To compensate for heat losses, the 
water bath temperature was set to 45.8°C. During the experiment, in addition to conductivity 
and temperature data, WAXS spectra were also recorded.  
3.3.2 Acoustic levitation  
The experimental solutions were prepared by dissolution of 2.500 g of L-glutamic acid in  
250 mL of purified and deionised water. Pure solution and solution with three other amino 
acid additives, namely glycine, L-alanine and L-phenylalanine, at two doping levels  
(2500 ppm and 10000 ppm mol/mol) were prepared. The mass and amount of water that were 
used correspond to a slightly undersaturated solution at 25°C.  
Each solution was heated up and stirred at 45°C for 30 minutes to ensure complete 
dissolution of the solute. The stirring was then turned off, the solution was filtered using  
a pre-heated vacuum filter and allowed to cool down. Once the temperature reached 25°C,  
5 μL of solution was drawn into a pipette (Eppendorf, Germany) and injected directly into  
a node of the standing sound wave generated in the levitator. The collection of WAXS and 
Raman spectra and recording of the droplet images was then started. Once the solvent had 
completely evaporated, the solid sample was removed from the levitator.  
 79 
Table 3.2 Chemical composition of all investigated solutions  
Expt. # 
Solution 
volume (mL) 
Initial supersat. 
level (σ) 
Mass of  
L-Glu (g) 
Crystallisation 
temp. (°C) 
Additive 
Additive level 
(ppm) 
Additive mass 
(g) 
 1 500 0.5 11.625 35 ― ― ― 
N
u
cl
ea
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n
 a
n
d
 t
ra
n
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o
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at
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n
 t
im
e 
m
ea
su
re
m
en
ts
 (
in
-h
o
u
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) 
2 500 0.6 12.400 35 ― ― ― 
3 500 0.7 13.175 35 ― ― ― 
4 500 0.8 13.950 35 ― ― ― 
5 500 0.9 14.725 35 ― ― ― 
6 500 0.5 11.625 35 Glycine 1250 0.007 
7 500 0.6 12.400 35 Glycine 1250 0.008 
8 500 0.7 13.175 35 Glycine 1250 0.008 
9 500 0.8 13.950 35 Glycine 1250 0.009 
10 500 0.9 14.725 35 Glycine 1250 0.009 
11 500 0.5 11.625 35 Glycine 2500 0.015 
12 500 0.6 12.400 35 Glycine 2500 0.016 
13 500 0.7 13.175 35 Glycine 2500 0.017 
14 500 0.8 13.950 35 Glycine 2500 0.018 
15 500 0.9 14.725 35 Glycine 2500 0.019 
16 500 0.5 11.625 35 Glycine 5000 0.030 
17 500 0.6 12.400 35 Glycine 5000 0.032 
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18 500 0.7 13.175 35 Glycine 5000 0.034 
19 500 0.8 13.950 35 Glycine 5000 0.036 
20 500 0.9 14.725 35 Glycine 5000 0.038 
21 500 0.5 11.625 35 Glycine 7500 0.044 
22 500 0.6 12.400 35 Glycine 7500 0.047 
23 500 0.7 13.175 35 Glycine 7500 0.050 
24 500 0.8 13.950 35 Glycine 7500 0.053 
25 500 0.9 14.725 35 Glycine 7500 0.056 
G
ro
w
th
 a
n
d
 
tr
an
sf
o
rm
at
io
n
 
(s
y
n
ch
ro
tr
o
n
-
b
as
ed
) 
26 500 0.5 16.719 45 ― ― ― 
27 500 0.5 16.719 45 Glycine 2500 0.021 
28 500 0.5 16.719 45 Glycine 5000 0.043 
29 500 0.5 16.719 45 Glycine 7500 0.064 
L
ev
it
at
ed
 d
ro
p
le
t 
30 250 saturated solution 2.500 25 ― ― ― 
31 250 saturated solution 2.500 25 Glycine 2500 0.003 
32 250 saturated solution 2.500 25 Glycine 10000 0.013 
33 250 saturated solution 2.500 25 L-Alanine 2500 0.004 
34 250 saturated solution 2.500 25 L-Alanine 10000 0.015 
35 250 saturated solution 2.500 25 L-Phenylalanine 2500 0.007 
36 250 saturated solution 2.500 25 L-Phenylalanine 10000 0.028 
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Chapter 4  
Nucleation and polymorphic transformation 
studies of pure and glycine-doped  
L-glutamic acid  
In this chapter, we show that glycine used as an additive in the crystallisation of polymorphic 
L-glutamic acid significantly enhances primary nucleation events and hence solution 
mediated polymorphic transformation rates with respect to the pure system. This previously 
unreported effect was observed using single-photon laser light scattering and time-resolved 
concentration monitoring based on in-situ conductivity measurements of the crystallising 
solution. An attempt has been made to rationalise, to some extent, the observed effects that 
accompany the time evolution of the overall complexity, with and without the additive.  
In parallel, we indicate what, in our opinion, is an essential evolutionary set of the 
crystallisation stages, the nature of events in each of them and their interdependence.  
4.1  Polymorphic transformation of L-glutamic acid in the presence and 
absence of glycine additive  
4.1.1  Pure L-glutamic acid solution  
The isothermal batch crystallisation of L-glutamic acid solution at 35°C was investigated 
using solution conductivity monitoring technique (Section 3.2.1.2) that produces data that can 
easily be translated into concentration evolution information, as described in detail in  
Section 3.2.6. The experiment with pure L-glutamic acid at supersaturation σ = 0.5 was 
performed first in order to identify the physical meaning of the recorded concentration plots 
and to establish a reference for comparison with doped systems.  
The concentration evolution data from crystallisation of pure L-glutamic acid solution is 
shown in Figure 4.1. The concentration curve that was derived can be divided into four 
characteristic regions, for convenience denoted by I, II, III and IV.  
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At the beginning of the experiment the solution was supersaturated and all L-glutamic acid 
was present in a dissolved form. Hence, the concentration of L-glutamic acid was initially 
highest. After the circulation pump was started and following the initial nucleation period,  
a rapid growth of mainly the metastable α-L-glutamic acid, but also small amounts of the 
stable β form, occurred, resulting in a sudden drop in solution concentration (region I).  
In region II of the curve the L-glutamic acid concentration remained almost constant, 
suggesting that the overall number of dissolved L-glutamic acid molecules did not change 
significantly throughout that period. At that stage, dissolution of the α form and growth of the 
β polymorph were simultaneous, i.e. the polymorphic transformation occurred. Since the 
concentration curve plateau corresponds to the solubility level of the α form, it can be 
assumed that the dissolution rate of the α form is much faster than the growth of β-L-glutamic 
acid. Consequently, it is the growth of the β form that is the driving force for dissolution of  
α-L-glutamic acid. As no conversion between the polymorphic forms of L-glutamic acid was 
observed in the solid state, the transformation mechanism is thought to be ‘solution-
mediated’. 
After a complete dissolution of the α crystals, the growth of β form continued, resulting in  
a further decrease in conductivity (region III of the concentration curve). Once the saturation 
concentration of β-L-glutamic acid was attained, the growth stopped and therefore the curve 
is seen to flatten out in the last part of the concentration evolution plot (region IV).  
Although the temperature on the water bath was fixed, some small fluctuations in the 
crystallisation temperature occurred at the beginning of the experiment, shortly after the 
circulation pump was started, due to the contact of solution with both the pump and tubing 
that were not temperature controlled. Since the recorded temperature fluctuations were well 
below 0.5°C, their overall effect on the crystallisation process remains negligible. On the 
other hand, as electrical conductivity is strongly dependent on temperature, the temperature 
variations were accounted for using the ‘temperature compensation’ function on the 
conductivity meter.  
Since the duration of the transformation from the less stable α form to the stable β polymorph 
is approximately equal to the duration of the plateau (region II), using the concentration 
evolution plot shown in Figure 4.1, it was estimated that the polymorphic interconversion for 
pure solution of L-glutamic acid was equal to 5.25 hours. The α form of L-glutamic acid 
ceased to exist in solution 4.79 hours after the beginning of the experiment and the 
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equilibrium concentration with respect to the more stable polymorph was attained after  
5.98 hours.  
4.1.2  L-Glutamic acid doped with glycine  
In order to investigate the effect of glycine on the L-glutamic acid crystallisation process, 
further experiments at four additive levels, namely 1250 ppm, 2500 ppm, 5000 ppm and  
7500 ppm (mol/mol), were performed for the same supersaturation of L-glutamic acid. The 
concentration evolution curves obtained for the above-mentioned experimental conditions are 
shown in Figures 4.2-4.5.  
Unexpectedly, it was observed that between 0 and 7500 ppm of glycine, the polymorphic 
transformation rate of L-glutamic acid was increased with respect to the pure system. The 
extent to which the rate of interconversion was promoted was dependent on the concentration 
of the additive.  
The α to β form interconversion time for solutions doped with 1250 and 2500 ppm of glycine 
was found to be 4.88 hours and 4.38 hours, respectively. The transition time for solution 
doped with 5000 ppm of the additive was measured to be 4.25 hours. Upon further addition 
of glycine, at 7500 ppm, the transformation process took only 3.95 hours.  
In all four experiments with glycine used as an additive, minor temperature fluctuations were 
observed during the first few minutes of the experiments until the pump and the piping 
attained the temperature of solution. However, since the amplitude of the observed variations 
was below 0.5°C, the fluctuations were assumed to be negligible and consequently the 
process was considered to be isothermal in all investigated cases.  
It has previously been observed that the introduction of various amino acids additives, such 
as L-phenylalanine, can successfully be applied in order to hinder the polymorphic 
transformation (Kitamura and Funahara, 1994, Sano et al., 1997, Cashell et al., 2005). 
Surprisingly and unexpectedly, in this study it was found that doping the L-glutamic acid 
solution with glycine can result in an increase of polymorphic transformation rate. To date, 
this fact has not been reported in the literature.  
The increase in polymorphic transformation rate suggests that the presence of glycine may 
enhance the crystal growth rate of β-L-glutamic acid and/or facilitate the dissolution process 
of the α form. It is likely that growth/dissolution rates of only certain crystal faces are 
affected while the formation of the others remains unchanged. The actual mechanism of the  
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Figure 4.1 Concentration evolution curve for batch crystallisation of pure L-glutamic acid  
 
 
Figure 4.2 Concentration evolution curve for batch crystallisation of  
L-glutamic acid doped with 1250 ppm of glycine  
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Figure 4.3 Concentration evolution curve for batch crystallisation of  
L-glutamic acid doped with 2500 ppm of glycine  
 
 
Figure 4.4 Concentration evolution curve for batch crystallisation of  
L-glutamic acid doped with 5000 ppm of glycine  
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Figure 4.5 Concentration evolution curve for batch crystallisation of  
L-glutamic acid doped with 7500 ppm of glycine  
 
process cannot, however, be determined without further investigation of the process using 
more advanced techniques such as in-situ laser interferometry measurements of crystal faces 
growth.  
Additionally, it was noted that doped solutions where the promoting effect was observed 
became turbid much earlier than the corresponding solution without glycine, suggesting that 
the additive may also affect the nucleation stage. The presence of glycine molecules may thus 
affect the conformation of the hydrated form of L-glutamic acid molecules and thus lead to 
primary nucleation of β-L-glutamic acid. Even a small amount of stable β-L-glutamic acid 
would be enough to drive the growth towards that more energetically favoured form and 
hence increase the polymorphic transformation rate.  
While the concentration evolution monitoring technique allows quantitative measurements of 
the polymorphic transformation time, it was not designed to probe events on a molecular-
level and thus cannot be used for investigation of the nucleation phenomena. Therefore,  
a single-photon laser light scattering technique was employed to investigate the influence of 
known amounts of glycine additive on the L-glutamic acid induction time.  
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4.2  Nucleation of L-glutamic acid in the presence and absence of glycine 
additive  
4.2.1  The effect of glycine on the nucleation time of L-glutamic acid  
A single-photon laser light scattering technique (Kopswerkhoven and Fijnaut, 1981, Dhont et 
al., 1992) was employed to monitor the isothermal nucleation process from pure and glycine-
doped solutions of L-glutamic acid at 35°C. A detailed description of the experimental set-up 
is given in Section 3.2.1.1. Experimental solutions at supersaturations σ between to 0.5 and 
0.9 were prepared using the method described in Section 3.3.1.1. For each supersaturation 
level, the nucleation time was measured for pure solution and at various additive levels, 
namely 1250 ppm, 2500 ppm, 5000 ppm and 7500 ppm (mol/mol). A selection of 
experimental data from individual experiments is given in Figures 4.6-4.10 below, whereas  
a complete set of results is summarised in Figures 4.11-4.15.  
A laser light was shown through a stirred custom-designed glass cell and the output, which is 
directly related to the number of scattered photons, was simultaneously recorded. Generally, 
this time-dependent scattering follows the same pattern irrespective of the additive 
concentration; the only difference lies in the duration of induction time. The agitated 
supersaturated solution gives a uniform low-intensity background signal resulting from minor 
light scattering of solution. At this stage, the clusters that are formed are smaller than the 
critical nucleus size and hence dissociate. The occasional spikes in the spectrum result from 
statistical fluctuations due to short sampling time. When the prenuclear clusters become large 
enough to grow into a thermodynamically stable crystal, the subsequent formation of minute 
solid bodies in solution leads to increased photon scattering and can be observed as a sudden 
rise of the signal from the photon counter. The induction time corresponds to the period 
between the moment when the agitation of supersaturated solution was started and the 
moment when an appreciable increase in the number of counted photons was detected. The 
subsequent increase in the number of nucleated crystals results in a further increase of the 
output signal. As the crystallisation process proceeds, the particle density continues to rise 
with time and eventually becomes so high that the solution becomes opaque to the laser light 
and the recorded signal drops to zero.  
It was noted that a large scatter in the value of the induction time measured for the same 
conditions was observed as was expected due to the stochastic nature of the nucleation 
process (Izmailov et al., 1999). Therefore, in order to reliably assess the effect of the additive  
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Figure 4.6 Single-photon laser light scattering data on the induction time of L-glutamic acid (σ = 0.5)  
obtained in one of the nucleation experiments for pure solution  
 
 
Figure 4.7 Single-photon laser light scattering data on the induction time of L-glutamic acid (σ = 0.5)  
obtained in one of the nucleation experiments for solution doped with 1250 ppm of glycine  
 
0
50
100
150
200
0 2000 4000 6000
N
u
m
b
er
 o
f 
p
h
o
to
n
s 
Time (s) 
Pure L-glutamic acid 
τ0 = 5900 seconds 
0
50
100
150
200
0 2000 4000 6000
N
u
m
b
er
 o
f 
p
h
o
to
n
s 
Time (s) 
L-Glutamic acid doped with 1250 ppm of glycine 
τ1250ppm = 4312 seconds 
 89 
 
Figure 4.8 Single-photon laser light scattering data on the induction time of L-glutamic acid (σ = 0.5)  
obtained in one of the nucleation experiments for solution doped with 2500 ppm of glycine  
 
 
Figure 4.9 Single-photon laser light scattering data on the induction time of L-glutamic acid (σ = 0.5)  
obtained in one of the nucleation experiments for solution doped with 5000 ppm of glycine  
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Figure 4.10 Single-photon laser light scattering data on the induction time of L-glutamic acid (σ = 0.5) 
 obtained in one of the nucleation experiments for solution doped with 7500 ppm of glycine  
 
on the nucleation rate, an average of ten measurements of induction time for a pure solution 
and for each level of glycine additive was determined.  
Unexpectedly, it was found that as the additive concentration was increased, a reduction in 
the induction time was also observed. The average induction time was measured to be  
5780 seconds in pure solution and 4249 seconds in solution doped with 1250 ppm of glycine. 
An increase in the additive concentration to 2500 ppm and subsequently to 5000 ppm resulted 
in further reduction of the average nucleation time to only 1840 seconds and 771 seconds, 
respectively. Since for a given volume of solution, the nucleation rate is inversely 
proportional to the induction time (J ∝ 1/) (Van Hook and Bruno, 1949, Nielsen, 1964), the 
addition of glycine increased the nucleation rate of L-glutamic acid.  
4.2.2  The effect of glycine on the surface free energy and critical nucleus radius of  
L-glutamic acid  
Using the data on the nucleation time, τ, as a function of the degree of supersaturation,  
S = 1 + σ, plots of ln τ against T −3(ln S)−2 can be constructed from which the effect of the 
additive on the values of surface free energy, γ, and critical nucleus radius, rcrit, can be 
estimated.  
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As shown in Equation 1.17, the slope (m) of the ln τ against T −3(ln S)−2 plots can be 
expressed using the following equation  
               (4.1) 
Thus, the value of γ for a given additive level is equal to  
  √           
 
 (4.2) 
Since the critical nucleus radius can be calculated using the following formula  
      
     
      
 (4.3) 
for a given supersaturation S, the critical nucleus radius is directly proportional to the surface 
free energy (rcrit ∝ γ).  
The plots obtained for a range of investigated supersaturation levels and various glycine 
concentrations are given in Figures 4.11-4.15 below; the respective slopes were determined 
using the least squares fit for a line (y = mx + b). The calculated values of surface free 
energies are shown in Figure 4.16; the error bars correspond to the standard error returned by 
the LINEST function in Microsoft Excel.  
The value of surface free energy obtained for a pure solution was estimated to be 5.8 mJ/m
2
 
and is in good agreement with the values published in the literature (Black and Davey, 1988). 
The critical nucleus radius calculated for pure solution at S = 1.5 was equal to 10.7 Å, which, 
assuming a spherical nucleus, corresponds to 32 L-glutamic acid molecules. A general 
decrease in the value of surface free energy and critical nucleus size was noted as the 
concentration of glycine was increased and for the solution at the same supersaturation doped 
with 5000 ppm of the additive the values of γ and rcrit were reduced to 4.7 mJ/m
2
 and 8.6 Å 
(i.e. 17 molecules), respectively. This implies that glycine molecules promote formation of  
L-glutamic acid crystals by lowering the activation energy barrier.  
While it has previously been reported that the introduction of various amino acids additives 
can successfully be applied in order to suppress nucleation of α and β forms of L-glutamic 
acid (Kitamura and Funahara, 1994), it is the first time when we see the rates of this process 
being enhanced. At this stage, however, it is not possible to establish which of the two 
polymorphic forms and to what extent is affected by the presence of the additive. Therefore, 
further research aimed at understanding the physical mechanism behind the observed effect  
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Figure 4.11 Plot of the dependence of ln τ on T−3(ln S)−2 obtained for nucleation of  
pure L-glutamic acid solution  
 
 
Figure 4.12 Plot of the dependence of ln τ on T−3(ln S)−2 obtained for nucleation of  
L-glutamic acid solution doped with 1250 ppm of glycine  
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Figure 4.13 Plot of the dependence of ln τ on T−3(ln S)−2 obtained for nucleation of  
L-glutamic acid solution doped with 2500 ppm of glycine  
 
 
Figure 4.14 Plot of the dependence of ln τ on T−3(ln S)−2 obtained for nucleation of  
L-glutamic acid solution doped with 5000 ppm of glycine  
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Figure 4.15 Plot of the dependence of ln τ on T−3(ln S)−2 obtained for nucleation of  
L-glutamic acid solution doped with 7500 ppm of glycine  
 
 
Figure 4.16 Plot of the dependence of surface free energy, γ, on the level of glycine additive  
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and correlating the nucleation and polymorphic transformation rate enhancements needs to be 
pursued.  
On the other hand, at the highest investigated doping level, i.e. 7500 ppm, it was noted that 
glycine hinders the nucleation process and the average induction time in the presence of the 
additive was found to be markedly longer than in the pure solution and the estimated value of 
γ was increased when compared to the pure solution. It is likely that at high additive 
concentration glycine molecules act as obstacles in the formation of nuclei of critical size. It 
is also possible that the additive molecules may become incorporated into some of the 
growing nuclei and therefore rendering them thermodynamically unstable. As a result, the 
effective critical nucleus size and the activation energy of the solution containing high levels 
of glycine would be higher than that of pure solution and the nucleation process would be 
inhibited.  
Since it is generally accepted that molecular modifiers in solution are capable of directing 
growth morphology, but have only neutral or inhibitory effects on primary nucleation and 
growth kinetics (Elhadj et al., 2006), and because the nucleation-hindering effect of the 
additives on crystallisation of L-glutamic acid has already been reported in the literature 
(Kitamura and Funahara, 1994), further studies presented in this thesis will focus on 
elucidating the mechanistic insights of the novel promoting effect of glycine and its relation 
to the polymorphic transformation rate enhancement.  
4.3  Scanning Electron Microscopy and High Performance Liquid 
Chromatography of pure and glycine doped L-glutamic acid samples  
Scanning Electron Microscopy was employed to assess visually any possible effect of the 
additive on the growth behaviour of L-glutamic acid crystals and its potential link to the data 
presented in Sections 4.1 and 4.2. For this purpose, crystalline samples were collected from 
pure and glycine-doped solutions at equal periods of time, after the crystallisation process 
began (the beginning of region I in Figures 4.1 and 4.3), i.e. before the polymorphic 
transformation started to occur. As L-glutamic acid is a non-conducting material, the samples 
were sputter coated with a 20 nm layer of gold using an EmScope Sputter Coater SC-500A 
(Ashford, England). Scanning Electron Micrographs were taken using Philips XL30 SEM 
(Netherlands). In both samples, three typical features of the crystalline particles were 
observed (Figure 4.17):  
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(i) Almost entirely dominant prismatic shape of α-LGA particles with small traces of 
needle-like β crystals;  
(ii) An appreciably larger number and average size of β in the glycine-doped sample 
compared to their counterparts in a pure solution;  
(iii) No noticeable morphological changes of the two forms, regardless of the growth 
media.  
To establish the amount of the additive that is incorporated into the growing crystal lattice, 
High Performance Liquid Chromatography analysis was carried out using a reversed phase 
Waters 2695 HPLC system equipped with a Waters 2487 UV absorbance detector at 254 nm. 
Phase separation was performed using Waters Symmetry Shield RP18 3.5 μm 
chromatographic column with a mobile phase of water and acetonitrile (97:3 v/v, flow rate of 
1.0 mL/min). It was confirmed that, in all samples grown from doped solutions, the level of 
glycine being incorporated was less than 1.5%. It is, therefore, unlikely that such a low level 
of incorporation would be entirely responsible for the observed effect and markedly affect the 
behaviour of the subsequent crystallisation stages.  
4.4  Discussion  
In spite of the fact that in the presence of glycine α was still the principal crystallisation 
product, there is no experimental evidence that the observed β polymorph nucleation-
promoting effect (Figure 4.17b) can be solely attributed to the substantial (over three-fold) 
decrease in the induction time. We do not know which of the two forms is triggered to 
nucleate first because the applied scattering technique does not differentiate between the 
polymorphic forms. It is, however, reasonable to assume that glycine molecules accelerate 
the overall nucleation rate of both α and β forms of L-glutamic acid (Figures 4.1-4.4  
and 4.17). To account for the observed macroscopic effects brought into play by glycine is 
rather limited because the molecular-level processes involved are not fully accessible not 
only to this technique, but also to any other scattering techniques (Burton et al., 2010).  
The overall increase of the nucleation rate in the presence of glycine can be rationalised to  
a certain extent by using quite recently proposed ‘rules for additives that modulate crystal 
nucleation’ (Anwar et al., 2009). According to the generic rules based on molecular 
simulations, the promotion of nucleation rate is generally possible and could be considered 
fast if additive exists as a dimer with the effective size smaller than solute and shows  
  
 97 
 
(a)  
 
(b)  
Figure 4.17. SEM images of samples extracted shortly after the crystallisation process was started, i.e.  
at the beginning of region I: (a) crystallisation without glycine and (b) with 2500 ppm of glycine as  
an additive. α- and β-L-glutamic acid crystals are indicated in blue and yellow, respectively.  
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a relatively weak degree of affinity for the solute and solvent particles. A comparison of these 
criteria with the markedly increased nucleation rate of L-glutamic acid in the presence of the 
additive suggests that the enhancement of the nucleation process (Figures 4.6-4.10) is likely 
to be caused by the existence of such dimers that confine themselves entirely to the interface 
and are able to promote nucleation but not inhibit the process (Anwar et al., 2009). However, 
the design rules do not provide any information about the reasons that may lead to an increase 
in the nucleation rate of a particular polymorph. In addition, it has recently been reported that 
glycine exists mainly as monomers (Huang et al., 2008), not dimers (Weissbuch et al., 2005), 
in supersaturated aqueous solutions. At this stage, we argue that the enhanced nucleation of β 
(Figure 4.17b) may be due to a catalytic role of glycine monomers in the nucleation process.  
Generally, when two solutes are dissolved in water, their solvation free energy can depend on 
their relative positions. This dependence may well be due to the structural change of the 
hydrogen-bonding network of water around one solute being perturbed by the presence of the 
other solute (Chandler and Varilly, 2012). Applying this approach to glycine-doped  
L-glutamic acid implies that there is a probability that molecular dynamics of the solvated 
monomers may provide a limited range of interactive configurations, with specific values of 
the electric field generated by the two solutes, at which the initial β conformed cluster could 
be created. However, without further studies, notably the structural changes of the solution 
caused by different levels of the additive, we cannot provide deeper insights into the nature of 
the observed nucleation effects. To investigate the structural response of L-glutamic acid 
solution imposed by different levels of glycine, combined neutron scattering experiments and 
modelling techniques are required (Soper, 1996, Soper, 2001, McLain et al., 2006).  
A marked reduction in the polymorphic transformation time in the presence of glycine 
(Figures 4.1-4.5) suggests that this process is likely to be caused by a distinguishable increase 
in the number and average size of β particles (Figure 4.17b) promoted by the additive in 
region I. The former is a result of the glycine-stimulated nucleation whereas the latter 
suggests that the additive may also enhance the growth rate of these crystals. Generally, for 
the most insightful information on the influence of different levels of an additive on the 
growth rate behaviour of a crystal as a whole, the normal growth rates of all habit faces need 
to be measured separately and accurately using most advanced techniques, e.g. in-situ laser 
interferometry or atomic force microscopy. Once the equilibrium of the metastable α is 
achieved, these crystals will begin to dissolve due to the continuation of the growth of the 
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existing β particles (Kitamura, 1989). Initially, the dissolution of α particles will commence 
at the energetically preferential crystal sites – the locally stressed fields at screw/mixed 
dislocation outcrops on its facets. The conditions under which some of these localities will be 
selectively activated for etching are likely to depend on the level of stress field, i.e. the 
corresponding critical undersaturation, |σ*| (Vanderhoek et al., 1982), and the time needed for 
increasing undersaturation, |σ(t)|, to achieve and surpass this barrier. The higher the stress 
field, the lower the barrier (Cabrera et al., 1954). Bearing in mind that the rate of 
undersaturation evolution, d|σ(t)| / dt, is proportional to the overall growth rate, Rov(t), of 
primary induced β crystals, Figure 4.17 suggests that these two strongly coupled processes 
will be appreciably faster for the glycine-doped solution than those induced by their 
counterparts in the pure solution (smaller number and size of primary β). It is reasonable to 
assume that a higher rate of undersaturation does not only shorten the time required to 
achieve and surpass the critical barrier for an etch pit dissolution, but also may activate more 
etch pits of weaker stress fields (Bennema and Vanenckevort, 1979, Vanenckevort and 
Vanderlinden, 1979). The most susceptible faces for etching of an α crystal are likely to be 
those with fast growth rates. Since these rates are directly proportional to the power and 
density of growth step generators (surface densities of screw/mixed dislocations outcrops) 
(Chernov, 1989), the related faces should have small areas (low morphological importance, 
MI). According to the kinetics and MI of a single α crystal (Kitamura and Ishizu, 2000), these 
faces are either {011} or {111}. We suggest that it is these faces on which an early formation 
of etch pits and the consequent nucleation and growth of secondary β occurs due to a local 
increase of concentration with respect to β equilibrium. This proposal seems to be in good 
agreement with SEM observations of needle-like β crystals on these surfaces (Figure 4.18) 
(Cashell et al., 2003a, Ferrari and Davey, 2004). Due to the fact that at the initial stage of 
polymorphic transformation a huge number of these faces is simultaneously exposed to 
etching, it is not surprising that a small increase of primary β and their average size (growth 
rate) (Figure 4.17b) can considerably amplify the overall dissolution/growth process of the 
two forms and hence reduce the transformation time (Figures 4.7-4.9). In other words, the 
values of these two factors at the transient point (the beginning of region II, where α starts 
dissolving), can be considered as the initial conditions for solution mediated polymorphic 
transformation which play a critical role in defining the duration of this process.  
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Figure 4.18. SEM image of β crystals growing on the {011} and {111} type faces of  
α-L-glutamic acid as a result of secondary nucleation of the more stable polymorph  
in region II. Image adapted from Ferrari and Davey (2004).  
 
4.5  Conclusions  
In summary, a study of nucleation and polymorphic transformation of L-glutamic acid with 
and without glycine as an additive, presented in this work, shows that both processes are 
accelerated in the additive range between 0 and 5000 ppm. In addition, it was found that the 
two are strongly correlated; the more additive promoted primary nucleated β crystals and the 
faster their growth, the more secondary nucleated β crystals on α surfaces and hence the 
shorter the polymorphic transformation time. These serendipitous findings suggest that an 
enhancement of the transformation rate from a metastable to a stable form is feasible when an 
additive promotes a primary nucleation rate of a stable polymorph, and either has a negligible 
or enhancing effect on its overall growth rate. Also, we defined a set of most critical issues 
that we believe need to be addressed in order to get a full appreciation of the complexity of 
the observed phenomena. Generally, such comprehensive insight may contribute to an 
improved understanding of diverse polymorphic systems and open the routes for design of 
new synthetic nucleation/growth modulators. Because of the remarkable effects and 
intricacies that have emerged in this work, the most general strategy to advance the 
knowledge in the newly open research avenues would be to treat each issue separately – with 
great care.  
(011) 
(011) 
_ 
(111) 
_ 
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Chapter 5  
Evolutionary behaviour of the polymorphic 
mole fractions during crystallisation of  
pure and glycine-doped L-glutamic acid  
In order to understand the mechanism behind the transformation-promoting effect presented 
and discussed in Chapter 4, the mole fraction evolutions of the two polymorphs of L-glutamic 
acid during batch crystallisation of pure and glycine-doped solutions were investigated using 
synchrotron WAXS technique. Quantitative analysis of the obtained data confirmed that the 
presence of the additive leads to stimulated nucleation of primary β crystals. The observed 
effect is in good agreement with the hypothesis postulated earlier and implies the latter is, 
indeed, the key factor contributing to the enhancement of the polymorphic transformation 
rate.  
5.1  WAXS as a tool to monitor the mole fraction evolutions of the 
crystallising L-glutamic acid  
5.1.1 Evidence of the effect of the additive  
The evolution of mole fractions of polymorphs of L-glutamic acid during batch crystallisation 
from supersaturated solution was examined using time-resolved Wide-Angle X-ray 
Scattering (WAXS) at BESSY II synchrotron (Berlin, Germany). The experiments were 
performed isothermally at 45°C and initial supersaturation (σ) equal to 0.5, corresponding to 
33.75 g/L, for pure solution of L-glutamic acid and in the presence of glycine additive at three 
doping levels, namely 2500 ppm, 5000 ppm and 7500 ppm (mol/mol). In addition to the 
scattering data, the conductivity of solution was also recorded in order to readily assess the 
extent of the crystallisation process during the experiments. The experimental apparatus is 
described in detail in Section 3.2.1.3.  
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The typical WAXS spectra recorded as a function of time during crystallisation of 
supersaturated L-glutamic acid solution in the absence and presence of glycine are given in 
Figures 5.1 and 5.2, respectively.  
The preliminary inspection of the recorded scattering spectra allows qualitative evaluation of 
the crystallisation process and reveals the characteristic features that distinguish the process 
at the two investigated conditions:  
(i) In the presence of glycine, the α polymorph achieves its maximum concentration, 
begins to dissolve and eventually ceases to exist earlier than in a pure solution, 
suggesting that the additive enhances the polymorphic transformation rate.  
(ii) Moreover, the additive stimulates the growth of the β phase and leads to quicker 
attainment of the maximum concentration of the latter, i.e. the equilibrium with 
respect to the liquid phase.  
The above observations are in a good agreement with the conclusions made in Section 4.4 
and, indeed, confirm that glycine used as an additive has a promoting effect on both the α- to 
β-L-glutamic acid transformation rate but also enhances crystallisation of the more stable 
polymorph. However, in order to obtain quantitative information on the mole fraction 
evolutions of the two polymorphs and consequently get a deeper insight into the mechanism 
of the promoting mechanism of glycine, a more in-depth analysis of the data is required.  
5.1.2 Assessment of the mole fraction evolutions  
A batch crystalliser is a thermodynamically closed system where the total number of moles of 
L-glutamic acid remains constant throughout the experiment. The law of conservation of 
mass can thus be used to quantify the crystalline mole fraction evolutions of each of the two 
polymorphs and mole fraction evolution of the material dissolved in solution.  
  ( )    ( )           ( )           (5.1) 
Where mα(t) and mβ(t) are the mass evolutions of the crystallised α and β polymorphs, 
msolution(t) is the mass evolution of the dissolved material, and minitial is the total mass of  
L-glutamic acid that was initially dissolved during preparation of the experimental solution.  
Both sides of the above equation can be divided by the molar mass of L-glutamic acid and 
hence be expressed in terms of moles:  
  ( )    ( )           ( )           (5.2) 
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Figure 5.1 Time-resolved WAXS spectra of L-glutamic acid crystallising from pure solution  
 
 
Figure 5.2 Time-resolved WAXS spectra of L-glutamic acid crystallising from solution  
doped with 5000 ppm of glycine  
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Thus,  
   ( )   
 
 ( )   
 
        ( )  
  ( )
        
 
  ( )
        
 
         ( )
        
   (5.3) 
The scattering intensity of the X-ray beam is proportional to the mass of the corresponding 
species in the irradiated sample. Additionally, since the intensity is proportional to the area 
under the diffraction peak (Cullity and Stock, 2001), the following relationships can be 
written for the two phases of L-glutamic acid:  
  ∝   ∝    (5.4) 
  ∝   ∝    (5.5) 
The corresponding proportionality constants, kα and kβ, can now be introduced:  
        (5.6) 
        (5.7) 
The number of moles of L-glutamic acid in the irradiated section of the flow cell is 
proportional to the total number of moles in solution with the proportionality parameter K:  
                (5.8) 
Where K is the ratio of the total volume of solution to the volume of solution irradiated in the 
cell. Because of low solubility of L-glutamic acid, the change in the total volume of solution 
during the crystallisation process is negligible and the value of K can be assumed to be 
constant.  
Therefore, at any time t, the number of moles of each of the crystallised polymorphs can be 
expressed as:  
  ( )  
     ( )
        
      
  ( )
     
      (5.9) 
  ( )  
     ( )
        
      
  ( )
     
      (5.10) 
Where nα,max and nβ,max correspond to the number of moles of the crystallised material at 
equilibrium levels and can be determined from the solubility diagram.  
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Substituting Equations 5.9 and 5.10 into Equation 5.3 gives:  
   ( )   
 
 ( )   
 
        ( )
 
  ( )
     
     
        
 
  ( )
     
     
        
 
         ( )
        
   
(5.11) 
Three peaks characteristic to the α form (at 2θ of 18.26°, 23.66° and 26.66°) and three peaks 
unique to the β polymorph (at 2θ of 21.44°, 22.05° and 25.62°) were integrated in each 
spectrum. The baseline was defined based on a series of anchor points on both sides of the 
respective peak and was subsequently subtracted from the collected spectrum. The Peak 
Analyzer module of the OriginPro software package was used to integrate the area under the 
peaks. The obtained numerical data was then used to calculate the time evolutions of the mole 
fractions of the two polymorphs, n
f
α and n
f
β.  
The mole fraction evolution of the number of moles of L-glutamic in solution, n
f
solution can 
now be calculated using the rearranged Equation 5.11:  
          ( )     
 
 ( )   
 
 ( ) (5.12) 
Since solution conductivity was also recorded throughout the experiments, the latter can 
alternatively be derived from the molar concentration evolution data, csolution(t), using the 
following formula:  
          ( )  
         ( )               
        
 (5.13) 
The mole fraction evolutions of dissolved L-glutamic acid calculated using Equations 5.12 
and 5.13 are given in Figure 5.3 and show nearly identical behaviour, confirming the validity 
of the adopted approach.  
It should also be noted that the recorded WAXS peaks result from X-rays scattered over the 
sampling time. Since every second hundreds of crystals of different size flow through the 
cell, the statistical fluctuations of the data are inherently included in the recorded spectra. In 
other words, each peak is a measure of the average signal over the exposure time. 
Consequently, it is not possible to quantitatively assess the experimental uncertainty. 
Moreover, even though great care was taken during determination of peak areas, some 
measurement errors could arise during the integration process, especially for peaks of low 
intensity that cannot be easily distinguished from the fluctuating background signal.  
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Figure 5.3 Mole fraction evolution of dissolved L-glutamic acid determined using two independent methods: 
from conductivity data (blue) and from WAXS data (red)  
 
Nevertheless, since there are only a few spectra in which such peaks were integrated, i.e. at 
the initial stage of the crystallisation process and when the metastable form ceases to exist, 
the magnitude of the possible measurement error is likely to be negligible and thus a reliable 
quantitative analysis of the overall evolution of the crystallisation process can be performed. 
5.2  Mole fraction evolutions of α and β polymorphs during crystallisation 
of the pure and glycine-doped solutions of L-glutamic acid  
The method described in Section 5.1.2 was used to quantitatively evaluate the mole fraction 
evolutions of the two polymorphic phases and the evolution of the mole fraction of  
L-glutamic acid in solution. The corresponding evolutions and the plots showing geometrical 
derivations of the rates of change of these evolutions for pure solution and solutions doped 
with 2500 ppm, 5000 ppm and 7500 ppm of glycine are shown in Figures 5.4-5.11, 
respectively.  
The obtained data indicates that the mole fraction evolutions of the two crystallised phases 
and the evolution of the solution composition are strongly coupled. This implies that the time 
development of the latter is heavily dependent on the crystallisation/dissolution evolutions of  
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Figure 5.4 Mole fraction evolutions of the crystallised phases and dissolved L-glutamic acid  
determined for pure solution (blue – α, red – β, green – L-glutamic acid in solution)  
 
 
Figure 5.5 The rate of change (first derivative) of mole fraction evolutions of the crystallised phases of  
L-glutamic acid determined for pure solution (blue – α, red – β-L-glutamic acid)   
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Figure 5.6 Mole fraction evolutions of the crystallised phases and dissolved L-glutamic acid determined  
for solution doped with 2500 ppm of glycine (blue – α, red – β, green – L-glutamic acid in solution) 
 
 
Figure 5.7 The rate of change (first derivative) of mole fraction evolutions of the crystallised phases of  
L-glutamic acid determined for solution doped with 2500 ppm of glycine  
(blue – α, red – β-L-glutamic acid)  
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Figure 5.8 Mole fraction evolutions of the crystallised phases and dissolved L-glutamic acid determined  
for solution doped with 5000 ppm of glycine (blue – α, red – β, green – L-glutamic acid in solution) 
 
 
Figure 5.9 The rate of change (first derivative) of mole fraction evolutions of the crystallised phases of  
L-glutamic acid determined for solution doped with 5000 ppm of glycine  
(blue – α, red – β-L-glutamic acid)  
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Figure 5.10 Mole fraction evolutions of the crystallised phases and dissolved L-glutamic acid determined  
for solution doped with 7500 ppm of glycine (blue – α, red – β, green – L-glutamic acid in solution)  
 
 
Figure 5.11 The rate of change (first derivative) of mole fraction evolutions of the crystallised phases of  
L-glutamic acid determined for solution doped with 7500 ppm of glycine  
(blue – α, red – β-L-glutamic acid)  
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the two polymorphic phases. Moreover, it was observed that the derived evolution of the 
mole fraction of the crystallised α phase appears to be heavily dependent on the mole fraction 
of the crystallised β polymorph.  
In the discussion below, we will attempt to find a rationale behind the evolution of the 
derived mole fraction curves of the crystallised and dissolved phases, explain the reasons for 
their close mutual interdependence, correlate these evolutions to the crystallisation events and 
ultimately shed some light on the physical meaning of the obtained curves. Due to the 
complexity of the data discussed in this chapter, to facilitate the interpretation of the results, it 
will be convenient to divide the obtained curves into four distinct regions:  
I. From the beginning of the experiment until the point when the crystallised mole 
fraction of α reaches its maximum value.  
II. From the point of the maximum molar concentration of α to the point where  
β becomes the dominant crystallised form, i.e. this region corresponds to the 
plateau on the solution concentration curve.  
III. Between the end of the first concentration plateau and the inflection point on the  
β mole fraction evolution curve.  
IV. From the inflection point on the curve describing the evolution of the β mole 
fraction until the attainment of the saturation concentration with respect to the  
β form, i.e. until the crystal growth stops.  
5.2.1 Region I: pure solution of L-glutamic acid  
The solution agitation process was started when solution achieved the desired crystallisation 
temperature. During the first 4 minutes of the experiment no change in solution composition 
was observed. The period between the beginning of the agitation and the moment when the 
first diffracted peak was recorded corresponds to the nucleation time. The induction period 
was followed by concurrent primary nucleation of both α and β polymorphs and an increase 
in the mole fraction of the respective phase. It was noted that region I was almost entirely 
dominated by nucleation and growth of the metastable phase. While the increase in the 
amount of α-L-glutamic acid was rapid, the crystallisation of the β polymorph was 
significantly slower. It was also noted that the crystallisation of the two polymorphs was 
accompanied by a fast decrease in the mole fraction of dissolved L-glutamic acid, i.e. a rapid 
drop of solution concentration.  
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At the point when n
f
α achieved its maximum value (tα,max,pure = 56 min), the concentration of 
solution reached the solubility level of the less stable polymorph, i.e. the equilibrium with 
respect to the α phase. If α was the only form present in solution, the crystallisation process 
would stop here. However, due to a small amount of β-L-glutamic acid present in solution, 
the system as a whole is in a non-equilibrium state. The stable form crystals will thus 
continue to grow at the expense of the α form dissolving.  
The calculated mole fraction evolution rates reflect the changes of the corresponding mole 
fractions with time and are proportional to the crystal growth rates. Due to high solution 
supersaturation and thus high driving force for crystallisation, the rate of change of the mole 
fraction of the α crystals, which dominated the initial nucleation stage, was initially rapid. As 
the crystallisation progressed, the rate of growth of the α crystals started to slow down and, 
after reaching its maximum value, began to decrease, eventually reaching its zero value, i.e. 
the point of the maximum mole fraction of the crystallised α polymorph. On the other hand, 
the mole fraction evolution rate of the more stable β polymorph was slowly but steadily 
increasing throughout region I.  
5.2.2 Region I: L-glutamic acid solution doped with glycine  
The general shape of the three mole fraction evolution curves for solutions doped with  
2500 ppm, 5000 ppm and 7500 ppm of glycine is similar to that corresponding to a pure 
solution. However, a number of distinctive features, differentiating between the three doping 
levels, needs to be pointed out.  
The initial nucleation process in the presence of the additive resulted in formation of both 
polymorphic phases. A careful inspection of the recorded data shows that the determination 
of the nucleation time using the WAXS technique remains a challenging task. The first peaks 
of the solid phase in the solutions doped with 2500 ppm and 5000 ppm of glycine appeared 
approximately after 4 minutes, i.e. no difference in the duration of the nucleation time was 
noticed in the presence of the additive. A comparison of these results with the laser light 
scattering data discussed in Section 4.2, where over three-fold reduction of the nucleation 
time was noted, suggests that L-glutamic acid crystals that are initially nucleated in the 
presence of glycine at 2500 ppm and 5000 ppm are most likely of minuscule size. Such tiny 
crystals are known to produce broad X-ray peaks and therefore cannot be differentiated from 
the relatively strong background signal of solution. Accordingly, the scattering signal from 
crystallised L-glutamic acid is only visible in the recorded data after the crystals had grown to 
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a certain size and not just after the nuclei were formed. Therefore, one should bear this 
inherent drawback in mind when considering the WAXS technique as a tool to measure the 
nucleation time. Moreover, the above observations also imply that single-photon laser light 
scattering is a more sensitive technique for measurement of the nucleation time in the 
investigated system.  
On the other hand, the nucleation time at 7500 ppm of glycine was noticed to be more than 
two times longer than in the pure solution (tnucl,7500ppm = 10 minutes). The nucleation 
hindering effect of glycine at the highest doping level agrees with the experimental results 
presented in the previous chapter. As suggested in Section 4.2, the observed induction time 
retardation is most likely caused by the additive molecules that, at high doping level, are 
more likely to be present in the vicinity of the developing nuclei, disrupt their growth and 
consequently increase the time of formation of the critical size nuclei.  
While in the presence of glycine α was still the major initial crystallisation product,  
a noticeable increase in the number of primarily nucleated β crystals was observed when 
compared to the pure solution. Furthermore, it was noted that the amount of nucleated  
β crystals increased with increasing concentration of the additive. It was found that in the 
presence of 2500 ppm of glycine, α-L-glutamic acid attained its maximum concentration 
earlier than in a pure solution. When the level of the additive was increased to 5000 ppm, the 
maximum mole fraction of the crystallised α form was also achieved within 50 minutes 
(tα,max,2500ppm = tα,max,5000ppm = 50 minutes). However, due to nucleation hindering, an increase 
in the level of glycine to 7500 ppm resulted in the time to attain the equilibrium level of the 
metastable form being slightly delayed (tα,max,7500ppm = 52 minutes).  
The mole fraction rate evolution curves show similar behaviour irrespective of the additive 
level. The most noticeable difference in the presence of glycine was a decreased maximum  
α crystals growth rate when compared to the pure solution. In the latter case, however, the 
attainment of the maximum growth rate was followed by its sharp decline, whereas in 
solutions doped with the additive the decrease of the rate was slower. Consequently, the 
equilibrium level of the metastable form was achieved faster in the presence of the additive. 
Furthermore, a closer inspection of the mole fraction rate evolution curve of the β polymorph 
indicated that the growth rate of the primarily nucleated β-L-glutamic acid increases with 
increasing concentration of the additive.  
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5.2.3 Region II: pure solution of L-glutamic acid  
Once the solubility level of the less stable polymorph of L-glutamic acid is achieved,  
α crystals begin to dissolve due to the growth of small amounts of homogeneously nucleated 
β crystals that are metastable with respects to their equilibrium concentration (Kitamura, 
1989). The dissolution process will initially occur at the locally stressed fields at screw and 
mixed dislocation outcrops on the α crystal facets leading to the formation of etch pits 
(Figure 5.12). The faces most susceptible to dissolution are likely to be those with fast 
growth rates. It will thus be the fast-growing faces where an early formation of etch pits and  
a local increase of solution concentration with respect to the β form equilibrium occurs. 
When the concentration attains an energetically favourable level, secondary nucleation and 
subsequent growth of β on the dissolving α crystal faces takes place (also see earlier 
discussion in Section 4.4). The driving force for the dissolution of α is the growth of the  
β form. Henceforth, two different types of the stable L-glutamic acid crystals can be identified 
in the experimental solution, i.e. originating from primary and secondary nucleation. Their 
two distinctive growth pathways should therefore be considered separately. Support for the 
above hypothesis is evidenced in the collected experimental data.  
The rate of dissolution of α crystals depends on the amount and growth rate of β. At the 
beginning of region II, the β crystals present in solution are almost exclusively resulting from 
primary nucleation. An inspection of WAXS data shows that the amount of initially nucleated 
primary β and its growth rate are both fairly low. Since the amount of the latter is small, the 
dissolution of α and the corresponding heterogeneous nucleation of β crystals on the surface  
 
 
Figure 5.12 Schematic representation of formation of an etch pit at screw dislocation outcrop  
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of the metastable form are slow. At this stage, the observed change in the mole fraction of the 
stable polymorph can be predominantly attributed to the growth of the primarily nucleated  
β crystals. Due to continuous agitation, these crystals are nearly homogeneously dispersed in 
the experimental solution and thus the probability of overlap between the concentration fields 
around not only the primarily nucleated β crystals but also between the concentration fields 
of primary β and the local concentration fields generated at the etch pits of the dissolving  
α crystal is low. The primary β crystals are thus suspended in the bulk solution of fairly low 
supersaturation where the driving force is low and hence their growth is slow. Accordingly, 
the initial increase of n
f
β with time in region II was found to be slow. One could argue that 
since secondary nucleation and growth of the more stable polymorph also takes place in the 
initial stage of region II, the X-ray scattering from these newly formed β crystals should also 
affect the intensity of the recorded peaks. However, as pointed out in the discussion above, 
small crystals are known to produce broad peaks of low intensity and thus their contribution 
to the recorded WAXS signal is initially likely to be negligible.  
It is only approximately 45 minutes after the beginning of the polymorphic transformation 
when the heterogeneous β crystals, nucleated on the surface of the metastable polymorph, 
grow large enough to become detectable in the scattering spectrum. One should still keep in 
mind that the formation of β crystals, in this case the secondary β, is the driving force for 
dissolution of α-L-glutamic acid. Because of the dissolution of α, the local concentration 
fields around the etch pits on dissolving α crystal face will be higher than in the bulk solution, 
and thus the corresponding growth rate of secondary β will be higher than that in the bulk. 
The latter is manifested by a pronounced rise in the rate of n
f
β in the second half of region II.  
Further examination of the mole fraction evolutions of α and β polymorphs in region II 
reveals strong coupling between the growth of the secondary β crystals and the dissolution of 
the α phase. The fact that the two curves are nearly symmetrical suggests that the number of 
L-glutamic acid molecules consumed by the growth of the secondary β is approximately 
equal to the number of molecules released into solution by dissolving α crystals. 
Consequently, since throughout most of region II the number of dissolved L-glutamic acid 
molecules does not change significantly with time, the overall concentration of solution 
remains almost constant and a plateau can be observed on the respective evolution curve. For 
that reason, the process can be described as solution-mediated polymorphic transformation. 
However, one should be aware that the plateau is only roughly parallel to the horizontal axis 
because of the presence of small amounts of primarily nucleated β crystals in the bulk 
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solution. The slow growth of these crystals, resulting from low supersaturation in the bulk, 
contributes to the decrease of solution concentration and results in the slope being close to 
zero on the negative side. The more general point, though, is that the steepness of the slope 
depends on the amount of primarily nucleated β crystals when the polymorphic 
transformation process begins, i.e. at the point when the mole fraction of the crystallised  
α form achieves its maximum value.  
Similarly to the mole fraction evolution curves of the two polymorphs, also the respective 
curves describing the evolutions of their rates show high degree of symmetry, confirming 
strong coupling between the growth of secondary β and the dissolution α-L-glutamic acid 
faces. The observed correlation between the rates of these two processes constitutes further 
evidence supporting the crystallisation mechanism postulated above.  
5.2.4 Region II: L-glutamic acid solution doped with glycine  
The shape of the curves characterising the time dependence of the crystallised mole fractions 
of the two polymorphs for solutions doped with glycine bears a certain degree of resemblance 
to that obtained for the pure solution. Firstly, regardless of the level of the additive, the α and 
β evolution curves remain symmetrical throughout region II. Moreover, as a consequence of 
the symmetry between the curves, the characteristic plateau corresponding to the 
polymorphic transformation process was observed on the concentration evolution plot. Both 
in the presence and in the absence of the additive, a general trend was also noted that the rates 
of dissolution of α and growth of β crystals increase as the crystallisation proceeds. The 
physical reasons behind the observed behaviour of the doped solutions are the same as for the 
case without glycine and are thoroughly described in the corresponding section above.  
Despite the general similarity of the evolutions outlined above, a number of apparent features 
differentiating between the curves behaviour can be pointed out. While a plateau in the 
concentration evolution curve is present in the recorded data under all investigated 
conditions, it was observed that its duration was significantly reduced in the presence of 
glycine and that the magnitude of the effect appeared to be more pronounced when the 
concentration of the additive was increased. As shown earlier in the analysis of region I, 
although at all investigated levels of glycine the initial nucleation process was dominated by 
precipitation of the α polymorph, the amount of primarily nucleated β was found to increase 
with increasing concentration of the doping material. When the polymorphic transformation 
process begins, i.e. at the point where solution reaches the solubility level of the metastable 
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form, the growth of primary β crystals is the driving force for the dissolution of α. 
Consequently, in the presence of glycine, the dissolution of the α crystal faces is faster and 
the resulting local concentration levels around these faces are higher. As a result of the latter, 
the corresponding rates of nucleation and later growth of secondary β are also increased, 
leading to a significant reduction in the duration of the polymorphic transformation time. 
Since the enhancement of the rates of these two processes is related to the amount of the 
primary β crystals nucleated at the initial stages of the crystallisation process and since the 
latter is stimulated when the concentration of the additive is increased, the time of the α to β 
transformation decreases as the level of glycine is increased.  
The dissolution of α and consequently enhanced nucleation of secondary β is also likely to be 
affected by the adsorption of glycine molecules on the surface of the growing α crystal. The 
attachment of the additive molecules on the growing α faces leads to formation of defects and 
consequently to an increased concentration of dislocation outcrops on the α crystal faces, 
promoting dissolution of the less stable form and thus stimulating the formation of secondary 
β. It is important to note that the adsorbed molecules of glycine are not permanently 
incorporated into the crystal structure and, after certain period of time, dissolve back into the 
bulk solution. The hypothesis postulated above is supported by the growth hindering of  
α observed in region I and by the results of HPLC analysis presented in Chapter 4 showing 
that only a negligible amount of the additive becomes incorporated into the α form crystals.  
The evolution of the concentration curve in region II exhibits linear behaviour as a result of 
the polymorphic transformation process, i.e. the growth of the stable polymorph at the 
expense of the metastable form dissolving. If exactly the same number of molecules 
dissolving from the surface of α was incorporated into the growing β, the slope would be 
equal to zero, i.e. the plateau would be exactly horizontal. However, the latter would only be 
possible if all of the following conditions were met:  
 α crystals were the only form present at the beginning of the polymorphic 
transformation.  
 β polymorph was heterogeneously nucleated on the surface of α and no stable form 
crystals were present in the bulk.  
 The growth of β was entirely from the fields of locally increased concentration 
generated at the expense of the α form dissolving and such field was not perturbed by 
shear stress due to solution agitation.  
 Diffusion from the local fields of high concentration into the bulk was negligible.  
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In reality, however, the above conditions cannot be satisfied because:  
 The α to β transformation process cannot start in the absence of the latter. In real 
systems, the dissolution of α is triggered by the growth of homogeneously  
nucleated β.  
 Both homogeneously and heterogeneously nucleated β are present in solution and thus 
scattering from crystals of both origins contributes to the value of n
f
β.  
 The agitation of solution perturbs the local concentration fields and helps the diffusion 
into the bulk.  
For these reasons, the absolute value of all slopes is near zero on the negative side. However, 
due to the complex nature of the process, it is not possible to determine and quantify the 
individual influence of the above factors on the evolution of the polymorphic transformation.  
Nonetheless, it was noted that the slope of the plateau becomes more negative as the level of 
glycine is increased. Since the amount of primary β was also observed increases with 
increasing concentration of the additive, the enhanced primary nucleation of the more stable 
polymorph is therefore the most likely factor leading to the disproportion between the rates of 
dissolution of α and growth of β. The growth of primary β does not, however, violate the 
linearity of the concentration evolution curve in region II. As a result of agitation, the primary 
β crystals are well dispersed in the crystalliser and the supersaturation level around them is 
relatively low. The growth of the stable form is thus slow and approximately a linear function 
of time. Accordingly, the linearity of the concentration plateau is maintained.  
The change of the additive concentration was found to markedly affect the dissolution rate of 
α crystals. It was observed that at higher levels of glycine: (i) the increase in the α dissolution 
rate with time appears to become more pronounced, (ii) the maximum dissolution rate 
increases and (iii) the latter value is attained earlier. On the other hand, while an increase in 
the overall growth rate of β was noted, the maximum rate of β growth did not change 
significantly. One may ask, why, in contrast to the less stable α form, the presence of glycine 
does not result in an increased formation of defects in the β crystals and thus hindering the 
growth of the more stable form. The answer to this question can be given on the basis of 
conformational arguments. It is plausible to suggest that, on average, the conformation of the 
dissolved glycine molecules resembles, to a certain extent, the conformation adopted by  
α-L-glutamic acid molecules in the crystalline state and therefore the chance of their 
attachment to the growing α crystal surface is greater than to the β form. In other words, 
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glycine molecules treated as growth units are more likely to be ‘compatible’ with the growing 
α crystal structure.  
Despite the observed significant reduction in the duration of the polymorphic transformation 
time, the general shape of the mole fraction evolution curves remained almost the same 
regardless of the doping material level implying that in all cases the underlying mechanism 
governing the crystallisation process remains largely unchanged. Furthermore, the former 
shows that even a small perturbation of the initial nucleation conditions may have  
a pronounced effect on further evolution of the crystallisation process.  
5.2.5 Region III: pure solution of L-glutamic acid  
The beginning of region III coincides with the point where the curves corresponding to the 
crystallised mole fractions of α and β polymorphs intersect, i.e. where the number of moles of 
both polymorphs is equal. From that point on, as a result of further crystallisation, the number 
of moles of β exceeds the number of moles of α. The latter is followed by a fast dissolution of 
the metastable crystals and a rapid growth of β.  
The rate of dissolution of the metastable α crystals was observed to increase in the initial 
period of region III and subsequently, after achieving its maximum value, begins to decrease 
until it eventually reaches zero later in region IV. On the other hand, the growth rate of  
β crystals increases throughout the entire region III and the moment when the curve attains its 
maximum value marks the end of the region. Since the coupling between the α and β mole 
fraction evolutions is no longer present, the symmetry between the two curves breaks. As  
a result, a fast non-linear decrease of solution concentration was also observed throughout 
region III.  
It is interesting that a significant increase in the rate of growth of β and a marked decrease in 
solution concentration were observed despite already low supersaturation. Such behaviour of 
the system can be explained by the fact that the breakage of the acicular β crystals generates 
particles that act as secondary nuclei for the formation of new β crystals. Since each α crystal 
has, on average, several β nucleated on its surface (Figure 4.18), the number of secondary 
nuclei of the stable polymorph resulting from breakage of β is significantly greater than that 
generated by dissolution of α crystals. Additionally, because of their needle-like shape and 
fragility, the needles of β-L-glutamic acid are prone to further fragmentation and breakage, as 
evidenced in SEM images of the crystals extracted in region III (Figure 5.13), leading to  
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Figure 5.13 SEM image of fragmented β-L-glutamic acid crystals extracted in region III  
 
further increase in the number of secondary β nuclei and further formation and growth of new 
β crystals.  
The breakage of β results from contributions of several factors: (i) shear stress due to 
agitation, (ii) mutual collisions between the crystallised particles and (iii) collisions with the 
elements of the crystalliser, i.e. walls of the batch reactor, tubing, pump impeller blades, etc. 
The breakage conditions vary randomly and the overall process is of stochastic nature, and 
therefore it does not have a strictly defined starting point. The needles of β are nucleated at 
different times and grow at different rates. It is not possible to experimentally measure the 
growth rate of individual crystals. The obtained mole fraction evolutions of the two 
polymorphic forms are macroscopic quantities, i.e. they are derived from X-ray scattering 
data for a certain volume of solution and not from individual crystals, and therefore represent 
the average values. One could argue that it is therefore likely that some breakage events occur 
earlier, towards the end of region II, but cannot be clearly discerned in the obtained evolution 
plot. Nevertheless, the high level of symmetry observed in Figure 5.4 between the mole 
fraction evolution curves of the α and β form of L-glutamic acid and the linear evolution of 
the concentration curve in region II both imply that such events, although possible, are rare 
and their influence on the process is negligible.  
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The significant increase in the number of secondary nuclei that result from the breakage of  
β crystals will result in a dramatic increase in the number of sites on crystal facets where 
molecules of L-glutamic acid can be incorporated. It is important to note that, in parallel, 
growth of homogeneous and heterogeneous crystals, present in solution prior to the onset of 
the pronounced fragmentation of β, also occurs. However, because of the abundance of sites 
for nucleation and attachment of growth units generated during the breakage of β crystals, it 
is predominantly the first of these processes that is responsible for the observed drop in 
solution concentration and a fast increase in the number of moles of crystallised β in region 
III. While the latter two also lead to incorporation of solute molecules from the bulk solution 
into the crystal structure, their influence on the overall evolution of solution concentration in 
this region is of considerably less importance.  
5.2.6 Region III: L-glutamic acid doped with glycine  
The general shape of the mole fraction and solution concentration evolution curves for the 
solutions doped with glycine is almost identical to that obtained in the pure solution. The 
arguments presented in the discussion above, when considering the crystallisation of solution 
without the additive, are therefore also valid here. However, as emphasised earlier, the rate of 
the polymorphic transformation of L-glutamic acid was observed to increase with increasing 
concentration of glycine. Accordingly, due to considerably shorter duration of region II in the 
presence of the additive, a translation of the curves towards the origin of the time axis, i.e. to 
the left, was noted.  
A careful inspection of the data also showed that the rate of dissolution of α increases as the 
concentration of glycine is increased. Since at higher levels of the additive the number of 
dislocation outcrops is increased, the nucleation of secondary β on the surface of α is 
promoted and consequently the population of the former is increased. As discussed above, the 
majority of these acicular crystals will undergo fragmentation generating sites for further 
secondary nucleation and growth of β that act as ‘sinks’ for growth units and therefore further 
enhance dissolution of α.  
On the other hand, the rate of growth of β remained largely independent of the additive level. 
The latter may suggests that (i) the rate of dissolution of α is not the rate-determining step for 
the growth of β or (ii) that the increased availability of growth units in solution, generated by 
faster dissolution of the metastable form, is counterbalanced by the increased level of glycine 
that hinders the rate of incorporation of L-glutamic acid molecules into the β crystal structure.  
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5.2.7 Region IV: pure solution of L-glutamic acid  
In the boundary area between regions III and IV, the curves describing the evolution of 
solution concentration, crystallised mole fractions of the two polymorphs of L-glutamic acid 
and their respective rates were observed to undergo marked changes in their behaviour. These 
characteristic events are the inflection points on the α and β mole fraction curves and the 
inflection point on the concentration curve, denoted Iα, Iβ, and IC, respectively. At each 
inflection point a respective curve changes its concavity, from concave upwards to concave 
downwards at Iα and IC, and vice versa at Iβ. Moreover, the latter two were found to occur at 
the same time and coincide with the maximum growth rate of the β polymorph, whereas the 
former one was observed simultaneously with the maximum dissolution rate of α and slightly 
earlier than Iβ and IC. The fact that these characteristic points occurred almost simultaneously 
suggests a high degree of coupling and mutual dependence between the observed 
evolutionary events.  
The coexistence of the inflection points on the mole fraction evolution curves and the 
extremes on the respective rate curves can be explained on the basis of geometrical 
consideration since the rates of dissolution of α and growth of β are the first order derivatives 
of the mole fraction time evolutions of the two polymorphs. However, the fact that the 
change in the concavity of the curve is observed denotes that the inflection point corresponds 
to the moment when the system undergoes a substantial change to its physical behaviour.  
The growth of β in region III occurs at the expense of the dissolving α form. At the point 
when the rate of dissolution achieves its maximum value, i.e. when the inflection point on the 
mole fraction evolution curve of α occurs, the dissolving metastable crystals become too 
small to solely sustain the delivery of molecules required by the growth of secondary β and 
the bulk solution gradually becomes the source of L-glutamic acid. While the growth rate of  
β continues to increase, because of decreasing dissolution rate of α and decreasing solution 
concentration, the rate of increase of the growth rate cannot be maintained and an inflection 
point on the β polymorph growth rate curve is observed. At the point when the maximum 
growth rate of β is attained, corresponding to the inflection point on the β mole fraction 
evolution curve, the bulk becomes that main molecular supply of L-glutamic acid and 
consequently an inflection point on the concentration curve is observed.  
The remaining small amount of the metastable crystals undergoes fast dissolution since the 
equilibrium temperature for small crystals and their mother liquor is lower than that for the 
large ones. The latter is also known as the Gibbs-Thomson effect (Gibbs, 1948). In other 
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words, the above observation can be attributed to the fact that small particles have higher 
solubility than the large ones. As a result, the complete dissolution of α was achieved before 
the solubility level of the more stable polymorph was achieved. Consequently, in the final 
stage of the crystallisation process, the source of L-glutamic acid molecules for the growth of 
β was only the bulk solution. Since the solution supersaturation was close to the equilibrium 
level of the stable polymorph, the driving force for the growth of β was relatively low and 
thus the growth of β in the final crystallisation stage was very slow. The crystallisation 
process stopped once the equilibrium concentration with respect to the β form was achieved.  
5.2.8 Region IV: L-glutamic acid solution doped with glycine  
The α and β mole fraction and concentration curves for solutions doped with glycine exhibit 
similar evolutionary behaviour to that observed in the pure solution. Therefore, the above 
discussion on the evolution of the respective curves also holds true for solutions crystallising 
in the presence of the additive.  
It was, however, observed that the higher the level of glycine, the faster the complete 
dissolution of α is accomplished. The latter effect can be explained by the fact that, as 
discussed earlier, structural defects, such as dislocations, are more likely to form in the 
presence of additives. It is also well established that the dissolution process is favoured at 
such structural imperfections. Accordingly, the increased number of defects in the α form 
crystals nucleated and grown in solutions doped with glycine results in the dissolution 
process occurring faster in the presence of the additive than in the pure solution. Since the 
average number of defects increases with increasing concentration of the additive, the 
dissolution enhancing effect was observed to become more pronounced as the concentration 
of glycine is increased.  
Moreover, it was observed that, up to 5000 ppm of glycine, the time elapsed after the α form 
ceased to exist until the solubility level of the stable polymorph was attained was equal to 
approximately one hour and was largely independent of the additive level. The latter is due to 
the fact that at low additive levels the molecules of glycine are not likely become 
incorporated into the growing crystal structure. On the other hand, when the level of the 
additive was increased to 7500 ppm, a marked inhibition of β growth was noted. At this 
doping level, the number of additive molecules adsorbing on the surface of the growing  
β crystal faces is high enough to disrupt the incorporation of L-glutamic acid growth units, 
lead to an increased formation of defects and consequently noticeably slow down the growth 
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of the stable polymorph. However, one may ask why similar β growth hindering effect was 
not observed at 7500 ppm at earlier stages of the crystallisation process. The answer to this 
question requires consideration of the driving force for crystallisation of β. It should be borne 
in mind that in regions I, II and III, the supersaturation of solution, and hence the driving 
force for the growth of the stable form, is relatively high. Consequently, throughout the first 
three stages of the crystallisation process, the growth of β remains essentially unaffected by 
the presence of the additive. On the other hand, in region IV, the concentration is nearly equal 
to the equilibrium value with respect to the β form and thus the relative effect of glycine 
becomes large enough to become apparent in the recorded data.  
5.3 Determination of the polymorphic transformation time from         
WAXS data 
The above findings can now be used to accurately determine the duration of the polymorphic 
transformation time of L-glutamic acid. In literature, the polymorphic transformation is 
defined as the process of growth of the stable crystal form at the expense of dissolution of the 
less stable polymorph. Accordingly, the duration of the transformation is the time between 
the beginning of the dissolution process of the metastable form due to the growth of the stable 
polymorph until the complete dissolution of the former is achieved. For many years, there has 
been a strong belief that that the α form ceases to exist at the end of the first plateau on the 
concentration evolution curve, i.e. at the end of region II (Kitamura, 1989, Garti and Zour, 
1997). In this study, however, using the in-situ Wide Angle X-ray Scattering technique, it 
was showed that the complete dissolution of α is rather accomplished at the beginning of the 
second plateau and, hence, this is where the polymorphic transformation process actually 
ends. Bearing in mind that the synchrotron-based method used in this work is considered to 
be the most advanced technique available at present to study the evolution of crystallised 
polymorphs in solution, it can be concluded that the generally accepted criterion for 
determination of the duration of the polymorphic transformation should be regarded as 
incorrect as the obtained data clearly demonstrated that the complete dissolution of the less 
stable polymorph is only accomplished at the beginning of the second concentration 
evolution plateau and not at the end of the first one as previously believed.  
For clarity and convenience, the key findings concerning the evolution of the transformation 
process are summarised in Table 5.1.   
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Table 5.1 Effect of various levels of glycine on the polymorphic transformation of L-glutamic acid  
Level of glycine 
(ppm) 
Onset of the 
transformation 
(min) 
Polymorphic 
transformation 
time (min) 
Slope of the 
plateau in 
region II 
Decrease in the 
trans. time 
(tadditive / tpure) 
0 56 128 −0.0066 1.00 
2500 50 94 −0.0159 0.73 
5000 50 84 −0.0294 0.66 
7500 52 62 −0.0320 0.48 
     
5.4 Conclusions  
Following the above in-depth analysis of the parameters characterising the behaviour of  
L-glutamic acid polymorphs during crystallisation from the pure and glycine-doped solutions, 
it is possible to make conclusive statements regarding the effect of glycine on its polymorphic 
transformation:  
(i) The growth rate of the α polymorph in region I, and consequently the attainment 
of its equilibrium level, was enhanced at all investigated levels of glycine.  
(ii) Due to enhanced homogeneous nucleation of the β form crystals in the presence of 
the additive, an increase in the dissolution rate of α was observed in region II.  
(iii) The effect of the additive was found to depend on the level of glycine and thus the 
absolute value of the slope of the transformation plateau was note to increase as 
the level of glycine was increased.  
(iv) As a result, a rapid decrease in the polymorphic transformation time was observed 
as the concentration of glycine was increased.  
Despite the fact that, at present, it is not possible to identify the actual mechanism responsible 
for the enhanced nucleation of the β polymorph in the presence of glycine, this work 
demonstrates that even a relatively small amount of the additive can perturb the initial series 
of nucleation events and ultimately have a significant effect on the subsequent polymorphic 
transformation and thus on the crystallisation process as a whole. In the investigated system 
the above was manifested by an appreciable increase in the amount of primarily nucleated  
β crystals and an increased formation of defects on the growing α form faces. As a result, 
once the maximum concentration of the metastable polymorph was attained, as  
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a consequence of the former, and aided by the latter, a significant increase in the dissolution 
rate of the less stable α was observed, ultimately resulting in a marked reduction of the 
polymorphic transformation time. Therefore, it was shown that the nucleation and growth 
events at the initial stage of crystallisation are the major factors influencing further evolution 
of the process. Since through manipulation of the level of the additive these events can 
selectively be influenced, it is thus also possible to control the polymorphic transformation 
process.  
Furthermore, although the analysis and discussion presented in this work focuses on the 
dissolution and growth processes of the dimorphic L-glutamic acid, the approach taken here is 
of general nature and can be further extended to characterise the transformation process in  
a wide range of polymorphic materials.  
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Chapter 6  
Crystallisation of L-glutamic acid  
in an acoustic levitator  
Crystallisation of L-glutamic acid is typically investigated in a batch reactor or in a cell.  
On the contrary, in this chapter, using in-situ WAXS, Raman spectroscopy and droplet size 
monitoring techniques, we study the nucleation and growth phenomena accompanying 
crystallisation of L-glutamic acid from a droplet suspended in an acoustic levitator. 
Interestingly, it was found that the more stable β-L-glutamic acid is the only polymorph that 
precipitates out from a droplet. Moreover, it was observed that the onset of nucleation and 
the rate of subsequent growth can, to some extent, be manipulated using molecular additives.  
6.1  Containerless crystallisation of pure L-glutamic acid solution  
Containerless nucleation and growth of L-glutamic acid were investigated in an acoustic 
levitator at room temperature using in-situ time-resolved WAXS and Raman spectroscopy 
experiments at BESSY II synchrotron (Berlin, Germany). A digital camera was employed to 
record images of the evaporating droplet. The images were then used to determine the change 
in droplet volume with time and hence estimate the evolution of solution supersaturation.  
A detailed description of the experimental set-up is given in Section 3.2.2. Pure solution of  
L-glutamic acid was investigated first. When a 5 μL droplet was injected into the levitator, 
simultaneous recording of WAXS spectra and sample images was started.  
6.1.1 Wide Angle X-ray Scattering  
Wide Angle X-ray Scattering data recorded as a function of time during crystallisation of 
pure solution of L-glutamic acid is given in Figures 6.1 and 6.2. Selected images of the 
sample captured during the experiment are shown in Figure 6.3.  
When the investigation of the crystallisation process was started, the concentration of 
solution in the droplet was slightly below the saturation level. Initially, broad scattering  
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Figure 6.1 Time evolution of WAXS spectra for crystallisation of pure L-glutamic acid. Red and purple curves 
correspond to solution and the final crystallisation product, respectively. The bar codes represent  
the powder patterns of the two L-glutamic acid polymorphs, α (grey lines) and β (black lines)  
 
spectrum with high-intensity maximum around 2θ = 28° and low-intensity maximum around 
2θ = 41° was observed and can be attributed to the scattering of solution. As the evaporation 
of the solvent progressed, the intensity of these broad peaks decreased. Since the total number 
of moles of solute inside the droplet remains constant throughout the experiment, the 
concentration of solution was gradually increasing what eventually led to the formation of  
L-glutamic acid crystals. The characteristic peaks of the solid phase were first observed  
24 minutes after the beginning of the experiment and were identified to match the XRD 
pattern of the β polymorph of L-glutamic acid. As the crystallisation proceeded further, the 
scattering signal from solution decreased in intensity. After approximately 34 minutes all 
experimental solution had evaporated and only the solid phase peaks of the remaining 
aggregate of the β-L-glutamic acid crystals were present in the recorded spectrum. No further 
crystallisation was possible and thus the experiment was stopped. Surprisingly and contrary 
to the Ostwald’s rule of stages, it was found out that the more stable β form of L-glutamic 
acid was the first and only polymorph that crystallised from a droplet.  
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Figure 6.2 Selected WAXS patterns (left) and Raman spectra (right) for crystallisation of pure L-glutamic acid. Red and purple lines  
correspond to solution and the final crystallisation product, respectively. The bar codes representing powder patterns and reference  
Raman spectra of the two L-glutamic acid polymorphs, α (grey lines) and β (black lines), are given at the bottom of each figure  
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Figure 6.3 Selected images of the shadow of the sample used to determine the change in its  
volume with time for a typical pure L-glutamic acid crystallisation experiment 
t = 0 min t = 3 min t = 5 min 
t = 7 min t = 9 min t = 11 min 
t = 13 min t = 15 min t = 17 min 
t = 19 min t = 21 min t = 23 min 
t = 25 min t = 27 min t = 29 min 
t = 31 min t = 33 min t = 35 min 
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One could argue that small short-lived crystals of the metastable α-L-glutamic, on which the 
stable β polymorph quickly nucleates due to high solution supersaturation, may actually 
form. Such tiny crystals would produce broad WAXS peaks that could be indistinguishable 
from the water background. However, since the molecular conformations of the two 
polymorphs of L-glutamic acid are significantly different through a torsion angle in the main 
carbon chain, they can, even in solution phase, be distinguished by Raman spectroscopy, as 
has been shown by Ono et al. (2004). If those tiny metastable crystals were present in 
solution just before nucleation of the β phase took place, the respective signal should appear 
in the recorded Raman spectrum. Therefore, in order to further confirm that the β form of  
L-glutamic acid is indeed the only one that precipitates from a droplet, additional experiments 
using combined in-situ WAXS and Raman spectroscopy were carried out.  
6.1.2 Raman spectroscopy measurements  
In the beginning of the experiment, the Raman spectra (Figure 6.2) display broad signals of 
water at 1642 cm
-1
 and around 3500 cm
-1
. During the induction period some additional weak 
peaks were also noted at 858 cm
-1
, 917 cm
-1
, 1357 cm
-1
 and 1419 cm
-1
. These peaks could 
result from molecular clusters of dissolved L-glutamic acid but cannot be assigned to  
a specific polymorph. The existence of such prenucleation clusters in supersaturated solutions 
has been reported in numerous experimental studies. Most of these studies, however, do not 
provide direct evidence about the structure of the clusters or their influence on the solid state 
outcomes (Erdemir et al., 2007). First signal of the crystalline phase appears after  
25.5 minutes and corresponds to the β polymorph (characteristic peaks at 575 cm-1, 705 cm-1, 
800 cm
-1
, 1145 cm
-1
 and 1214 cm
-1
). As the crystallisation process progressed, these peaks 
were observed to increase while the broad signals of the solvent became less pronounced. No 
further changes in the Raman spectrum were noted after 37 minutes. The time evolution 
behaviour of the simultaneously recorded X-ray diffraction pattern was consistent with our 
previous findings. In both WAXS and Raman data no metastable phase was detected.  
The simultaneous WAXS-Raman experiments were subsequently repeated at lower 
temperature, to investigate precipitation from a droplet when the process is slowed down, and 
in a stream of dry nitrogen, where the crystallisation rate was increased due to faster 
evaporation of the solvent. In all of these complementary experiments, the recorded signal of 
WAXS and Raman could only be assigned to β-L-glutamic acid. The only difference that was 
noted was the duration of the crystallisation process.  
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6.1.3 Sample volume and aspect ratio  
The images of the sample recorded during the experiment (Figure 6.3) were used to 
determine the change in its volume and aspect ratio (Figures 6.4 and 6.5, respectively) as 
evaporation of the solvent proceeded.  
The volume of the sample was observed to decrease with time due to solvent evaporation 
(Figure 6.4). Since at constant external conditions of temperature, pressure and humidity, the 
total number of moles of solvent leaving the system per unit time is proportional to the 
surface area of the droplet (dnsolv / dt ∝ 4πr
2
), the evaporation rate was found to decrease with 
time due to shrinking of the sample. Consequently, the volume evolution curve has a concave 
shape.  
Before crystallisation commences, the recorded change in volume of the sample corresponds 
solely to the change in volume of solution (dnsolv / dt = −ρsolv dVsample / Msolv dt, where ρsolv and 
Msolv are the density and molar mass of the solvent, respectively, and Vsample is the volume of 
the sample). Thus, for time t less than 24 minutes, a second degree polynomial fit to the 
experimental data describes the change in volume of the solvent as a function of time. 
However, one should bear in mind that once crystals start to form on the surface of the 
droplet, the measured volume of the sample becomes the sum of the volume of solution and 
the volume of the crystallised material. Thus, a departure from the fit is observed at the final 
stage of the crystallisation process when the sample consisted mainly of L-glutamic acid 
crystals. For the latter reason, although no solution phase was present at the end of the 
experiment, the final volume of the sample was estimated to be approximately 0.3 μL and 
corresponds to the volume of the crystalline aggregate that remained levitated after all 
experimental solution had evaporated.  
It was noted that initially the width of the levitated sample was greater than its height. This 
deformation to an ellipsoidal shape is caused by the anisotropic acoustic force field, in which 
the axial levitation force is some five times greater than the radial one (Trinh and Hsu, 1986). 
The aspect ratio (Dh / Dv) was found to decrease with time and eventually approach 1.0 as  
a result of a faster decrease in Dh than in Dv which is caused by an increase in surface tension 
and hence lower deformability of the droplet as it shrinks during evaporation (Kastner et al., 
2001). In the final stage of the experiment the aspect ratio of the sample was observed 
fluctuate significantly, being either markedly below or above 1.0. These variations can be 
attributed to the fact that after about 30 minutes the levitated sample comprised  
  
 133 
                
Figure 6.4 Change in volume of the sample as a function of time  
for a typical pure L-glutamic acid crystallisation experiment  
 
 
Figure 6.5 Change in the aspect ratio and the horizontal and vertical diameters of the sample  
as a function of time for a typical pure L-glutamic acid crystallisation experiment  
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predominantly of a non-spherical β-L-glutamic acid crystal aggregate that was rotating in the 
acoustic field (cf. Figures 6.2 and 6.3).  
6.2 Molar concentration and crystallised mole fraction evolutions  
6.2.1 Assessment method  
Since the total number of moles of L-glutamic acid in the system does not change with time, 
the sum of the number of moles of L-glutamic acid in solution phase and that in the solid state 
is equal to the total initial number of moles of L-glutamic acid that was used to prepare the 
experimental solution. Because the β polymorph was the only form that precipitated, the 
following relationship can be written:  
                          (6.1) 
Hence,  
          (  
      
        
)           (6.2) 
The integral of the β-L-glutamic acid WAXS peaks (the area under the peaks) is directly 
proportional to the mass, and therefore the number of moles, of the crystallised material. 
Thus, assuming that all of the dissolved material crystallised when the solvent has completely 
evaporated, at any time t, the crystallised mole fraction is equal to:  
       ( )  
      ( )
        
 
      ( )
      
 (6.3) 
The volume of the droplet at time t is equal to the sum of the volume of solution and the 
volume of the crystallised material at time t.  
       ( )           ( )        ( ) (6.4) 
Thus,  
         ( )         ( )        ( ) (6.5) 
Since the volume of the crystallised L-glutamic acid is proportional to the mass, and so the 
number of moles, of the crystallised material, the change in volume of solution with time can 
be written as:  
         ( )         ( )   
 
     ( )         (6.6) 
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Consequently, the evolution of the molar concentration of solution with time can be described 
using the following equation:  
 ( )  
         ( )
         ( )
 
[  (      ( )       ⁄ )]          
       ( )  (      ( )       ⁄ )        
 (6.7) 
The combined WAXS and droplet volume evolution data could thus be used to determine the 
concentration and crystallised mole fraction evolution curves for the crystallising solution of 
L-glutamic acid (Figures 6.6-6.8). Due to the reasons discussed in Section 5.1.2, the 
experimental uncertainty cannot be quantified but the possible experimental error is likely to 
be negligible.  
6.2.2 Physical meaning of the key points on the evolution curves  
The obtained concentration evolution curve can be divided into two segments:  
 Region I, before nucleation of β-L-glutamic acid crystals occurred, i.e. when  
n
f
cryst = 0, where the increase of solution concentration results solely from the solvent 
evaporation process. The change in concentration in this region is only a function of 
the volume of the droplet and can be described using the following equation:  
 ( )  
        
         ( )
 (6.8) 
 Region II, after nucleation and crystal growth of β-L-glutamic acid began to take 
place, i.e. n
f
cryst > 0, where the change in concentration is a result of two competing 
processes: solvent evaporation and incorporation of L-glutamic acid molecules into 
the structure of growing crystals. Accordingly, additional term accounting for  
a decrease in the number of molecules available in solution needs to be introduced 
into the equation describing the concentration evolution curve:  
 ( )  
        
         ( )
 
      ( )
         ( )
 (6.9) 
The concentration of L-glutamic acid in the droplet was initially equal to the saturation level 
at room temperature, cinitial = 10 g/L = 68 mmol/L. As the evaporation of the solvent 
progressed, the volume of the droplet decreased and thus the concentration of solution was 
found to gradually increase with time. For the same reason, the rate of change of 
concentration was observed to increase throughout region I and achieved its maximum at its 
final stage (d
2
c / dt
2
 = 0 and dc / dt > 0), just before crystallisation of the solute began.  
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Figure 6.6 Molar concentration and crystallised mole fraction evolution curves determined for  
a typical pure L-glutamic acid solution crystallising from a droplet  
 
 
Figure 6.7 The rate of change (first derivative) of concentration and crystallised mole fraction evolution curves 
determined for a typical pure L-glutamic acid solution crystallising from a droplet   
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Figure 6.8 The rate of change of the rate of change (second derivative) of concentration and crystallised mole 
fraction evolution curves determined for a typical pure L-glutamic acid solution crystallising from a droplet  
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place, the concentration change rate began to drop due to formation and growth of crystals 
and thus the inflection point I1 can be seen on the concentration evolution curve. However, at 
this stage, solvent evaporation appeared to be still the dominating process and hence the 
concentration of solution continued to increase until it reached its maximum value (dc / dt = 0 
and c > 0) at point M.  
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that leave the solution phase to adsorb on the growing crystals faces exceeded the increase 
resulting from solvent evaporation. Consequently, concentration of solution began to fall. 
Since solution supersaturation, which is a function of concentration, is the driving force for 
crystal growth, point M of the maximum concentration coincides with the inflection point I2 
where the rate of increase of the crystallised mass fraction is highest, i.e. where the value of 
d
2
(n
f
cryst) / dt
2
 achieves its maximum.  
-0.06
-0.04
-0.02
0.00
0.02
0.04
0.06
-0.03
-0.02
-0.01
0.00
0.01
0.02
0.03
0 10 20 30 40
d
2
(n
f c
ry
st
)/
d
t2
 
d
2
c/
d
t2
  
Time (min) 
 138 
The total crystallised number of moles of L-glutamic acid continued to increase as 
crystallisation proceeded. The inflection point I3 on the crystallised mole fraction evolution 
curve (Figure 6.6) corresponds to the moment when the crystal growth rate was highest 
(d
2
(n
f
cryst) / dt
2
 = 0 and d(n
f
cryst) / dt > 0). At this point, the effective crystal surface area 
available for attachment of L-glutamic acid molecules was largest. However, crystal 
aggregation began to occur at later stages of the experiment. The latter phenomenon resulted 
in several types of events taking place inside and on the surface of the droplet:  
 Inner faces of adjacent crystals becoming unavailable for adsorption of L-glutamic 
acid molecules due to intergrowth.  
 Formation of occlusions where crystal growth proceeds only until saturation 
concentration of the trapped solution is achieved.  
 Peripheral crystals eventually having their surface outside bulk solution.  
As a result, the accessible surface area began to decrease and growth hindering was observed.  
It was noted that the inflection point I4 on the concentration evolution curve, where the rate of 
decrease of solution concentration is highest (d
2
(n
f
cryst) / dt
2
 = 0 and d(n
f
cryst) / dt < 0), lagged 
in time with respect to the point I3 corresponding to the maximum rate of crystal growth. As 
mentioned above, the concentration of solution in region II is a function of the volume of the 
droplet and the crystallised mass fraction. Even though from point M onwards the latter 
component is dominating, the former one is also present for the duration of the entire 
experiment. Evaporation of the solvent effectively increases the concentration of solution and 
thus shifts the inflection point on its evolution curve later in time. The faster the evaporation 
rate, the later would the inflection point on the concentration curve occur. Conversely, in  
a system where the volume of the solvent does not change with time, such as a batch 
crystalliser, the inflection points I4 and I3 on concentration and crystallised mass fraction 
evolution curves, respectively, would coincide.  
The inflection point I5 on the crystallised β-L-glutamic acid mole fraction evolution curve, i.e. 
where the rate of decrease of the crystallised mass fraction achieves its maximum, i.e. where 
the value of d
2
(n
f
cryst) / dt
2
 is lowest, corresponds to the moment when solution enters the low 
supersaturation region. From that point on, assuming spiral growth mechanism, the 
approximation of the Burton-Cabrera-Frank (BCF) equation changes from R ∝ σ to R ∝ σ2 
(c.f. Section 1.5). In other words, as the supersaturation becomes low, a decrease in the 
crystal growth rate is observed since the growth law changes from linear to parabolic.  
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Synchrotron radiation penetrates through the droplet and the obtained WAXS signal is the 
value resulting from scattering of the entire irradiated volume. However, due to evaporation 
of solvent from the surface, a gradient of solution concentration exists along the radius of the 
droplet. The local concentration is always highest at the surface, where removal of the solvent 
from the system occurs, and decreases towards the centre of the droplet. Therefore, 
throughout the whole experiment, the chemical potential of the liquid phase at the surface of 
the droplet is greater than the chemical potential of the solid phase (μL > μS). Consequently, 
the crystal growth and the resulting depletion of concentration continued even after the 
average concentration of solution calculated using WAXS data fell below the value 
corresponding to the saturation level at 25°C, until all of solution has completely evaporated.  
6.2.3 Chemical potential and the irreversible change in entropy  
The chemical potential of a substance in solution can be expressed as:  
            (6.10) 
Where R is the ideal gas constant, T is the temperature, μ0 is the standard chemical potential 
and ac is the solute activity expressed on a molar basis, which is related to concentration, c, 
through the corresponding activity coefficient, γL, by:  
       (6.11) 
For non-electrolyte solute in a dilute solution (concentrations about 0.1 molar and lower), the 
relative activity of the solute can be approximated by its concentration (Foulkes, 2012). 
Therefore, the following expression for the chemical potential can be used:  
           (6.12) 
Since the maximum concentration of L-glutamic acid in a droplet is of the above order of 
magnitude, the chemical potential in the liquid phase, μL, can be written as:  
             (6.13) 
Accordingly, the chemical potential of the solute in a solid state is equal to:  
             (6.14) 
The difference in the chemical potential between the liquid and solid phase, Δμ, can thus be 
expressed as follows:  
                       (6.15) 
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Now, taking the final stage of the droplet crystallisation process as a reference point  
(RT ln cS = 0), the difference in the chemical potential with respect to the crystal at a given 
time t is equal to:  
       ( )        ( ) (6.16) 
Irreversible entropy that is produced by the chemical reactions going on in the system is 
equal to:  
     
  
 
 
 
  (6.17) 
Where A is the chemical affinity, which is the driving force for the reaction, i.e. the difference 
in chemical potentials, and r is the net conversion rate, i.e. the net rate of molecule 
incorporation.  
When crystallisation of L-glutamic acid in a levitated droplet is concerned, the chemical 
affinity corresponds to the difference in chemical potential and the crystallisation rate is equal 
to the rate of change of crystallised mole fraction. However, since thermodynamics stipulates 
that at constant conditions of pressure and temperature reactions proceed in a direction that 
lowers the Gibbs free energy of the system (ΔG < 0), the difference in the chemical potential 
will be a negative number and hence the absolute value of Δμcryst should be taken. The 
irreversible change of entropy with time for the instigated system, from the moment when the 
nucleation process starts until the solute has completely crystallised, can thus be expressed 
using the equation below and is shown in Figure 6.9:  
     
  
 
|       ( )|
 
 (       )
  
  |    ( )|
 (       )
  
 (6.18) 
The total entropy change of a system is, however, the sum of two contributions:  
                (6.19) 
Where dSheat results from heat and mass flux with the surroundings and dSirr is the 
irreversible change of entropy due to the system going from one state to another. Therefore, 
the total entropy change for an irreversible process depends on how that state is achieved.  
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Figure 6.9 Irreversible change of entropy for a typical pure L-glutamic acid  
solution crystallising from a droplet  
 
6.3  Why is β-L-glutamic acid the only polymorph that forms in an acoustic 
levitator?  
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means of controlling polymorph selection. Despite its fundamental and technological 
importance, our ability to control polymorph formation is still far from being solved because 
of our extremely poor understanding of the underlying microscopic kinetic processes 
occurring during crystallisation of polymorphic systems.  
Several approaches for controlling nucleation and selection of polymorphic forms of  
a compound have been pursued through crystallisation with tailor-made soluble additives 
(Weissbuch et al., 1991, Lahav and Leiserowitz, 1993), epitaxial growth (Bonafede and 
Ward, 1995, Mitchell et al., 2001), laser-induced nucleation (Zaccaro et al., 2000), 
crystallisation in capillaries (Chyall et al., 2002, Hilden et al., 2003), confinement within 
porous materials (Ha et al., 2004), and more traditional methods, such as varying solvent, 
temperature, and extent of supersaturation. Most high throughput polymorph generation is 
limited to combinatorially changing solvent, temperature, and supersaturation conditions 
(Peterson et al., 2002). Such approaches do not explicitly address the vital role of nucleation 
despite the fact that this is the critical step in controlling the phenomenon of polymorphism.  
In the context of this work, there are two critical questions to be answered: (i) Why at the 
isothermal conditions only the stable β form crystallises from a levitated droplet and (ii) why 
the onset of crystallisation occurs at supersaturations which are several times bigger than 
those that can be achieved by cooling stagnant solution in a closed container?  
6.3.1 Thermodynamic consideration of nucleation in the bulk  
To begin with, it is worth considering the nucleation process in the bulk solution from the 
thermodynamic point of view. In general, the change in the Gibbs free energy of a system is  
a function of the change in its enthalpy and entropy and is defined as:  
          (6.20) 
Where ΔH is the change in enthalpy, ΔS is the change in entropy and T is the temperature.  
The change in enthalpy is negative when heat is being released from a system (exothermic 
process), whereas the change in entropy is positive when a system is becoming more 
disordered. While both decrease of enthalpy and increase of entropy are thermodynamically 
favourable, in order to determine the spontaneity of a process, the overall change in the Gibbs 
free energy must be taken into consideration. Under constant conditions of temperature and 
pressure, a process can occur spontaneously only if the change in the Gibbs free energy of the 
system is negative (ΔG < 0).  
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The change of the Gibbs free energy during formation of α and β polymorphs of L-glutamic 
acid can be written as follows:  
             (6.21) 
             (6.22) 
In batch crystallisation, the metastable α polymorph is kinetically favoured and forms first 
from a supersaturated solution (|ΔG α| < |ΔG β|). Since the values of the change in enthalpy 
during formation are comparable for both L-glutamic acid polymorphs (ΔH α ≈ ΔH β) (Deij et 
al., 2007), the absolute change in entropy of formation must be greater for the more stable 
form of L-glutamic acid (|ΔS α| < |ΔS β|). The following energy change diagram for 
crystallisation of the two polymorphs of L-glutamic acid can thus be produced (Figure 6.10).  
While the above semi-qualitative explanation shows, to some extent, why, from  
a thermodynamic point of view, the initial formation of the α polymorph may be favoured in 
the bulk solution, the principle does not seem to operate for crystallisation from a droplet 
where the Ostwald’s rule of stages is not followed. However, one should bear in mind that 
these two systems provide two very different environments for the crystallising solutions and 
consequently should be considered separately.  
 
 
 
Figure 6.10 Schematic representation of the change of enthalpy and entropy during crystallisation of α and β 
polymorphs of L-glutamic acid  
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6.3.2 Crystallisation from a levitated droplet in the light of classical nucleation theory  
Figures 6.2 and 6.6 show typical time-dependent evolutions of concentration and WAXS and 
Raman spectra in the levitated droplet of L-glutamic acid solution. At the same point of time 
(t ≈ 24 min), all three undergo the first pronounced change in their evolutionary behaviour. 
This is manifested by a decrease in the concentration rate (inflection point I1 in Figure 6.6) 
and simultaneous occurrence of appreciable peaks of the stable β phase on WAXS and 
Raman spectra (Figure 6.2). Further evolution of the latter two spectra indicate that, from this 
point until the accomplishment of the crystallisation process, the relaxation of the metastable 
solution of the droplet takes place exclusively through the formation of the β form. This 
surprising and entirely new effect demonstrates that different experimental techniques and 
strategies may provide not only a new mode of polymorph selection from a pure solution but 
also open many fundamental questions on how nature finds intriguing ways to help 
crystallisation of a stable polymorph, the process that does not follow the most credited and 
widely accepted Ostwald’s rule of stages (Ostwald, 1897). In addition, we find that 
supersaturation at which the containerless nucleation process begins in a droplet of  
L-glutamic acid was almost an order of magnitude higher than that in a stagnant solution 
enclosed in a traditional container such as a growth cell or a batch crystalliser. Here, we shall 
try to give a brief and purely qualitative rationale for these novel observations by focusing 
only on the possible prenucleation events that lead to the formation of only the stable  
β crystals.  
At initial point of time (t0 = 0) the solution in the droplet is slightly undersaturated. At this 
stage the structure of the levitated droplet can be considered as a phase with complete 
translational and rotational symmetry, and both are isotropic and homogeneous. Because of 
evaporation of water molecules, the solution enters the state of metastability accompanied 
with the onset of small density and orientational fluctuations. Further evaporation of the 
solvent results in two simultaneous and time-dependent processes: (i) a permanent increase in 
the average supersaturation and (ii) the spatio-temporal changes of the size distribution, 
density and microstructure of the evolving inhomogeneities. The former one is characterised 
by somewhat higher concentration of L-glutamic acid at the surface than in the centre of the 
droplet, whilst the latter is accompanied by the tendency of smaller subcritical nuclei of  
a new phase to disappear but for the larger ones to grow. The absence of crystallisation of the 
metastable α form and its consequent solution mediated transformation into a stable β form 
indicates that factors such as microscopic thermodynamic pathways and kinetics of the 
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building up supersaturation in a levitated droplet, including its interfacial interaction with air, 
are quite distinctive from those in a crystallisation cell or a batch crystalliser.  
It spite of fact that classical nucleation theory (CNT) provides some insight into the essential 
physics of nucleation and growth of crystals (Turnbull, 1969, DeBenedetti, 1996, Onuki, 
2002), it cannot provide a rationale for the selective nucleation of only β form of L-glutamic 
acid during isothermal containerless crystallisation from a levitated droplet. The principle 
limitation of this theory lies in the assumption that all properties of even very small 
crystallites (subcritical nuclei) are the same as in their bulk crystals and differ from them only 
in their relatively large surface-to-volume ratio. For that reason, the classical theory cannot 
identify or be used to study different crystallisation pathways as various order parameters do 
not all change at the same time.  
6.3.5  Qualitative rationale for selective crystallisation of β-L-glutamic acid in  
an acoustic levitator  
At the beginning of our discussion of why β is selectively formed during containerless 
crystallisation, it is important to note that a levitated droplet is a thermodynamically open 
system where water molecules are released from the surface into the surroundings. As a result 
of evaporation, a radial gradient of concentration is generated inside the droplet with the 
concentration of L-glutamic acid molecules being highest at the air-droplet interface  
(Figure 6.11). Consequently, nucleation is most likely to take place at the surface. We argue 
that the freedom of movement of molecules in the prenucleation stage in a droplet is greater 
than in the bulk because of imbalance of the attractive forces at the interface in the former 
case (Figure 6.12). Accordingly, the probability of L-glutamic acid locally adopting  
a conformation similar to that of the β form is greater at the surface than in the 
centrosymmetric bulk. Consequently, we suggest that the resulting reduction in the nucleation 
barrier for the β phase would be enough to lead to the direct formation of only the more 
thermodynamically stable polymorph.  
However, it should be borne in mind that X-ray scattering from minuscule crystals results in 
broad peaks that can be indistinguishable from a relatively strong signal of water. Moreover, 
as observed in Section 6.1, when crystallisation of L-glutamic acid is concerned, Raman 
spectroscopy was found to be less sensitive method than WAXS as the first Raman peaks 
corresponding to the solid phase appeared approximately one and a half minutes after than 
the first signal from the latter technique was recorded. Therefore, one may ask a question:  
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 Saturated solution  Increasing metastability  Nucleation at the surface 
 
Figure 6.11 Evolution of solution concentration in a levitated droplet  
 
 
 
 
 
 (a)  (b)  
Figure 6.12 Schematic representation of the balance of attractive forces  
(a) in the bulk and (b) at the surface of a droplet  
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‘How do you know whether small amount of the α form was not present in solution before 
the first WAXS and Raman signals were observed, i.e. below the detection limit of these 
techniques?’ To answer this question, we should consider the conditions for the growth of  
α and the subsequent polymorphic transformation in the interval of time between the moment 
when solution achieved metastability and when the first WAXS peaks were observed. If the  
α form was indeed nucleated, because of high and increasing solution supersaturation, the  
resulting driving force for its crystallisation would lead to its further growth and the 
respective signal of α would eventually become detectable in the recorded spectra. 
Furthermore, as shown in Chapters 4 and 5, the transformation from α to β is a slow process 
lasting dozens or even hundreds of minutes. Therefore, we argue that it would be physically 
impossible for α to completely transform to β within the timescale of the experiment.  
It was also observed that the onset of crystallisation in a levitated droplet occurs at 
supersaturations which are an order of magnitude higher than those that can be achieved by 
cooling stagnant solution in a closed container. The latter suggests that formation of the new 
solid phase in a typical batch crystalliser is, in fact, predominantly a heterogeneous process 
where container walls, tubing and agitator blades act as centres for nucleation. On the other 
hand, excluding trace amounts ambient dust particles and water or solute impurities that can 
never be completely removed, solution contained in a droplet is free of contact with any 
foreign bodies. Consequently, it can be assumed that during containerless crystallisation it is 
the homogeneous component that plays the key role in the nucleation process.  
6.4  Containerless crystallisation of L-glutamic acid solution doped with 
additives  
Further experiments probing crystallisation of levitated samples of L-glutamic acid solution 
were performed in the presence of three different amino acid additives, namely glycine,  
L-alanine and L-phenylalanine. Each of the additives was investigated at two doping levels, 
2500 ppm and 10000 ppm. Selected WAXS spectra for the range of investigated conditions 
are shown in Figures 6.13-6.18.  
6.4.1 Results  
In all investigated samples, the WAXS peaks were observed at exactly the same positions 
corresponding only to the β polymorph of L-glutamic acid. It is particularly interesting that 
even in the presence of L-alanine or L-phenylalanine, the additives that are generally accepted  
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Figure 6.13 Selected WAXS spectra for a typical crystallisation of L-glutamic acid doped with 
2500 ppm of glycine. Red and purple lines correspond to solution and the final  
crystallisation product, respectively. The bar codes represent the powder patterns of the two 
L-glutamic acid polymorphs, α (grey lines) and β (black lines). 
Figure 6.14 Selected WAXS spectra for a typical crystallisation of L-glutamic acid doped with 
10000 ppm of glycine. Red and purple lines correspond to solution and the final 
crystallisation product, respectively. The bar codes represent the powder patterns of the two 
L-glutamic acid polymorphs, α (grey lines) and β (black lines). 
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Figure 6.15 Selected WAXS spectra for a typical crystallisation of L-glutamic acid doped with 
2500 ppm of L-alanine. Red and purple lines correspond to solution and the final 
crystallisation product, respectively. The bar codes represent the powder patterns of the two 
L-glutamic acid polymorphs, α (grey lines) and β (black lines). 
Figure 6.16 Selected WAXS spectra for a typical crystallisation of L-glutamic acid doped with 
10000 ppm of L-alanine. Red and purple lines correspond to solution and the final 
crystallisation product, respectively. The bar codes represent the powder patterns of the two 
L-glutamic acid polymorphs, α (grey lines) and β (black lines). 
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Figure 6.17 Selected WAXS spectra for a typical crystallisation of L-glutamic acid doped with 
2500 ppm of L-phenylalanine. Red and purple lines correspond to solution and the final 
crystallisation product, respectively. The bar codes represent the powder patterns of the two 
L-glutamic acid polymorphs, α (grey lines) and β (black lines). 
Figure 6.18 Selected WAXS spectra for a typical crystallisation of L-glutamic acid doped with 
10000 ppm of L-phenylalanine. Red and purple lines correspond to solution and the final 
crystallisation product, respectively. The bar codes represent the powder patterns of the two 
L-glutamic acid polymorphs, α (grey lines) and β (black lines). 
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to hinder the nucleation and growth rates of β-L-glutamic acid and thus stabilise the  
α polymorph (Staab et al., 1990, Weissbuch et al., 1994, Kitamura and Funahara, 1994), no 
peaks that could be attributed to the metastable form were observed. As noted in the 
discussion below, the above-mentioned doping materials were also found to supress the onset 
of the crystallisation process. Consequently, due to longer evaporation time, the background 
signal of the solvent at the moment of nucleation in the doped sample is weaker than in a pure 
solution. For these reasons, if small α form crystals were formed in a droplet, they would be 
likely to give an appreciable signal in the recorded spectrum. Thus, the lack of the  
α-L-glutamic acid peaks in the presence of the transformation hindering agents further 
supports the hypothesis postulated in Sections 6.1.1 and 6.1.2 that the metastable polymorph 
does not nucleate during crystallisation in the acoustic levitator.  
The scattering intensity is proportional to the volume of the irradiated sample. Because the 
solid material that precipitates out from a droplet forms a non-uniform crystalline aggregate, 
the intensity of the scattering peaks depends on the spatial orientation of the sample in the 
standing wave node. In Section 6.1.3 it was noted that the levitated sample was in constant 
rotational motion caused by the acoustic field. Therefore, a variation of the maximum 
scattering intensity between different samples and fluctuations of the peak intensity for 
different measurements of the same sample were observed. The time evolution of the 
recorded peaks has been discussed in detail in Section 6.2 and thus will not be discussed 
further here.  
The obtained WAXS spectra were used to determine the nucleation time and the crystal 
growth time for each sample. Since nucleation is a stochastic process, each experiment was 
repeated multiple times (between 2 and 6, depending on the additive). The average values 
were then calculated and are presented in Table 6.1.  
In pure solution, the average induction time was measured to be 26 minutes. It was found that 
upon addition of 2500 ppm of glycine, the nucleation time was reduced to approximately  
22 minutes. However, when the level of the additive was increased to 10000 ppm, the effect 
of glycine on the nucleation rate was found to be negligible. At 2500 ppm of L-phenylalanine 
and both levels of L-alanine, the effect of the additive on the nucleation process was 
negligible or slightly hindering. A significant retardation of the nucleation process was only 
noted when the concentration of L-phenylalanine was increased to 10000 ppm. In the latter 
case, the average nucleation time was increased to 32 minutes.   
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Table 6.1 Average values of the nucleation and crystal growth time during crystallisation of L-glutamic acid in 
the acoustic levitator in the presence of additives. The estimated error is the standard deviation of the average.   
Additive Additive level (ppm) 
Average nucleation 
time (min) 
Average crystal 
growth time (min) 
Pure L-glutamic acid – 25 ± 3 7 ± 2 
Glycine 2500 22 ± 1 7 ± 1 
Glycine 10000 26 ± 2 7 ± 2 
L-Alanine 2500 26 ± 2 8 ± 1 
L-Alanine 10000 27 ± 2 9 ± 1 
L-Phenylalanine 2500 26 ± 2 10 ± 1 
L-Phenylalanine 10000 32 ± 3 5 ± 1 
    
 
The average crystal growth time in pure solution was determined to be approximately  
7 minutes and did not change significantly upon addition of 2500 ppm or 10000 ppm of 
glycine. L-alanine appeared to slow down the growth process and the effect was found to 
become more pronounced as the concentration of the additive was increased; the average 
crystal growth time was found to be 8 and 9 minutes at low and high level of L-alanine, 
respectively. It was determined that in the presence of 2500 ppm of L-phenylalanine the 
crystal growth was hampered even further and stopped, on average, 10 minutes after the 
nucleation of L-glutamic acid was noted. However, the crystal growth time recorded at  
10000 ppm of L-phenylalanine was measured to be only 5 minutes.  
6.4.2 Discussion  
The presence of the additive was observed to markedly affect the nucleation rate of  
L-glutamic acid from a droplet only at 2500 ppm of glycine, where acceleration of the 
nucleation process was noted, and at 10000 ppm of L-phenylalanine, where hindering effect 
of the additive was observed. Interestingly, in the batch crystallisation both low level of 
glycine and high concentration of L-phenylalanine were found to affect the process in the 
same direction, markedly stimulating and retarding the nucleation of L-glutamic acid, 
respectively. Despite the obvious differences between the two systems, it is plausible to 
suggest that the mechanism of action of the additives and their effect on L-glutamic acid 
molecules in the solution phase could be similar. If that indeed was the case, low levels of 
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glycine would increase the nucleation rate by promoting formation of the β polymorph  
(c.f. Chapter 4). On the other hand, the increased nucleation time in the presence of high 
levels of L-phenylalanine would result from the additive molecules incorporating into the 
structure of the pre-nuclear clusters and consequently disrupting the formation of a stable 
nucleus.  
The other investigated doping materials were, however, found to affect the nucleation rate 
only insignificantly. Therefore, the question that arises is why, in contrast to the batch 
crystallisation process, do high levels of glycine, the presence of L-alanine and low 
concentrations of L-phenylalanine not have a pronounced effect on the nucleation time of  
L-glutamic acid during crystallisation from a droplet? The answer requires consideration of 
solution concentration at the point when the nucleation process begins. Since crystallisation 
from a levitated droplet is essentially containerless, the number of external factors that could 
potentially affect the nucleation barrier and hence trigger the nucleation events is limited.  
On the other hand, in a batch crystalliser, the nucleation barrier is lowered by the interaction 
of the agitated solution with the vessel walls and the stirrer. As a result, when crystals begin 
to form, the concentration of solution in a droplet is several times higher than can be achieved 
in a conventional batch crystalliser. The nucleation process in the former system is thus 
almost entirely dominated by the drive towards the thermodynamic equilibrium and its 
behaviour approaches that of the pure system. Consequently, although the nucleation rate 
promoting/hindering effect in a droplet is likely to operate to some extent for all of the 
investigated additives, it is evident in the experimental data only for the conditions where the 
corresponding effect in the batch system would be most pronounced.  
The overall effect of additives on L-glutamic acid crystallising from a droplet appears to be 
similar to that in the bulk also when the growth rate of the already nucleated crystals is 
concerned. In batch crystallisation, both L-alanine and L-phenylalanine were reported to 
hinder the crystal growth of β-L-glutamic acid (Sano et al., 1997, Kitamura and Ishizu, 1998). 
The growth retardation is considered to be due to the steric hindrance of the side groups of 
the additives that adsorb on the crystal faces. As suggested by Sano et al. (1997), the strength 
of the inhibition depends on the multiplication of the two factors that affect the surface 
diffusion of the growth units: (i) the similarity in the hydrogen bond formation and (ii) the 
bulk of the side group that hinders the next molecule to be adsorbed. It was indeed observed 
that both L-alanine and L-phenylalanine slow down the growth of the β-L-glutamic acid 
polymorph that precipitates out in a droplet. As expected, for the same doping level of  
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2500 ppm, L-phenylalanine, containing a bulky phenyl side chain, was observed to have  
a more pronounced hindering influence on the growth rate than L-alanine, whose molecules 
are relatively small. Moreover, it was found that the effect increases with increasing 
concentration of L-alanine. Interestingly, in the presence of 10000 ppm of L-phenylalanine, 
where the growth rate was expected to be also dependent on concentration and thus markedly 
reduced when compared to the pure solution, the crystallisation process was observed to 
cease much earlier than for the other solutions. However, one should bear in mind that the 
levitated droplet is an open system where the amount of solvent decreases with time due to 
evaporation. On average, at 10000 ppm of L-phenylalanine, the nucleation process did not 
begin until the 32
nd
 minute of the experiment thus leading to a much higher supersaturation at 
the point of nucleation when compared to the other solutions. Additionally, as was observed 
by monitoring of the size of the droplet (Section 6.1.3), after approximately 36 minutes, 
hardly any water is still present in the experimental sample. Consequently, the growth driving 
force in this region, caused by high solution supersaturation and decreasing amount of 
solvent, would overbalance any, even a very prominent, effect of the additive and lead to 
complete precipitation of L-glutamic acid earlier than otherwise expected. Lastly, despite its 
potential incorporation into the crystal structure, especially at higher additive levels, the 
disrupting effect of glycine on the overall growth rate remains negligible, be it at 2500 ppm 
or 10000 ppm. It can thus be concluded that the experimental observations are in good 
agreement with the proposed hypothesis. The mechanism of the additives action that is 
believed to be present in batch crystallisation is therefore also likely to be in operation during 
crystallisation from a droplet using an acoustic levitator.  
6.5 Conclusions  
Crystallisation of L-glutamic acid from a droplet of supersaturated solution suspended in  
an acoustic field was investigated using simultaneous in-situ WAXS, Raman spectroscopy 
and droplet size monitoring techniques. It was observed that, unlike in a typical batch 
crystalliser, the more stable β is the first and only polymorph that nucleates from the droplet. 
Despite the inherent complexity of the problem, we made an attempt to provide a qualitative 
rationale explaining why the Ostwald’s rule of stages is not followed and why the nucleation 
process does not lead to the initial formation of the metastable polymorph. Bearing in mind 
that the nucleation process is most likely to take place at the air-droplet interface, we argue 
that the freedom of movement of molecules in the prenucleation stage in a droplet is greater 
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than in the bulk. Accordingly, during containerless crystallisation, the probability of  
L-glutamic acid locally adopting a conformation similar to that of the β form is increased. We 
suggest that the resulting reduction in the nucleation barrier for the β phase would be enough 
to lead to the direct formation of only the more stable polymorph.  
Additionally, in order to probe the effect of additives on the crystallisation from a droplet, 
further experiments were performed in the presence of glycine, L-alanine and L-phenylalanine 
at two doping levels, 2500 ppm and 10000 ppm. It was showed that the rates of both 
nucleation and crystal growth can be manipulated using selectively chosen amino acid 
additives. Since similar result has also been observed during batch crystallisation of  
L-glutamic acid, it was suggested that the mechanism responsible for the observed effect is of 
similar nature, i.e. the additive molecules adsorb on the crystal faces and are subsequently 
incorporation into the growing crystal structure. However, because the driving force for 
crystallisation in a droplet is markedly greater than during the batch process, the effect of the 
additives in the former case is much less pronounced.  
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Chapter 7  
Conclusions  
In the first part of this work, batch crystallisation of L-glutamic acid was investigated.  
 Using single-photon laser light scattering and concentration monitoring techniques, it 
was observed that both nucleation and polymorphic transformation rates were 
enhanced in the presence of glycine additive. It was the first time when it was 
demonstrated that the crystallisation rates of one amino acid can be promoted using 
another amino acid as an additive.  
 The nucleation-promoting effect was found to be concentration dependent and 
increase up to 5000 ppm of glycine. The critical nucleus radius was estimated to 
decrease with increasing concentration of the additive. The latter implies that glycine 
molecules promote formation of L-glutamic acid crystals by lowering the activation 
energy barrier. On the other hand, hampering of the nucleation process was observed 
at 7500 ppm. It was suggested that at the highest investigated doping level the 
molecules of glycine may become incorporated into some of the growing nuclei, 
rendering them thermodynamically unstable, increasing the activation energy barrier 
and consequently inhibiting the nucleation process.  
 Scanning Electron Microscopy of the crystalline samples collected at the beginning of 
the crystallisation process showed that although in both pure and glycine-doped 
samples the α form crystals were dominant, an appreciably larger number and average 
size of β was present in the sample crystallised in the presence of the additive.  
 Wide Angle X-ray Scattering measurements were carried out to quantify the observed 
polymorphic transformation enhancing effect. Time-resolved diffraction patterns were 
used to derive mole fraction evolutions of the two polymorphs of L-glutamic acid and 
their respective rates. Consequently, the evolution of the growth and dissolution of 
each polymorph could be monitored.  
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 A noticeable increase in the number of primarily nucleated β crystals was observed 
during crystallisation from solution doped with glycine. Furthermore, it was found 
that the growth rates of both α and β polymorphs were promoted in the presence of 
the additive. The crystallisation promoting effect of glycine was found to increase 
with increasing concentration of the doping material.  
 Due to an increased amount of homogeneously nucleated β in the presence of glycine, 
the dissolution rate of the metastable α crystals was promoted leading to increased 
formation of secondary β. Consequently, a significant increase in the polymorphic 
transformation rate was observed. The former also results in the slope of the plateau 
on the concentration evolution curve becoming more negative as the level of glycine 
is increased.  
 An improved method for determination of the polymorphic transformation time from 
the concentration evolution curves was proposed since the obtained data showed that 
the generally accepted criterion is not reliable.  
 In general, this work demonstrated that even a relatively small amount of the additive 
can perturb the initial series of nucleation events and ultimately have a significant 
effect on the subsequent polymorphic transformation and thus on the crystallisation 
process as a whole.  
The second part of this thesis considered, for the first time, crystallisation of L-glutamic acid 
from a droplet of supersaturated solution suspended in an acoustic field.  
 Containerless nucleation and growth were investigated using in-situ time-resolved 
WAXS, Raman spectroscopy and droplet size monitoring techniques. It was found 
that, contrary to the Ostwald’s rule of stages, the more stable β was the first and only 
polymorph that forms during crystallisation from a levitated droplet. The metastable 
polymorph did not nucleate even in the presence of the additives that were reported to 
stabilise the α form.  
 It was postulated that the freedom of movement of molecules on the surface of  
a droplet, where the nucleation process takes place, is greater than in the bulk 
solution. Accordingly, the nucleation barrier for the β phase is lowered resulting in the 
direct formation of only the more thermodynamically stable polymorph.  
 It was observed that the onset of crystallisation in a levitated droplet occurs at 
supersaturations which are an order of magnitude higher than those that can be 
achieved in a conventional crystalliser. The latter implies that it is the homogeneous 
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component that plays the key role in the nucleation process during containerless 
crystallisation, whereas crystallisation in a closed container is predominantly  
a heterogeneous process.  
 Further experiments revealed that the rates of both nucleation and growth can, to 
some extent, be manipulated using other amino acids as additives. It was postulated 
that the observed effect is due to adsorption of the additive molecules on the growing 
crystal faces. However, since the driving force for crystallisation in a droplet is 
greater than during the batch process, the magnitude of the observed effect in the 
former case is much less pronounced.  
 The presented results indicate that factors such as microscopic thermodynamic 
pathways and kinetics of the building up supersaturation in a levitated droplet, 
including its interfacial interaction with air, are quite distinctive from those in  
a crystallisation cell or a batch crystalliser. 
 This entirely new effect demonstrates that different experimental techniques and 
strategies may provide not only a new mode of polymorph selection but also open 
many fundamental questions on how nature finds intriguing ways to help 
crystallisation of a stable polymorph.  
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Chapter 8  
Further work  
The results and their critical consideration presented in this work have not only markedly 
advanced the knowledge in the area of nucleation and crystal growth of the polymorphic 
materials but also opened new research avenues for more comprehensive appreciation of the 
overall complexity of the crystallisation process. Although a considerable effort was made to 
find a rationale for these new phenomena, several puzzling questions still remain. The 
following chapter outlines the experimental strategies that, in our opinion, should be adopted 
in order to shed more light on the molecular mechanisms of the underlying processes and 
answer (i) why under certain conditions primary nucleation of the stable β form of  
L-glutamic acid is promoted and (ii) why crystallisation of the latter from a droplet 
suspended in an acoustic field does not follow the Ostwald’s rule of stages.  
8.1 Investigation of the mechanism leading to the enhanced primary 
nucleation of β-L-glutamic acid in the presence of glycine additive  
The results from the WAXS experiment provided valuable qualitative insight into the nature 
of the α to β transformation-promoting effect and showed that it is the enhanced nucleation of 
primary β that is primarily responsible for the observed increase in the polymorphic 
transformation rate. However, the exact mechanism leading to the increased nucleation of the 
more stable form of L-glutamic acid remains an open question. To tackle this problem, two 
different approaches can be taken: (i) neutron diffraction studies of L-glutamic acid solution 
with and without glycine additive and (ii) molecular modelling of the respective solutions.  
Previous studies on two-component solutions (McLain et al., 2006, Burton et al., 2008, 
Burton et al., 2009, Burton et al., 2010) showed that neutron scattering experiments with 
isotope substitution and empirical potential structure refinement (EPSR) can provide detailed 
atomistic level data on the structure of saturated and supersaturated solutions. Most notably, 
these techniques have also been used to extract structural information for a three component 
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system, L-glutamic acid dissolved in a two molar sodium hydroxide solution (Soper, 1996). 
The above approach demonstrated a significant role of the nature of the solvent-solute 
interactions in determining the viability of the nucleation clusters and hence the structural 
crystallisation outcome.  
In the aforementioned work, however, the investigated materials were highly soluble in the 
respective solvents and consequently the experimental solution contained more solute than 
solvent molecules. On the other hand, solubility of amino acids in water, including  
L-glutamic acid, is much lower and therefore the resulting solution would be too dilute for 
any diffraction method to directly probe the local solvation of these species. Nonetheless, the 
neutron diffraction experiment, a technique that is the accepted standard for production of the 
most accurate models of water structure (Soper, 2007), would provide detailed insights into 
the time-averaged environment of solvent and solute molecules in pure and glycine-doped 
solutions of L-glutamic acid and, hence, shed some light on understanding of the molecular 
aggregating events leading to the direct formation of the stable β polymorph and their nature 
at the initial, most critical, stage which defines the overall time-dependent crystallisation 
evolution of the system.  
Experimental investigation of crystallisation kinetics in molecular systems is a challenging 
task since the formation of crystal nuclei in a supersaturated solution is a rare event but, when 
it happens, the process is typically very fast. On the other hand, a detailed investigation of 
short time processes can, in general, be performed using molecular dynamics (MD) 
modelling. Conventional MD simulations cannot, however, be used to study crystal 
nucleation under realistic conditions. Crystallisation in a molecular system may take minutes 
or hours. In a simulation, the situation would be worse because the volume that can be 
studied is several orders of magnitude smaller, and the probability of crystal formation is 
decreased by the same amount. Moreover, the computational cost of molecular dynamics 
simulations that cover more than 10
−8
 s becomes prohibitive (tenWolde and Frenkel, 1997).  
One way to circumvent this problem is to simulate a system at a much higher supersaturation, 
where the free energy barrier for the crystal nuclei formation is sufficiently low to allow the 
system to crystallise spontaneously on a time scale that is accessible to MD simulation. 
However, Auer and Frenkel (2005) point out that at such extreme supersaturations 
crystallisation may proceed differently than at moderate levels, i.e. many crystal nuclei may 
form simultaneously and may interact in an early stage of their development. Instead, in order 
to study crystal nucleation at moderate superasaturations, Auer and Frenkel (2004) suggest 
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using a combination of numerical techniques, including umbrella sampling and a local bond-
order analysis for the identification of crystal nuclei, to compute the shape and the height of 
the nucleation barrier and to study the structure of critical nuclei.  
While molecular dynamics simulations can provide atomistic-level information on the 
structure and dynamics of the forming nucleus, one should also be aware of several 
limitations of this approach. Firstly, the computational techniques use a set of parameters 
defining equilibrium bond lengths, bond and torsional angles, partial charge values, force 
constants and van der Waals parameters, collectively known as force fields. Although  
an extensive effort is made to adjust these parameters to accurately represent specific aspects 
of a physical system, the relatively complex systems, such as solutions of amino acids, 
remain notoriously difficult to estimate (Oostenbrink et al., 2004). Secondly, the commonly 
used models assume the nucleation process to be homogeneous and steady-state, while, in the 
real world, crystallisation is usually initiated by heterogeneous nucleation.  
8.2 Molecular dynamics modelling to determine the order parameters 
leading to selective nucleation of β-L-glutamic acid in a levitated 
droplet  
Since the phenomena occurring at the surface of a crystallising droplet of L-glutamic acid are 
very rapid and of atomic scale, probing the nucleation events using the experimental 
techniques available at present is virtually impossible. For that reason, in order to try to 
answer why β is the only polymorph that nucleates in a levitated droplet, one should, in our 
opinion, tackle the problem by employing molecular dynamics (MD) simulations. The goal of 
the modelling approach would be to describe the sequence of events preceding the formation 
of critical nuclei using two parameters: (i) positional order parameter (density) and  
(ii) orientational order parameter. The questions that additionally arise are: ‘How are these 
parameters coupled, are they acting simultaneously, and which one is more important?’  
However, modelling of the nucleation process remains a very difficult task. In addition to  
a number of apparent challenges arising during simulation of the formation of crystals in the 
bulk solution, discussed in Section 8.1, modelling of a levitated droplet requires consideration 
of significantly more complex conditions for which the order parameters are to be estimated: 
(i) the levitated droplet is a thermodynamically open system where water molecules are 
released from the surface into the surroundings, (ii) a radial gradient of concentration is 
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present inside the droplet, (iii) the nucleation process occurs at the surface and (iv) due to 
constant solvent evaporation, the composition at the surface of the droplet is changing with 
time. Furthermore, as revealed by Kawasaki and Tanaka (2010), the existence of additional 
transient medium-ranged structural order states that help crystallisation beyond the simplified 
model should not be ruled out.  
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